choline has been researched along with Prostatic Neoplasms in 635 studies
Prostatic Neoplasms: Tumors or cancer of the PROSTATE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We present a case of carotid glomus paraganglioma incidentally detected using 18F-choline PET/CT in a 63-year-old man with prostate cancer." | 8.12 | An Incidental Uptake of 18F-Choline in Paraganglioma. ( Bonatto, E; Castellani, M; Castello, A; Florimonte, L; Zuccotti, G, 2022) |
| " In addition to prostate cancer recurrence, F-choline allowed partial initial staging of an incidental diffuse large B-cell lymphoma which was further confirmed and staged using F-FDG and a biopsy." | 7.88 | 18F-Choline and 18F-FDG PET/CT in a Patient With Diffuse Large B-Cell Lymphoma and Recurrent Prostate Cancer. ( De Leiris, N; Djaileb, L; Leenhardt, J; Riou, L; Vuillez, JP, 2018) |
| "We report the incidental finding of a pituitary macroadenoma on an F-choline PET/CT in a patient with recurrent prostate cancer." | 7.83 | Pituitary Non-Functioning Adenoma Disclosed at 18F-Choline PET/CT to Investigate a Prostate Cancer Relapse. ( Colletti, PM; Maffione, AM; Mandoliti, G; Pasini, F; Rubello, D, 2016) |
| "A 62-year-old patient with prostate adenocarcinoma underwent PET with radiolabeled choline (18F-Fcholine) for pretreatment staging of a high-risk prostate cancer." | 7.81 | Anthracosis mimicking mediastinal lymph node metastases with 18F-FCholine in high-risk prostate cancer. ( De Clermont, H; Fernandez, P; Parrens, M; Pasticier, G; Pinaquy, JB, 2015) |
| " The purpose was to determine what proportion of a well-defined cohort of hormone-naïve patients who were candidates for early salvage radiotherapy had (18)F-choline PET/CT findings suggesting metastases." | 7.81 | (18)F-choline PET/CT for early detection of metastases in biochemical recurrence following radical prostatectomy. ( Ahlgren, G; Almquist, H; Bratt, O; Kjölhede, H; Liedberg, F; Lyttkens, K; Ohlsson, T, 2015) |
| "We report the results of whole body 18F-fluorocholine (FCH) PET/CT in a single patient with biochemical suspicion of prostate adenocarcinoma relapse and recent history of minor head injury." | 7.80 | Intense 18F-choline uptake after minor head injury: misleading PET/CT result in a patient with biochemical relapse of prostate adenocarcinoma. ( Imperiale, A; Leyendecker, P; Matern, JF; Namer, IJ; Noël, G, 2014) |
| "Nodular fasciitis is a rapidly growing benign soft tissue neoplasm that is typically self-limiting." | 5.91 | Nodular Fasciitis: False Positive on 18F-Piflufolastat and 11C-Choline PET/CT. ( Broski, SM; Pitot, MA; Powell, GM; Thompson, SM; Woodrum, DA, 2023) |
| "An 80-year-old man with a history of prostate cancer, treated with radical prostatectomy and bilateral obturator nodal dissection, underwent an 18F-choline PET/CT because of biochemical recurrence." | 5.72 | Incidental Finding of Testicular Seminoma by 18F-Choline PET/CT in a Prostate Cancer Patient. ( Bertagna, F; Bosio, G; Calabrò, A; Drera, E; Giubbini, R, 2022) |
| "A 76-year-old man, who experienced prostate cancer biochemical relapse after 12 years from radical prostatectomy, underwent abdominal CT scan for restaging purposes, negative for metastases, and then C-choline PET/CT." | 5.56 | Incidental Finding on 11C-Choline-PET/CT of Hepatocellular Carcinoma Recurrence in a Prostate Cancer Patient With Negative Abdominal CT Scan. ( Boero, M; Guglielmo, P; Pisu, N; Pung, BLJ; Sanna, S, 2020) |
| "A 73-year-old man with a prostate cancer treated by radical prostatectomy in 2006." | 5.51 | Pleural Mesothelioma Detects by 18F-Choline PET/CT in a Patient With Biochemical Recurrence of Prostate Cancer. ( Di Gregorio, F; Evangelista, L; Ferretti, G; Rensi, M, 2019) |
| "Here we present the case of a meningeal inflammatory pseudotumor evidenced by F-FCH." | 5.51 | 18F-Fluorocholine Uptake by a Head and Neck Meningeal Inflammatory Pseudotumor. ( Cobelli, M; Morassi, M; Savelli, G; Stefanelli, A; Zaniboni, A, 2019) |
| "Prostate carcinoma is the most common cancer in men." | 5.46 | Parathyroid Adenoma Mimicking a Malignant Lymph Node on 18F-Choline PET-CT. ( De Gersem, R; De Maeseneer, D; De Man, K; Van den Broeck, B, 2017) |
| "A 70-year-old man with prostate cancer and increased prostate-specific antigen level of 55 ng/mL underwent staging F-fluorocholine PET/CT, which demonstrated the primary prostate tumor and a focal area corresponding to a 2-cm hypodense nodule in the left thyroid lobe." | 5.43 | Incidental Detection of Oxyphilic Papillary Thyroid Carcinoma by 18F-Fluorocholine PET/CT. ( Bruna-Muraille, C; Garbar, C; Lalire, P; Morland, D; Zalzali, M, 2016) |
| "A 74-year-old man with history of prostate cancer underwent F-choline PET/CT for restaging." | 5.42 | Incidental detection of colorectal cancer via 1(8)F-choline PET/CT in a patient with recurrent prostate cancer: usefulness of early images. ( Bagni, O; Filippi, L; Schillaci, O, 2015) |
| "Neurofibromas are benign peripheral nerve sheath tumors." | 5.42 | Incidental Neurofibroma on 18F-Fluorocholine PET/MR. ( Agrawal, K; Bomanji, J; Fraioli, F; Gavra, M; Sajjan, RS; Syed, R, 2015) |
| "Lymph node metastasis was present in 32% of resected lymph nodes (681 of 2,122), resulting in 238 positive subregions and 111 positive regions." | 5.40 | Detection of lymph node metastasis in patients with nodal prostate cancer relapse using (18)F/(11)C-choline positron emission tomography/computerized tomography. ( Drendel, V; Grosu, AL; Henne, K; Hölz, S; Jandausch, A; Jilg, CA; Krauss, T; Reske, SN; Rischke, HC; Schultze-Seemann, W; Vach, W; Weber, WA; Wieser, G, 2014) |
| "The finding was suggestive for a parathyroid adenoma on subsequent ultrasound, then finally confirmed by parathyroid scintigraphy and histopathological analysis performed after hemithyroidectomy." | 5.38 | Incidental finding of parathyroid adenoma with 11C-choline PET/CT. ( Busnardo, E; Freschi, M; Gianolli, L; Magnani, P; Mapelli, P; Messa, C; Picchio, M, 2012) |
| " Choline PET/CT (positron emission tomography/computed tomography) and magnetic resonance imaging (MRI) have been used for the evaluation of lymph node metastasis in patients with prostate cancer for the past decade." | 4.98 | Direct comparison of choline PET/CT and MRI in the diagnosis of lymph node metastases in patients with prostate cancer. ( Huang, SM; Li, YF; Lin, ZC; Yang, Y; Yin, L; Yue, JL, 2018) |
| " The fluorine-18 ((18)F)-labeled choline derivative fluorocholine (FCH) in particular has demonstrated potential utility for imaging of a variety of neoplasms, including those of the breast, prostate, liver, and brain." | 4.84 | Cancer imaging with fluorine-18-labeled choline derivatives. ( Coel, MN; DeGrado, TR; Gutman, F; Kwee, SA; Talbot, JN, 2007) |
| "We present a case of carotid glomus paraganglioma incidentally detected using 18F-choline PET/CT in a 63-year-old man with prostate cancer." | 4.12 | An Incidental Uptake of 18F-Choline in Paraganglioma. ( Bonatto, E; Castellani, M; Castello, A; Florimonte, L; Zuccotti, G, 2022) |
| "The aim of the present study was to evaluate how neoadjuvant androgen deprivation therapy (ADT) can impact 18F-choline uptake in primary prostate cancer (PC) and its metastases before radical prostatectomy (RP) or radiation therapy (RT)." | 3.91 | The effects of androgen deprivation therapy on the 18F-Chcoline uptake in prostate cancer patients undergoing neoadjuvant treatment. ( Basso, U; Evangelista, L; Guttilla, A; Zattoni, F, 2019) |
| " In addition to prostate cancer recurrence, F-choline allowed partial initial staging of an incidental diffuse large B-cell lymphoma which was further confirmed and staged using F-FDG and a biopsy." | 3.88 | 18F-Choline and 18F-FDG PET/CT in a Patient With Diffuse Large B-Cell Lymphoma and Recurrent Prostate Cancer. ( De Leiris, N; Djaileb, L; Leenhardt, J; Riou, L; Vuillez, JP, 2018) |
| "We report the incidental finding of a pituitary macroadenoma on an F-choline PET/CT in a patient with recurrent prostate cancer." | 3.83 | Pituitary Non-Functioning Adenoma Disclosed at 18F-Choline PET/CT to Investigate a Prostate Cancer Relapse. ( Colletti, PM; Maffione, AM; Mandoliti, G; Pasini, F; Rubello, D, 2016) |
| "A 62-year-old patient with prostate adenocarcinoma underwent PET with radiolabeled choline (18F-Fcholine) for pretreatment staging of a high-risk prostate cancer." | 3.81 | Anthracosis mimicking mediastinal lymph node metastases with 18F-FCholine in high-risk prostate cancer. ( De Clermont, H; Fernandez, P; Parrens, M; Pasticier, G; Pinaquy, JB, 2015) |
| "A 65-year-old patient with prostate adenocarcinoma was explored by 18F-fluorocholine (FCH) PET/CT for pretreatment staging because of a high risk of prostate cancer." | 3.81 | Unusual lymph node metastases of prostate cancer detected by 18F-fluorocholine PET/CT. ( Allard, JB; Cornelis, F; De Clermont, H; Pasticier, G; Pinaquy, JB, 2015) |
| " The purpose was to determine what proportion of a well-defined cohort of hormone-naïve patients who were candidates for early salvage radiotherapy had (18)F-choline PET/CT findings suggesting metastases." | 3.81 | (18)F-choline PET/CT for early detection of metastases in biochemical recurrence following radical prostatectomy. ( Ahlgren, G; Almquist, H; Bratt, O; Kjölhede, H; Liedberg, F; Lyttkens, K; Ohlsson, T, 2015) |
| "Furosemide administration reduced choline uptake in tumour lesions, especially significant in pelvic lymph node metastases." | 3.80 | Furosemide diminishes ¹⁸F-fluoroethylcholine uptake in prostate cancer in vivo. ( Beck, T; Grosu, AL; Jilg, CA; Meyer, PT; Rischke, HC; Schultze-Seemann, W; Vach, W; Wieser, G, 2014) |
| "We report the results of whole body 18F-fluorocholine (FCH) PET/CT in a single patient with biochemical suspicion of prostate adenocarcinoma relapse and recent history of minor head injury." | 3.80 | Intense 18F-choline uptake after minor head injury: misleading PET/CT result in a patient with biochemical relapse of prostate adenocarcinoma. ( Imperiale, A; Leyendecker, P; Matern, JF; Namer, IJ; Noël, G, 2014) |
| " Staging with (18)F-fluorocholine PET/CT ((18)F-FCH PET/CT) demonstrated lymph node metastasis." | 3.79 | Metastatic prostate cancer proven by 18F-FCH PET/CT staging scan in patient with normal PSA but high PSA doubling time. ( Cimitan, M; Fettich, J; Gubina, B; Hodolič, M; Maffione, AM; Rubello, D, 2013) |
| " The aim of this study was to determine if [(11)C]choline PET could be used to localize the carcinomatous tissue within the prostate in order to specifically target this area for example with high-precision radiation therapy." | 3.79 | Tumour volume delineation in prostate cancer assessed by [11C]choline PET/CT: validation with surgical specimens. ( Bundschuh, RA; Eiber, M; Geinitz, H; Grosu, AL; Gschwend, JE; Krause, BJ; Kübler, H; Maurer, T; Souvatzoglou, M; Treiber, U; Weirich, G; Wendl, CM; Ziegler, SI, 2013) |
| "This study was undertaken to determine respective associations between prostatic citrate or metabolic atrophy (no detectable citrate, choline, and creatine) at magnetic resonance spectroscopy (MRS) and time on hormone-deprivation therapy, serum PSA, and biopsy Gleason score." | 3.74 | Magnetic resonance spectroscopy in patients with locally confined prostate cancer: association of prostatic citrate and metabolic atrophy with time on hormone deprivation therapy, PSA level, and biopsy Gleason score. ( Kurhanewicz, J; Mueller-Lisse, UG; Swanson, MG; Vigneron, DB, 2007) |
| "To retrospectively compare sensitivity and specificity of magnetic resonance (MR) imaging, three-dimensional (3D) MR spectroscopy, combined MR imaging and 3D MR spectroscopy, and carbon 11 (11C)-choline positron emission tomography (PET)/computed tomography (CT) for intraprostatic tumor sextant localization, with histologic findings as reference standard." | 3.74 | Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT. ( Barbiroli, B; Brunocilla, E; Canini, R; Castellucci, P; Coe, M; Corti, B; Fanti, S; Farsad, M; Grigioni, WF; Kurhanewicz, J; Lodi, R; Manferrari, F; Martorana, G; Monetti, N; Salizzoni, E; Schiavina, R; Testa, C; Tonon, C, 2007) |
| "The aim of this study was to assess the accuracy and clinical impact of [(11)C]choline PET/CT for localizing occult relapse of prostate adenocarcinoma after radical prostatectomy." | 3.74 | [11C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy. ( Blumstein, NM; Glatting, G; Reske, SN, 2008) |
| "By comparing the intensity of resonances assigned to choline, creatine, lipid, and lysine, MR spectroscopy can depict prostate carcinoma with a high degree of sensitivity and specificity." | 3.72 | Pathologic characterization of human prostate tissue with proton MR spectroscopy. ( Himmelreich, U; Khadra, M; Lean, C; McCredie, S; Mountford, C; Russell, P; Swindle, P, 2003) |
| "In this study, a panel of normal human prostate cells (HPCs) and tumor cells derived from metastases were studied by (1)H NMR spectroscopy to determine whether the malignant transformation of HPCs results in the elevation of choline compounds." | 3.71 | Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells. ( Ackerstaff, E; Bhujwalla, ZM; Nelson, JB; Pflug, BR, 2001) |
| " The (choline + creatine)/ citrate values in regions of histologically confirmed benign prostatic hyperplasia (0." | 3.69 | Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging. ( Carroll, PR; Hricak, H; Kurhanewicz, J; Nelson, SJ; Parivar, F; Shinohara, K; Vigneron, DB, 1996) |
| "18F-Choline PET/CT (FCH) in prostate cancer (PCa) patients (pts) with biochemical recurrence (BCR)." | 3.30 | Comparison of 18F-PSMA-1007 and 18F-Choline PET/CT in prostate cancer patients with biochemical recurrence: a phase 3, prospective, multicenter, randomized study. ( Apostolopoulos, D; Chatzipavlidou, V; Datseris, I; Exarhos, D; Fragkiadaki, V; Klampatsas, A; Kypraios, C; Liatsikos, E; Panagiotidis, E; Papathanasiou, N; Paschali, A; Zarokosta, F, 2023) |
| "Prostate cancer is the second leading cause of cancer-related deaths in men in the United States." | 3.01 | PSMA PET imaging in the diagnosis and management of prostate cancer. ( Behr, S; Houshmand, S; Lawhn-Heath, C, 2023) |
| "Recurrence occurs in more than 50% of prostate cancer." | 2.94 | Qualitative and quantitative reproducibility of [18]fluoromethycholine PET/computed tomography in prostate cancer. ( Cheze Le Rest, C; Gallais, C; Perdrisot, R; Pinto-Leite, T; Tixier, F; Upadhaya, T, 2020) |
| "Limited pelvic nodal relapse of prostatic cancer is a paramount challenge for locoregional salvage treatments." | 2.90 | Early Toxicity of a Phase 2 Trial of Combined Salvage Radiation Therapy and Hormone Therapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer (OLIGOPELVIS GETUG P07). ( Beckendorf, V; Buthaud, X; Campion, L; Créhange, G; De Laroche, G; Denis, F; Goineau, A; Hasbini, A; Lagrange, JL; Latorzeff, I; Loos, G; Palpacuer, C; Pasquier, D; Pommier, P; Rio, E; Sargos, P; Silva, M; Supiot, S; Vaugier, L, 2019) |
| "Choline-PET/CT has a high global sensitivity while WB-DW-MRI has a high specificity, and so they are complementary techniques." | 2.84 | Whole-body diffusion-weighted magnetic resonance imaging (WB-DW-MRI) vs choline-positron emission tomography-computed tomography (choline-PET/CT) for selecting treatments in recurrent prostate cancer. ( Broseta-Torres, R; Conde-Moreno, AJ; Cozar-Santiago, MP; Ferrer-Albiach, C; Ferrer-Rebolleda, J; García-Piñón, F; Herrando-Parreño, G; Muelas-Soria, R, 2017) |
| "Localized very high-risk prostate cancer (VHR PCa) has long suffered from the inex-istence of good lymph node staging methods other than invasive surgery, as computed tomogra-phy has low sensitivity for nodal disease." | 2.82 | Accuracy of PET-choline in nodal staging of localized very high-risk prostate cancer. ( Barbé, Y; Botelho, F; Cathelineau, X; Colandrea, G; Dias, N; Macek, P; Rodriguez-Sanchez, L, 2022) |
| "Twelve prostate cancer patients (nine staging, three re-staging) were included." | 2.80 | BAY 1075553 PET-CT for Staging and Restaging Prostate Cancer Patients: Comparison with [18F] Fluorocholine PET-CT (Phase I Study). ( Beheshti, M; Dinkelborg, L; Haim, S; Kunit, T; Langsteger, W; Loidl, W; Schiller, C; Stephens, A; Zakavi, R, 2015) |
| "The pretherapeutic assessment of prostate cancer is challenging and still holds the risk of over- or undertreatment." | 2.79 | Combined PET/MRI improves diagnostic accuracy in patients with prostate cancer: a prospective diagnostic trial. ( Bechtloff, W; Danz, B; Hacker, M; Hartenbach, M; Hartenbach, S; Klemenz, B; Kraft, K; Sparwasser, C, 2014) |
| "This prospective study included 250 prostate cancer patients with PSA relapse who underwent (18)F-FCH PET/CT." | 2.78 | Impact of 18F-choline PET/CT in prostate cancer patients with biochemical recurrence: influence of androgen deprivation therapy and correlation with PSA kinetics. ( Beheshti, M; Haim, S; Kunit, T; Langsteger, W; Loidl, W; Nader, M; Steinmair, M; Waldenberger, P; Zakavi, R, 2013) |
| "Findings consistent with recurrent prostate cancer were noted on FCH PET/CT in 31/50 (62%) patients, with positive findings in 17/18 (94%), and 11/13 (85%), 2/7 (29%), and 1/12 (8%) patients with PSA >4, >2-4, >0." | 2.77 | Detection of recurrent prostate cancer with 18F-fluorocholine PET/CT in relation to PSA level at the time of imaging. ( Coel, MN; Kwee, SA; Lim, J, 2012) |
| "Twenty-six men (15 newly diagnosed with prostate cancer, 2 with recurrent prostate cancer, 6 with no evidence of prostate cancer recurrence after treatment, and 3 with no history of prostate cancer) underwent dual-phase PET consisting of initial whole-body PET starting 7 min after injection of 3." | 2.72 | Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET. ( Coel, MN; Kwee, SA; Sesterhenn, I; Wei, H; Yun, D, 2006) |
| "11C-choline PET is a feasible technique for evaluation of treatment for localized prostate cancer." | 2.71 | 11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer. ( de Jong, IJ; Elsinga, PH; Mensink, HJ; Pruim, J; Vaalburg, W, 2003) |
| "Prostate cancer is the second leading cause of death from cancer among US men." | 2.71 | In vivo uptake of [11C]choline does not correlate with cell proliferation in human prostate cancer. ( Breeuwsma, AJ; de Jong, IJ; Jongen, MM; Nijman, RJ; Pruim, J; Suurmeijer, AJ; Vaalburg, W, 2005) |
| "Imaging plays an increasing role in prostate cancer diagnosis and staging." | 2.66 | Positron emission tomography (PET) radiotracers for prostate cancer imaging. ( Choyke, PL; Lim, I; Lindenberg, L; Mena, E; Turkbey, B; Walker, SM, 2020) |
| "The management of prostate cancer has dramatically changed over the last decades, mainly due to improvement of diagnostic modalities and development of new therapeutic strategies." | 2.66 | Prostate imaging: Contribution of PET PSMA and MRI. ( Abecassis, JP; Ghazzar, N; Giraud, P; Peyromaure, M, 2020) |
| "Prostate cancer is a very heterogeneous disease, and contemporary management is focused on identification and treatment of the prognostically adverse high-risk tumors while minimizing overtreatment of indolent, low-risk tumors." | 2.61 | Multimodality Imaging of Prostate Cancer. ( Burger, IA; Ghafoor, S; Vargas, AH, 2019) |
| "Oligorecurrent prostate cancer with exclusive nodal involvement represents a common state of disease, amenable to local therapy." | 2.61 | Oligorecurrent prostate cancer limited to lymph nodes: getting our ducks in a row : Nodal oligorecurrent prostate cancer. ( Castellucci, P; Ceci, F; Di Muzio, N; Fodor, A; Hoyer, M; Incerti, E; Ingrosso, G; Jereczek-Fossa, BA; Lancia, A; Ost, P; Picchio, M, 2019) |
| "The pooled specificities for bone metastases detection using CH-PET/CT, WB-MRI, and BS were 99% (95% CI, 93-100%), 95% (95% CI, 90-97%), and 82% (95% CI, 78-85%), respectively." | 2.55 | Rationale for Modernising Imaging in Advanced Prostate Cancer. ( Collins, DJ; de Bono, J; De Keyzer, F; Fanti, S; Koh, DM; Lecouvet, FE; Padhani, AR; Petralia, G; Sala, E; Schlemmer, HP; Tombal, B; Tunariu, N; Vargas, HA, 2017) |
| "Prostate cancer is a prevalent public health problem worldwide." | 2.53 | Positron emission tomography in imaging evaluation of staging, restaging, treatment response, and prognosis in prostate cancer. ( Jadvar, H, 2016) |
| "PET/CT imaging in men with prostate cancer (PCa) is rapidly growing as clinicians are becoming aware of its possible fundamental role in the diagnostic flow chart of these patients." | 2.53 | Rapidly changing landscape of PET/CT imaging in prostate cancer. ( Fanti, S; Hofman, MS; Morigi, JJ; Murphy, D, 2016) |
| "Recurrence of prostate cancer is suspected when an increase in the prostate-specific antigen level is detected after radical treatment; the recurrence could be local relapse, distant relapse, or both." | 2.53 | 11C- or 18F-Choline PET/CT for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer. ( Castellucci, P; Ceci, F; Fanti, S; Incerti, E; Mapelli, P; Picchio, M, 2016) |
| " However, dose-response relationships between egg intake and such cancers are unclear." | 2.52 | Egg intake and cancers of the breast, ovary and prostate: a dose-response meta-analysis of prospective observational studies. ( Aune, D; Giovannucci, EL; Greenwood, DC; Keum, N; Lee, DH; Liu, H; Marchand, N; Oh, H, 2015) |
| "prostate cancer is the most frequent solid malignant tumor in Western Countries." | 2.50 | The role of positron emission tomography/computed tomography imaging with radiolabeled choline analogues in prostate cancer. ( Cózar-Olmo, JM; Gómez-Río, M; Llamas-Elvira, JM; Navarro-Pelayo Láinez, MM; Rodríguez-Fernández, A; Vázquez-Alonso, F, 2014) |
| "Choline PET/CT has shown limitations for the detection of primary prostate cancer and nodal metastatic disease, mainly due to limited sensitivity and specificity." | 2.49 | Role of choline PET/CT in guiding target volume delineation for irradiation of prostate cancer. ( Gocke, Ch; Hildebrandt, G; Krause, BJ; Kuhnt, T; Kurth, J; Schwarzenböck, SM, 2013) |
| "In patients with a high risk of distant metastases and suitable for systemic salvage therapy, a positive lesion must be obviously visualized with one of the currently available imaging techniques." | 2.49 | The dilemma of localizing disease relapse after radical treatment for prostate cancer: which is the value of the actual imaging techniques? ( Borghesi, M; Brunocilla, E; Castellucci, P; Ceci, F; Fanti, S; Gacci, M; Martorana, G; Nanni, C; Schiavina, R; Vagnoni, V, 2013) |
| "Primary prostate cancer can be detected with moderate sensitivity using PET and PET/CT using [(11)C]- and [(18)F]-labeled choline derivates--the differentiation between benign prostatic hyperplasia, prostatitis, or high-grade intraepithelial neoplasia (HGPIN) is not always possible." | 2.49 | Imaging of prostate cancer with PET/CT and radioactively labeled choline derivates. ( Krause, BJ; Souvatzoglou, M; Treiber, U, 2013) |
| "Choline is an essential nutrient that is necessary for cell membrane synthesis and phospholipid metabolism and functions as an important methyl donor." | 2.48 | The role of choline in prostate cancer. ( Awwad, HM; Geisel, J; Obeid, R, 2012) |
| "The role of imaging in prostate cancer should include diagnosis, localization, and characterization (indolent vs." | 2.47 | Prostate cancer: PET with 18F-FDG, 18F- or 11C-acetate, and 18F- or 11C-choline. ( Jadvar, H, 2011) |
| "Prostate cancer is a major health problem, and the exploration of noninvasive imaging methods that have the potential to improve specificity while maintaining high sensitivity is still critically needed." | 2.44 | Diffusion-weighted imaging with apparent diffusion coefficient mapping and spectroscopy in prostate cancer. ( Jacobs, MA; Macura, KJ; Ouwerkerk, R; Petrowski, K, 2008) |
| "When MRS and MR imaging agree on prostate cancer presence, the positive predictive value is about 80-90%." | 2.44 | Proton MR spectroscopy of the prostate. ( Mueller-Lisse, UG; Scherr, MK, 2007) |
| "The role of PET imaging in prostate cancer is gradually evolving but still remains within the experimental realm." | 2.44 | Is there a role for positron emission tomography imaging in the early evaluation of prostate cancer relapse? ( Cascini, GL; Greco, C; Tamburrini, O, 2008) |
| "Nodular fasciitis is a rapidly growing benign soft tissue neoplasm that is typically self-limiting." | 1.91 | Nodular Fasciitis: False Positive on 18F-Piflufolastat and 11C-Choline PET/CT. ( Broski, SM; Pitot, MA; Powell, GM; Thompson, SM; Woodrum, DA, 2023) |
| "18 F-choline PET/CT was performed for initial staging and displayed several intense foci uptake of sternum and thoracic vertebrae, suggestive of bone metastasis." | 1.91 | A False-Positive Bone Oligometastatic Prostate Cancer in 18 F-Choline PET/CT : Be Aware of Chronic Vascular Pitfalls. ( Kryza, D; Larrouquere, L; Mognetti, T; Moreau, A; Pretet, V, 2023) |
| "Eight prostate cancer patients scheduled for radical prostatectomy underwent multi-parametric MRI at 3 T, including 3D water-unsuppressed semi-LASER MRSI." | 1.72 | Absolute choline tissue concentration mapping for prostate cancer localization and characterization using 3D ( Heerschap, A; Tayari, N; Wright, AJ, 2022) |
| "An 80-year-old man with a history of prostate cancer, treated with radical prostatectomy and bilateral obturator nodal dissection, underwent an 18F-choline PET/CT because of biochemical recurrence." | 1.72 | Incidental Finding of Testicular Seminoma by 18F-Choline PET/CT in a Prostate Cancer Patient. ( Bertagna, F; Bosio, G; Calabrò, A; Drera, E; Giubbini, R, 2022) |
| "The confirmation of second primary cancer was obtained from the cancer registry." | 1.72 | Detection of a second primary cancer in a 18F-fluorocholine PET/CT - multicentre retrospective analysis on a group of 1345 prostate cancer patients. ( Cegla, P; Chrapko, B; Czepczyński, R; Kubiak, A; Kycler, W; Scibisz-Dziedzic, K; Wierzchoslawska, E; Witkowska, K, 2022) |
| "Vaccination against coronavirus disease 2019 (COVID-19) is currently under worldwide deployment." | 1.72 | Vaccine-Related Lymph Nodes: The Emerging Pitfalls of 18F-Fluorocholine and 68Ga-PSMA-11 PET/CT in the Era of COVID-19 Vaccination. ( Ah-Thiane, L; Ferrer, L; Fleury, V; Le Thiec, M; Maucherat, B; Rousseau, C; Rusu, D, 2022) |
| "We identified 124 consecutive prostate cancer patients from 2008 to 2018 with a solitary oligorecurrent metastatic lesion on positron emission tomography imaging who were treated with metastasis-directed therapy without androgen deprivation therapy from the Mayo Clinic C-11 choline registry." | 1.72 | Metastasis-directed Therapy Without Androgen Deprivation Therapy in Solitary Oligorecurrent Prostate Cancer. ( Ahmed, ME; Andrews, JR; Boorjian, SA; Britton, C; Joshi, VB; Karnes, RJ; Kendi, AT; Kwon, ED; Phillips, R; Sharma, V; Sood, A; Stish, B; Tollefson, MK, 2022) |
| "We identified all men with prostate cancer undergoing FCH PET/CT for initial staging followed by RALP and ePLND at Skåne University Hospital between 2015 and 2018." | 1.62 | A retrospective study assessing the accuracy of [18F]-fluorocholine PET/CT for primary staging of lymph node metastases in intermediate and high-risk prostate cancer patients undergoing robotic-assisted laparoscopic prostatectomy with extended lymph node ( Amidi, J; Anand, A; Bjartell, A; Bjöersdorff, M; Jiborn, T; Kjölhede, H; Puterman, C; Soller, W; Trägårdh, E, 2021) |
| "Biochemical recurrence of prostate cancer after radiation therapy occurs in 5 to 50% of cases depending on the radiation technique used." | 1.62 | Comparison between MRI and choline-PET trans-perineal target biopsies and saturation biopsies for detection and topography of intra-prostatic recurrence after primary radiation therapy for prostate cancer. ( Biscans, C; Chalhoub, K; Debiais-Delpech, C; Guérif, S; Ingrand, P; Raynaud, N; Vallée, M, 2021) |
| "F-choline PET/CT is a potential tool for predicting sPCa in patients with persistently increased PSA levels and previous negative biopsies, and also it could improve the performance of score risk in predicting sPCa." | 1.56 | 18F-choline PET/computed tomography and clinical parameters in the detection of significant prostate cancer in patients with increased prostate-specific antigen levels and previous negative biopsies. ( Amo-Salas, M; Fúnez Mayorga, F; García Vicente, AM; Jiménez Londoño, GA; López Guerrero, MA; Noriega Álvarez, E; Pena Pardo, FJ; Soriano Castrejón, ÁM, 2020) |
| "We report a rare case of a prostate cancer patient with incidentally detected Peyronie disease." | 1.56 | Peyronie Disease as an Example of Nononcological, Inflammatory Uptake of 18F-Fluorocholine in Patient With Prostate Cancer. ( Cegla, P; Czepczyński, R; Kubiak, A; Witkowska, K, 2020) |
| "The fluorocholine PET/CT was positive for 81% and negative for 19% of patients." | 1.56 | Diagnostic performance of imaging techniques for detecting of local recurrence after prostate brachytherapy. ( Blais, E; Cazeau, AL; De Vaugelade, C; Fontes, F; Hindié, E; Karahissarlian, V; Mariey, A; Petitpierre, F; Rigou, G; Sargos, P; Thomas, L, 2020) |
| "F-choline PET/CT was performed in 545 cases (16." | 1.56 | 10-Year Clinical Experience With 18F-Choline PET/CT: An Italian Multicenter Retrospective Assessment of 3343 Patients. ( Alongi, P; Baresic, T; Bartolomei, M; Bartolotta, TV; Borsatti, E; Brugola, E; Burei, M; Capobianco, D; Cecchin, D; Chiaravalloti, A; Chierichetti, F; Dal Moro, F; Donner, D; Evangelista, L; Farsad, M; Rambaldi, I; Ravelli, I; Rensi, M; Schillaci, O; Tredici, M; Trifirò, G; Zattoni, F, 2020) |
| "A 76-year-old man, who experienced prostate cancer biochemical relapse after 12 years from radical prostatectomy, underwent abdominal CT scan for restaging purposes, negative for metastases, and then C-choline PET/CT." | 1.56 | Incidental Finding on 11C-Choline-PET/CT of Hepatocellular Carcinoma Recurrence in a Prostate Cancer Patient With Negative Abdominal CT Scan. ( Boero, M; Guglielmo, P; Pisu, N; Pung, BLJ; Sanna, S, 2020) |
| "The response for the 8 prostate cancer-treatment courses was PMD, which correlated well with changes in serum prostatic specific antigen (PSA) (7 of 8 cases showed increased PSA)." | 1.51 | Evaluation of Treatment Response in Prostate Cancer and Renal Cell Carcinoma Patients Using 11C-choline PET/CT Findings. ( Fujiwara, M; Go, S; Hashimoto, T; Kaida, H; Kanda, T; Kanematsu, A; Kitajima, K; Nakanishi, Y; Nojima, M; Suzuki, T; Tamaki, Y; Tsurusaki, M; Yamada, Y; Yamakado, K; Yamamoto, S, 2019) |
| "Patients with prostate cancer are monitored by prostate-specific antigen (PSA) evaluation and PET [PET/computed tomography (CT)]." | 1.51 | 18F-choline positron emission tomography/computed tomography for the detection of prostate cancer relapse: assessment of maximum standardized uptake value correlation with prostate-specific antigen levels. ( Cholewiński, W; Czepczyński, R; Miechowicz, I; Ruchała, M; Siminiak, N; Wojciechowska, K, 2019) |
| "Metastases from prostate cancer are best detected at DWI or gadolinium-enhanced T1-weighted VIBE sequences." | 1.51 | Comparison of MRI Sequences in Whole-Body PET/MRI for Staging of Patients With High-Risk Prostate Cancer. ( Chan, R; Ghai, S; Metser, U; Tau, N; Veit-Haibach, P, 2019) |
| "A 73-year-old man with a prostate cancer treated by radical prostatectomy in 2006." | 1.51 | Pleural Mesothelioma Detects by 18F-Choline PET/CT in a Patient With Biochemical Recurrence of Prostate Cancer. ( Di Gregorio, F; Evangelista, L; Ferretti, G; Rensi, M, 2019) |
| "Betaine intake was inversely associated with lethal (tertile 3 vs 1, HR 0." | 1.51 | Dietary choline and betaine intakes and risk of total and lethal prostate cancer in the Atherosclerosis Risk in Communities (ARIC) Study. ( Barber, JR; Bidulescu, A; Han, P; Joshu, CE; Platz, EA; Prizment, AE; Vitolins, MZ; Zeisel, SH, 2019) |
| "Reirradiation of patients with prostate cancer who underwent previous radiation therapy is a valuable option that can be safely considered to delay the beginning of hormonal treatment." | 1.51 | Reirradiation of Locally Recurrent Prostate Cancer With Volumetric Modulated Arc Therapy. ( Clerici, E; D'Agostino, GR; Di Brina, L; Franceschini, D; Franzese, C; Iftode, C; Mancosu, P; Navarria, P; Scorsetti, M; Tozzi, A, 2019) |
| "Forty-nine consecutive prostate cancer patients diagnosed with oligometastatic recurrence on Ch-PET have been prospectively treated." | 1.51 | Outcomes after a first and/or second salvage treatment in patients with oligometastatic prostate cancer recurrence detected by (18-F) choline PET-CT. ( Ahtamon, A; Bilbao, P; Cacicedo, J; Casquero Ocio, F; Fernandez, I; Garcia-Olaverri, J; Gomez-Iturriaga, A; Llarena, R; Ortiz de Zarate, R; Ost, P; Rodeño, E, 2019) |
| "38%)." | 1.51 | Recurrent prostate cancer after radical prostatectomy: restaging performance of 18F-choline hybrid PET/MRI. ( Achard, V; De Perrot, T; Denis, A; Garibotto, V; Iselin, C; Lamanna, G; Mainta, IC; Miralbell, R; Ratib, O; Zilli, T, 2019) |
| "Here we present the case of a meningeal inflammatory pseudotumor evidenced by F-FCH." | 1.51 | 18F-Fluorocholine Uptake by a Head and Neck Meningeal Inflammatory Pseudotumor. ( Cobelli, M; Morassi, M; Savelli, G; Stefanelli, A; Zaniboni, A, 2019) |
| "In patients with high-risk prostate cancer, FCH PET and FCH PET/WBMRI depict significantly more metastatic lesions than do conventional imaging and WBMRI." | 1.48 | ( Berlin, A; Ghai, S; Halankar, J; Jhaveri, KS; Metser, U; Murphy, G; Tau, N, 2018) |
| "A 76-year-old man with metastatic prostate cancer and back pain was referred for palliative radiotherapy." | 1.48 | Prostate Cancer Lytic Bone Metastases Imaged With 18F-Fluorocholine PET/CT. ( Alabed, YZ, 2018) |
| "In patients with early recurrence of PC, F-FCH PET/CT is able to detect OMD in 40% of cases." | 1.48 | Oligometastatic recurrent prostate cancer detects by fluorine-18-choline positron emission tomography/computed tomography in patients with prostate-specific antigen levels of up to 5 ng/ml. ( Agostini, A; Basso, U; Cuppari, L; Evangelista, L; Gardi, M; Guttilla, A; Ruggera, L; Saladini, G, 2018) |
| "without SIB)." | 1.48 | Intensity-modulated radiotherapy of prostate cancer with simultaneous integrated boost after molecular imaging with 18F-choline-PET/CT : Clinical results and quality of life. ( Berneking, V; Eble, MJ; Krenkel, B; Mottaghy, FM; Pinkawa, M; Schlenter, M; Vögeli, TA, 2018) |
| "56 patients diagnosed with prostate cancer underwent 99mTc-methylendiphosphonates bone scintigraphy (99mTc-MDP-BS) and fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG-PET/CT) or fluorine-18-fluorocholine PET/CT (18F-FCH-PET/CT) within six weeks." | 1.48 | Detection of the Prostate Cancer Bone Metastases: Is It Feasible to Compare 18F-fluorocholine PET/CT, 18F-fluorodeoxyglucose PET/CT and 99mTc-methyl Diphosphonate Bone Scintigraphy? ( Cholewinski, W; Czepczynski, R; Pietrzak, AK; Wierzchoslawska, E, 2018) |
| "A 65-year-old man with prostate cancer surgically treated in June 2016 underwent F-choline PET/CT in April 2017 for a biochemical recurrence of disease." | 1.48 | Ectopic Salivary Gland in a Patient With Prostate Cancer at 18F-Choline PET/CT: An Incidental Finding. ( Cuppari, L; Evangelista, L, 2018) |
| "Twenty Japanese prostate cancer patients underwent 11C-choline and FDG PET/CT before (n=5) or after (n=15) treatment." | 1.48 | Diagnostic Performance of 11C-choline PET/CT and FDG PET/CT in Prostate Cancer. ( Fujiwara, M; Fukushima, K; Hashimoto, T; Kamikonya, N; Kanematsu, A; Kitajima, K; Kobayashi, K; Nakanishi, Y; Nojima, M; Odawara, S; Suzuki, T; Yamada, Y; Yamakado, K; Yamamoto, S, 2018) |
| "A 72-year-old man with prostate cancer (stage T3b, Gleason score 7) treated by radical prostatectomy was found to have biochemical failure (prostate-specific antigen 8." | 1.46 | Biopsy-Proven Diffuse Mediastinal Prostate Cancer Metastases Negative on 18F-Fluorocholine, Diagnosed on 68Ga-PSMA and 18F-PSMA PET/CT. ( Abikhzer, GS; Chaussé, G; Niazi, T; Probst, SM, 2017) |
| "Post-treatment 11C-Choline-PET showed metabolic complete response in 17 metastases (44,7%), partial response in 9 metastases (38%)." | 1.46 | 11C-Choline-Pet Guided Stereotactic Body Radiation Therapy for Lymph Node Metastases in Oligometastatic Prostate Cancer. ( Chiti, A; D'Agostino, GR; Di Brina, L; Franzese, C; Lopci, E; Mancosu, P; Navarria, P; Scorsetti, M; Tomatis, S, 2017) |
| "An 84-year-old man with a history of prostate cancer, treated with radiotherapy, presented with an increase in PSA levels." | 1.46 | Internal Auditory Canal Tumor as an Incidental Finding on a Choline PET/CT Scan in a Prostate Cancer Patient. ( Efthymiadou, R; Malamitsi, J; Pipikos, T; Prassopoulos, V; Vlachou, F, 2017) |
| "11C-choline-PET/CT-guided HTT is safe and effective in the treatment of LN relapses of prostate cancer in previously treated patients." | 1.46 | Toxicity and efficacy of salvage carbon 11-choline positron emission tomography/computed tomography-guided radiation therapy in patients with lymph node recurrence of prostate cancer. ( Berardi, G; Busnardo, E; Calandrino, R; Cozzarini, C; Dell'Oca, I; Di Muzio, NG; Fiorino, C; Fodor, A; Gianolli, L; Incerti, E; Kirienko, M; Mangili, P; Pasetti, M; Picchio, M, 2017) |
| "Forty-six prostate cancer patients were scanned at 3T." | 1.46 | Quantification of metabolite concentrations in benign and malignant prostate tissues using 3D proton MR spectroscopic imaging. ( Ahlström, H; Häggman, M; Ladjevardi, S; Ortiz-Nieto, F; Tolf, A; von Below, C; Wassberg, C; Weis, J, 2017) |
| "Management of recurrent prostate cancer (CaP) after radiotherapy (RT) is dependent on accurate localization of the site of recurrent disease." | 1.46 | Identification of Site-specific Recurrence Following Primary Radiation Therapy for Prostate Cancer Using C-11 Choline Positron Emission Tomography/Computed Tomography: A Nomogram for Predicting Extrapelvic Disease. ( Boorjian, SA; Choo, R; Davis, BJ; Evans, JD; Gettman, MT; Haloi, R; Harmsen, WS; Karnes, RJ; Kwon, ED; Lowe, VJ; Moreira, DM; Mynderse, LA; Nathan, MA; Olivier, KR; Park, SS; Parker, WP; Sobol, I; Tollefson, MK; Welch, TJ; Zaid, HB, 2017) |
| "Prostate carcinoma is the most common cancer in men." | 1.46 | Parathyroid Adenoma Mimicking a Malignant Lymph Node on 18F-Choline PET-CT. ( De Gersem, R; De Maeseneer, D; De Man, K; Van den Broeck, B, 2017) |
| "Patients with suspected recurrence of prostate cancer undergoing [18F]fluoromethyl choline ([18F]FCH) PET/CT were retrospectively evaluated to investigate the influence of hormonal therapy (HT) in [18F]FCH uptake." | 1.43 | Influence of hormonal therapy in prostate cancer patients undergoing [18F]fluoromethyl choline PET/CT: a retrospective study. ( Aristei, C; Bellavita, R; Buresta, T; Ferretti, F; Fravolini, ML; Mearini, L; Palumbo, B; Palumbo, I; Pelliccia, G; Radicchia, V; Scialpi, M; Sivolella, S, 2016) |
| "The early diagnosis of prostate cancer (PCa) appears to be of vital significance for the provision of appropriate treatment programs." | 1.43 | Comparison of meta-analyses among elastosonography (ES) and positron emission tomography/computed tomography (PET/CT) imaging techniques in the application of prostate cancer diagnosis. ( Duan, Z; Jiao, G; Lei, J; Ouyang, Q, 2016) |
| "Fifty-seven prostate cancer patients underwent an MR examination followed by prostatectomy." | 1.43 | Contribution of Histopathologic Tissue Composition to Quantitative MR Spectroscopy and Diffusion-weighted Imaging of the Prostate. ( Bruggink, CC; Hambrock, T; Heerschap, A; Hulsbergen-van de Kaa, CA; Kobus, T; Maas, MC; Scheenen, TW; van der Laak, JA, 2016) |
| "Choline is an important source of phospholipids and methyl groups in mammalian cells." | 1.43 | Choline-phospholipids inter-conversion is altered in elderly patients with prostate cancer. ( Awwad, HM; Aziz, R; Geisel, J; Obeid, R; Ohlmann, CH; Stoeckle, M, 2016) |
| "A new entity of patients with recurrent prostate cancer limited to a small number of active metastatic lesions is having growing interest: the oligometastatic patients." | 1.43 | [(18)F]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: preliminary results. ( Cocuzza, P; Coraggio, G; Derosa, L; Erba, PA; Fabrini, MG; Ferrazza, P; Galli, L; Greco, C; Mannelli, L; Matteucci, F; Monzani, F; Ortori, S; Panichi, M; Pasqualetti, F; Pasqualetti, G; Ricci, S; Sainato, A; Sollini, M, 2016) |
| "F-choline PET/CT was performed for suspected prostate cancer relapse in a 67-year-old man with hip pain and a rapid rise in prostate-specific antigen values (1." | 1.43 | 18F-Choline PET/CT-Positive Lytic Bone Lesions in Prostate Cancer and Accidental Myeloma Detection. ( Castellani, M; Cortelezzi, A; Florimonte, L; Longari, V; Orunesu, E, 2016) |
| "A 70-year-old man with prostate cancer and increased prostate-specific antigen level of 55 ng/mL underwent staging F-fluorocholine PET/CT, which demonstrated the primary prostate tumor and a focal area corresponding to a 2-cm hypodense nodule in the left thyroid lobe." | 1.43 | Incidental Detection of Oxyphilic Papillary Thyroid Carcinoma by 18F-Fluorocholine PET/CT. ( Bruna-Muraille, C; Garbar, C; Lalire, P; Morland, D; Zalzali, M, 2016) |
| "Choline PET-CT was positive in 38." | 1.43 | A pilot study of the utility of choline PET-CT in prostate cancer biochemical relapse following radical prostatectomy. ( Francis, RJ; Joseph, D; Leong, E; Loh, NK; McCarthy, M; Morandeau, L; Segard, T; Siew, T; Tan, H; Trevenen, M, 2016) |
| "In two cases history of a second malignancy (lung cancer and cutaneous basocellular carcinoma) was known (diagnosed 12 and 6 years after PCa, respectively)." | 1.43 | Detection of a second malignancy in prostate cancer patients by using [(18)F]Choline PET/CT: a case series. ( Boni, R; Castellucci, P; Coraggio, G; Erba, PA; Galeandro, M; Lazzeri, E; Paiar, F; Pasqualetti, F; Perri, M; Roncali, M; Sollini, M; Versari, A, 2016) |
| "FECH PET/CT showed findings of prostate cancer in 46/56 lobes (82%)." | 1.43 | ( Ahmed, HU; Almuhaideb, A; Bomanji, J; Cathcart, P; Dickson, J; Emberton, M; Freeman, A; Haroon, A; Kayani, I; Kirkham, A, 2016) |
| "Clinical management of prostate cancer increasingly aims to distinguish aggressive types that require immediate and radical treatment from indolent tumors that are candidates for watchful waiting." | 1.42 | Non-invasive estimation of prostate cancer aggressiveness using diffusion-weighted MRI and 3D proton MR spectroscopy at 3.0 T. ( Busse, H; Do, M; Franz, T; Garnov, N; Horn, LC; Kahn, T; Moche, M; Otto, J; Stolzenburg, JU; Thörmer, G, 2015) |
| "We report a case of squamous cell carcinoma of the tonsil incidentally detected by F-choline PET/CT." | 1.42 | Squamous cell carcinoma of the tonsil incidentally detected by 18F-choline PET/CT. ( Barizzi, J; Bertagna, F; Ceriani, L; Giovanella, L; Treglia, G, 2015) |
| "Two patients died of prostate cancer." | 1.42 | Salvage lymph node dissection for prostate cancer nodal recurrence detected by 11C-choline positron emission tomography/computerized tomography. ( Bergstralh, EJ; Cheville, JC; DiMonte, G; Karnes, RJ; Kwon, ED; Lowe, VJ; Murphy, CR; Mynderse, LA, 2015) |
| "Choline-PET/CT was positive in 111 of 233 patients (detection rate 47." | 1.42 | Clinical utility of (18)F-fluorocholine positron-emission tomography/computed tomography (PET/CT) in biochemical relapse of prostate cancer after radical treatment: results of a multicentre study. ( Alonso-Farto, JC; Coronado-Poggio, M; de la Jara, AC; García-Garzón, JR; García-Vicente, AM; Maldonado-Suárez, A; Rodado-Marina, S; Rodríguez-Fernández, A, 2015) |
| "multi-parametric MRI in the prostate cancer relapse." | 1.42 | (11)C-choline PET/CT and multiparametric MRI in patients with biochemical relapse of prostate cancer. ( Cozar, M; Escobar, M; Garcia, JR; Moragas, M; Romera, N; Soler, M, 2015) |
| "Brain metastases are a rare complication of prostate cancer." | 1.42 | Brain metastases in patient with prostate cancer found in 18F-choline PET/CT. ( Buraczewska, A; Dziuk, M; Gizewska, A; Stembrowicz-Nowakowska, Z; Witkowska-Patena, E, 2015) |
| "A 74-year-old man with history of prostate cancer underwent F-choline PET/CT for restaging." | 1.42 | Incidental detection of colorectal cancer via 1(8)F-choline PET/CT in a patient with recurrent prostate cancer: usefulness of early images. ( Bagni, O; Filippi, L; Schillaci, O, 2015) |
| "Choline kinase is upregulated in prostate cancer, resulting in increased (18)F-fluoromethylcholine uptake." | 1.42 | Quantification of 18F-fluorocholine kinetics in patients with prostate cancer. ( Boellaard, R; Hendrikse, NH; Hoekstra, OS; Lammertsma, AA; Oprea-Lager, DE; Schuit, RC; Schwarte, LA; van den Eertwegh, AJ; van Moorselaar, RJ; Verwer, EE; Windhorst, AD, 2015) |
| "Early F-choline images improve pelvic prostate cancer lesion clarity." | 1.42 | Optimized protocol for (18)F-choline PET/CT in patients with biochemically relapsed prostate cancer: experiences on 250 consecutive cases. ( Chondrogiannis, S; Colletti, PM; Grassetto, G; Marzola, MC; Massaro, A; Rampin, L; Rubello, D, 2015) |
| "Primary therapies for prostate cancer were 19 radical prostatectomy, 18 radiotherapy, 13 radiotherapy with hormonal treatment, 3 brachytherapy." | 1.42 | [Biochemical recurrence after curative treatment for localized prostate cancer: Performance of choline PET/CT in the assessment of local recurrence]. ( Arnoux, V; Boillot, B; Carnicelli, D; Descotes, JL; Dubreuil, J; Fiard, G; Lanchon, C; Long, JA; Poncet, D; Rambeaud, JJ; Terrier, N; Verry, C, 2015) |
| "Thirty patients with localized prostate cancer (mean age 69." | 1.42 | Usefulness of MRI-assisted metabolic volumetric parameters provided by simultaneous (18)F-fluorocholine PET/MRI for primary prostate cancer characterization. ( Cheon, GJ; Cho, JY; Chung, JK; Kang, KW; Kim, EE; Kim, YI; Kwak, C; Lee, DS; Paeng, JC, 2015) |
| "11C-choline has been used in the diagnosis and follow-up of patients with prostate cancer for years." | 1.42 | [11C-choline PET/CT in the diagnosis of prostate cancer -- Hungarian experience]. ( Berczi, C; Farkas, B; Flaskó, T; Galuska, L; Garai, I; Oszlánszki, A, 2015) |
| "Thirty patients with localized prostate cancer underwent (18)F-choline PET/CT before treatment." | 1.42 | Volumetric modulated arc therapy planning for primary prostate cancer with selective intraprostatic boost determined by 18F-choline PET/CT. ( Hirata, E; Kuang, Y; Kwee, SA; Miyazaki, K; Sato, M; Wu, L, 2015) |
| "We report a case of Hodgkin lymphoma incidentally detected on (18)F-choline PET/CT in a prostate cancer patient and show a comparison with (18)F-FDG PET/CT." | 1.42 | Incidental Detection of a Hodgkin Lymphoma on 18F-Choline PET/CT and Comparison With 18F-FDG in a Patient With Prostate Cancer. ( Colombié, M; Goineau, A; Rousseau, C; Sadot-Lebouvier, S; Supiot, S, 2015) |
| "A 65-year-old man who had prostate cancer presented with slightly progressive prostate-specific antigen values." | 1.42 | Prostate-Specific Membrane Antigen PET/CT in Splenic Sarcoidosis. ( Chang, DH; Drzezga, A; Fischer, T; Kobe, C; Maintz, D, 2015) |
| "Neurofibromas are benign peripheral nerve sheath tumors." | 1.42 | Incidental Neurofibroma on 18F-Fluorocholine PET/MR. ( Agrawal, K; Bomanji, J; Fraioli, F; Gavra, M; Sajjan, RS; Syed, R, 2015) |
| "Fifty patients radically treated for prostate cancer and presenting with rising prostate-specific antigen (PSA) levels were consecutively and prospectively enrolled." | 1.42 | 18F-Fluciclovine PET/CT for the Detection of Prostate Cancer Relapse: A Comparison to 11C-Choline PET/CT. ( Borghesi, M; Boschi, S; Brunocilla, E; Fanti, S; Martorana, G; Nanni, C; Pettinato, C; Schiavina, R; Zanoni, L, 2015) |
| "¹⁸F-choline PET/CT is a valuable and an established functional diagnostic imaging method for staging and restaging prostate cancer." | 1.42 | The nonspecific lymph node uptake of 18F-choline in patients with prostate cancer--a prospective observational study. ( Golubić, AT; Huić, D; Mutvar, A; Žuvić, M, 2015) |
| " Genito-urinary (GU) and rectal and bowel toxicity were scored by common terminology criteria for adverse events version 4 (CTCAE V." | 1.40 | 11C choline PET guided salvage radiotherapy with volumetric modulation arc therapy and hypofractionation for recurrent prostate cancer after HIFU failure: preliminary results of tolerability and acute toxicity. ( Alongi, F; Arturo, C; Ascolese, AM; Bellorofonte, C; Comito, T; Iftode, C; Liardo, RL; Lopci, E; Mancosu, P; Navarria, P; Scorsetti, M; Tomatis, S; Tozzi, A; Villa, E, 2014) |
| "[C]Choline uptake was quantified using the average and maximum standardized uptake values at 60 min (SUV60,ave and SUV60,max), the tumour-to-muscle ratios (TMR60,max) and net irreversible retention of [C]choline at steady state (Kimod-pat)." | 1.40 | Exploring the potential of [11C]choline-PET/CT as a novel imaging biomarker for predicting early treatment response in prostate cancer. ( Aboagye, EO; Al-Nahhas, A; Barwick, T; Behan, K; Challapalli, A; Contractor, K; Coombes, C; Mangar, S; O' Doherty, M; Stewart, S; Tomasi, G, 2014) |
| "The major outcome measure was disease progression at PET2." | 1.40 | Prostate-specific antigen kinetics parameters are predictive of positron emission tomography features worsening in patients with biochemical relapse after prostate cancer treatment with radical intent: Results from a longitudinal cohort study. ( Bartolini, M; Cai, T; Carini, M; Ceroti, M; Detti, B; Gacci, M; Giannì, G; Livi, L; Minervini, A; Pupi, A; Saieva, C; Siena, G; Torshizi, MF, 2014) |
| "Salvage surgery for prostate cancer is a fascinating but controversial approach." | 1.40 | First case of 18F-FACBC PET/CT-guided salvage retroperitoneal lymph node dissection for disease relapse after radical prostatectomy for prostate cancer and negative 11C-choline PET/CT: new imaging techniques may expand pioneering approaches. ( Bianchi, L; Borghesi, M; Brunocilla, E; Cevenini, M; Concetti, S; Fanti, S; Gentile, G; Martorana, G; Molinaroli, E; Nanni, C; Schiavina, R, 2014) |
| "In the initial staging of high-risk prostate cancer, metastatic nodes could be detected if there are more than 5 mm, especially those localized outside the lymphadenectomy area." | 1.40 | [Focus: Prostate cancer and PET-choline]. ( Brenot-Rossi, I, 2014) |
| "F-choline PET/CT is an important diagnostic tool in the management of patients with prostate cancer (PC)." | 1.40 | (18)F-choline PET/CT pitfalls in image interpretation: an update on 300 examined patients with prostate cancer. ( Calabria, F; Chiaravalloti, A; Schillaci, O, 2014) |
| "The reviewers assessed for local recurrence in the prostatectomy bed as well as LN and bone metastases, rating their diagnostic confidence with a 5-point scoring system for each location." | 1.40 | Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil. ( Froemming, AT; Hagen, CE; Kawashima, A; Kitajima, K; Murphy, RC; Nathan, MA; Takahashi, N, 2014) |
| "Lymph node metastasis was present in 32% of resected lymph nodes (681 of 2,122), resulting in 238 positive subregions and 111 positive regions." | 1.40 | Detection of lymph node metastasis in patients with nodal prostate cancer relapse using (18)F/(11)C-choline positron emission tomography/computerized tomography. ( Drendel, V; Grosu, AL; Henne, K; Hölz, S; Jandausch, A; Jilg, CA; Krauss, T; Reske, SN; Rischke, HC; Schultze-Seemann, W; Vach, W; Weber, WA; Wieser, G, 2014) |
| "In the present case, atypical cancer recurrence in the right distal lower leg was suspected on 18F-FEC PET/CT in a patient with a history of prostate cancer and an increased prostate-specific antigen level." | 1.40 | Unexpected diagnosis of peripheral schwannoma on 18F-fluoroethylcholine PET/CT for localization of prostate cancer recurrence and biopsy under real-time PET/ultrasound fusion guidance. ( Drescher, R; Freesmeyer, M; Winkens, T, 2014) |
| "Fifty-five patients with biopsy-proven prostate cancer or suspected recurrent prostate cancer were examined with simultaneous [18F] choline Positron emission tomography (PET)/MRI at 3 T." | 1.40 | Quantitative evaluation of bone metastases from prostate cancer with simultaneous [18F] choline PET/MRI: combined SUV and ADC analysis. ( Heusch, P; Lauenstein, TC; Lipponer, C; Nagarajah, J; Nensa, F; Pöppel, TD; Rübben, H; Schlosser, TW; Wetter, A, 2014) |
| "To evaluate, in prostate cancer (PCa) patients the potential of (11)C-choline PET/CT as a guide to helical tomotherapy (HTT) of lymph-node (LN) relapses with simultaneous integrated boost (SIB)." | 1.40 | (11)C-Choline PET/CT as a guide to radiation treatment planning of lymph-node relapses in prostate cancer patients. ( Berardi, G; Busnardo, E; Crivellaro, C; Di Muzio, N; Fiorino, C; Fodor, A; Gianolli, L; Giovacchini, G; Incerti, E; Kirienko, M; Messa, C; Picchio, M, 2014) |
| "Prostate cancer is common and may be treated immediately or managed conservatively by observation." | 1.40 | Multiparametric 3T MRI in the evaluation of intraglandular prostate cancer: correlation with histopathology. ( Bergen, N; Duchesne, G; Ferris, N; Frydenberg, M; Mills, J; Mitchell, C; Murphy, D; Pedersen, J; Styles, C, 2014) |
| "35 patients with primary prostate cancer underwent simultaneous [18F] choline PET/MRI." | 1.40 | Combined PET imaging and diffusion-weighted imaging of intermediate and high-risk primary prostate carcinomas with simultaneous [18F] choline PET/MRI. ( Bockisch, A; Forsting, M; Heusch, P; Lauenstein, TC; Nagarajah, J; Nensa, F; Pöppel, T; Schenck, M; Schlosser, TW; Wetter, A, 2014) |
| "1%), by requesting 15 frequent items of adverse events from the Common-Terminology-Criteria for Adverse Events Version 4." | 1.40 | Toxicity and quality of life after choline-PET/CT directed salvage lymph node dissection and adjuvant radiotherapy in nodal recurrent prostate cancer. ( Grosu, AL; Henne, K; Jilg, CA; Kirste, S; Leifert, A; Rischke, HC; Schlager, D; Schnell, D; Schultze-Seemann, W; Volegova-Neher, N; Wieser, G, 2014) |
| "Nine patients with prostate cancer were scanned with an endorectal coil (ERC) on a 7-T MR scanner." | 1.40 | Temporal B0 field variation effects on MRSI of the human prostate at 7 T and feasibility of correction using an internal field probe. ( Arteaga de Castro, CS; Bhogal, A; Boer, VO; Klomp, DW; Luijten, PR; Luttje, MP; van der Heide, UA; van der Velden, TA; van Vulpen, M, 2014) |
| "Recurrent prostate cancer is usually treated by combining radiotherapy and androgen deprivation therapy." | 1.39 | Influence of androgen deprivation therapy on choline PET/CT in recurrent prostate cancer. ( Breeuwsma, AJ; de Jong, IJ; Dost, RJ; Glaudemans, AW, 2013) |
| "F-18 choline PET/CT was performed in 45 patients for early staging of biopsy-proven prostate cancer." | 1.39 | Evaluation of extraprostatic disease in the staging of prostate cancer by F-18 choline PET/CT: can PSA and PSA density help in patient selection? ( Calabria, F; Chiaravalloti, A; Ragano-Caracciolo, C; Schillaci, O; Tavolozza, M, 2013) |
| " The aim of this study was to assess the biodistribution and pharmacokinetic characteristics of a novel choline-bound GNP (choline-GNP) stabilized with polyethelenimine (PEI)." | 1.39 | The biodistribution and pharmacokinetic evaluation of choline-bound gold nanoparticles in a human prostate tumor xenograft model. ( Amanie, J; Bédard, EL; Moore, RB; Pervez, N; Razzak, R; Roa, WH; Shaw, A; Yang, X; Zhou, J, 2013) |
| "On testis removal, a Leydig cell tumor of 2." | 1.39 | Incidental detection of Leydig cell tumor via fluorine-18-Choline PET/CT in a patient with recurrent prostate cancer disease. ( Borsatti, E; Cimitan, M; Colletti, PM; Hodolič, M; Maffione, AM; Rubello, D; Urso, C, 2013) |
| "11C-Choline PET was positive in 124/185 cases (65%) (in 22/61 (36%) after RP, 102/124 (82%) after EBRT)." | 1.39 | Impact of total PSA, PSA doubling time and PSA velocity on detection rates of 11C-Choline positron emission tomography in recurrent prostate cancer. ( Breeuwsma, AJ; de Jong, IJ; Dierckx, RA; Leliveld, AM; Pruim, J; Rybalov, M, 2013) |
| "The effectiveness of salvage therapy in prostate cancer is greater for low prostate specific antigen values." | 1.39 | [11C]choline positron emission tomography/computerized tomography for early detection of prostate cancer recurrence in patients with low increasing prostate specific antigen. ( Briganti, A; Garcia-Parra, R; Gianolli, L; Giovacchini, G; Mapelli, P; Messa, C; Montorsi, F; Picchio, M, 2013) |
| "We evaluated 170 prostate cancer patients, previously radically treated, that were referred for restaging with [18F]-Choline PET/CT." | 1.39 | Predictive factors of [18F]-Choline PET/CT in 170 patients with increasing PSA after primary radical treatment. ( Biti, G; Carini, M; Cassani, S; Ceroti, M; Cipressi, S; Detti, B; Franceschini, D; Gacci, M; Livi, L; Nicita, G; Pertici, M; Pupi, A; Saieva, C; Scoccianti, S; Vaggelli, L; Villari, D, 2013) |
| "Disease relapse was local in 17% of cases, distant in 66%, and combined in 17%." | 1.39 | Role of 18F-choline PET/CT in biochemically relapsed prostate cancer after radical prostatectomy: correlation with trigger PSA, PSA velocity, PSA doubling time, and metastatic distribution. ( Al-Nahhas, A; Castellucci, P; Chondrogiannis, S; Colletti, PM; Ferretti, A; Grassetto, G; Marcolongo, A; Marzola, MC; Massaro, A; Picchio, M; Rampin, L; Rubello, D, 2013) |
| "The androgen-dependent human prostate cancer cell line LNCaP was implanted subcutaneously into the left flanks of 17 SCID-mice, 12." | 1.39 | [[¹¹C]choline as a pharmacodynamic marker for docetaxel therapy. Response assessment in a LNCaP prostate cancer xenograft mouse model]. ( Krause, BJ; Nawroth, R; Sachs, D; Schuster, T; Schwaiger, M; Schwarzenböck, S; Senekowitsch-Schmidtke, R; Souvatzoglou, M; Treiber, U; Weirich, G; Wester, HJ; Ziegler, S, 2013) |
| "This is especially true for prostate cancer, a disease that is characterized by increasing DNA methylation changes with increasing grade of the cancer." | 1.38 | Progression of prostate carcinogenesis and dietary methyl donors: temporal dependence. ( Carducci, MA; Herman, JG; Shabbeer, S; Simons, BW; Williams, SA, 2012) |
| "Gold seeds cause small effects (in the order of the standard deviation) on the ratio of the metabolite's CC/Ci in the phantom study done on a 1." | 1.38 | Effect of gold marker seeds on magnetic resonance spectroscopy of the prostate. ( Buyyounouski, MK; Chen, L; Hossain, M; Ma, CM; Richardson, T; Schirmer, T, 2012) |
| "Forty-nine prostate cancer patients underwent T2w MRI and (11)C-choline PET-CT before radical prostatectomy and extended lymphadenectomy." | 1.38 | Is there an additional value of ¹¹C-choline PET-CT to T2-weighted MRI images in the localization of intraprostatic tumor nodules? ( Bormans, G; Budiharto, T; Deroose, CM; Haustermans, K; Isebaert, S; Joniau, S; Koole, M; Lerut, E; Mottaghy, F; Oyen, R; Van den Bergh, L; Van Poppel, H, 2012) |
| "Promoter methylation of two prostate cancer-associated genes, GSTP1 and RARB2, was assessed by methylation-specific PCR of bisulfite-converted cfDNA." | 1.38 | Measurement of circulating cell-free DNA in relation to 18F-fluorocholine PET/CT imaging in chemotherapy-treated advanced prostate cancer. ( Cheng, I; Kwee, S; Loo, L; Song, MA; Tiirikainen, M, 2012) |
| "This supports long-term HT in advanced prostate cancer." | 1.38 | Locally advanced prostate cancer: three-dimensional magnetic resonance spectroscopy to monitor prostate response to therapy. ( Bonomo, P; Clementi, V; D'Agostino, GR; Di Molfetta, IV; Gui, B; Mantini, G; Mattiucci, G; Valentini, AL, 2012) |
| "Patients with prostate cancer with prostate specific antigen (PSA) levels between 20 and 99 ng/mL and/or Gleason score 8-10 tumours, planned for treatment with curative intent based on routine staging with a negative or inconclusive bone scan, were further investigated with a (18)F-fluorocholine and a (18)F-fluoride PET/CT." | 1.38 | Combined 18F-fluorocholine and 18F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer. ( Ahlgren, G; Almquist, H; Bratt, O; Kjölhede, H; Liedberg, F; Lyttkens, K; Ohlsson, T, 2012) |
| "The finding was suggestive for a parathyroid adenoma on subsequent ultrasound, then finally confirmed by parathyroid scintigraphy and histopathological analysis performed after hemithyroidectomy." | 1.38 | Incidental finding of parathyroid adenoma with 11C-choline PET/CT. ( Busnardo, E; Freschi, M; Gianolli, L; Magnani, P; Mapelli, P; Messa, C; Picchio, M, 2012) |
| "IMRT dose painting for localized prostate cancer using (11)C-choline PET scans is technically feasible." | 1.38 | Intensity modulated radiation therapy dose painting for localized prostate cancer using ¹¹C-choline positron emission tomography scans. ( Anderson, NJ; Bolton, D; Chang, JH; Clouston, D; Davis, ID; Gong, SJ; Hamilton, CS; Khoo, V; Lee, ST; Lim Joon, D; Scott, AM, 2012) |
| "Twenty high-risk prostate cancer patients underwent a pelvic SPECT acquisition following a transrectal ultrasound guided injection of 99mTc-Nanocoll into the prostate." | 1.38 | Target volume definition in high-risk prostate cancer patients using sentinel node SPECT/CT and 18 F-choline PET/CT. ( Buchegger, F; Chouiter, A; Dipasquale, G; Miralbell, R; Namy, S; Ratib, O; Steiner, C; Vees, H; Velazquez, M; Zilli, T, 2012) |
| "As prostate cancer is the most prevalent form of cancer in men and constitutes the third most common cause of cancer associated deaths, early diagnosis of primary prostate cancer and accurate staging influencing the appropriate choice of therapy is crucial." | 1.38 | PET/CT and choline: diagnosis and staging. ( Farsad, M; Krause, BJ; Schwarzenböck, S, 2012) |
| "[11C]Choline-PET/CT was done within 14 days before SRT." | 1.38 | [11C]Choline-PET/CT for outcome prediction of salvage radiotherapy of local relapsing prostate carcinoma. ( Kull, T; Moritz, S; Reske, SN, 2012) |
| "So far no effect on prostate cancer specific survival has been proven by 3 randomized controlled trials (RCTs) on adjuvant radiotherapy." | 1.38 | Correlation of [11C]choline PET-CT with time to treatment and disease-specific survival in men with recurrent prostate cancer after radical prostatectomy. ( Breeuwsma, AJ; de Jong, IJ; Leliveld, AM; Pruim, J; Rybalov, M, 2012) |
| "Fourteen patients with prostate cancer underwent DWI at 1." | 1.37 | Restricted water diffusibility as measured by diffusion-weighted MR imaging and choline uptake in (11)C-choline PET/CT are correlated in pelvic lymph nodes in patients with prostate cancer. ( Beer, AJ; Eiber, M; Gaa, J; Ganter, C; Holzapfel, K; Krause, BJ; Kübler, H; Maurer, T; Souvatzoglou, M; Weirich, G; Wester, HJ, 2011) |
| "The early detection of the site of recurrence could lead to a prompt instauration of the most appropriate treatment, i." | 1.37 | Is there a role for ¹¹C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml? ( Allegri, V; Ambrosini, V; Boschi, S; Castellucci, P; Fanti, S; Fuccio, C; Martorana, G; Marzola, MC; Montini, GC; Nanni, C; Rubello, D; Santi, I; Schiavina, R, 2011) |
| "Choline metabolites were resolved by ion-exchange chromatography." | 1.37 | Human prostate cell lines from normal and tumourigenic epithelia differ in the pattern and control of choline lipid headgroups released into the medium on stimulation of protein kinase C. ( Maitland, N; Rodrigues, G; Rumsby, M; Schmitt, J; Sharrard, M; Stower, M, 2011) |
| "Eight men with prostate cancer who had (11)C-choline PET scans prior to radical prostatectomy were studied." | 1.37 | Histopathological correlation of (11)C-choline PET scans for target volume definition in radical prostate radiotherapy. ( Bolton, D; Chang, JH; Clouston, D; Davis, ID; Gong, SJ; Hamilton, CS; Joon, DL; Khoo, V; Lee, ST; Scott, AM, 2011) |
| "This study demonstrates that high-grade prostate cancer shows significantly higher Ki-67 staining and concentrations of phosphocholine (PC) and glycerophosphocholine (GPC) than does low-grade prostate cancer (2." | 1.37 | Correlation of phospholipid metabolites with prostate cancer pathologic grade, proliferative status and surgical stage - impact of tissue environment. ( Delos Santos, L; Iman, R; Keshari, KR; Kurhanewicz, J; Shinohara, K; Tabatabai, ZL; Tsachres, H; Vigneron, DB, 2011) |
| "Thirty-eight patients with prostate cancer (PCa) and thirty-three patients with benign prostate hyperplasia (BPH) were included in this study." | 1.36 | 1H-MRSI of prostate cancer: the relationship between metabolite ratio and tumor proliferation. ( Gao, ZQ; Liu, JG; Liu, ZQ; Niu, QL; Sun, ZK; Wang, B; Wang, XZ; Yuan, YX, 2010) |
| "Detection of recurrence in prostate cancer patients with biochemical failure after radical prostatectomy by [(11)C]choline PET/CT depends on the prostate-specific antigen (PSA) level." | 1.36 | Predictive factors of [(11)C]choline PET/CT in patients with biochemical failure after radical prostatectomy. ( Bettinardi, V; Coradeschi, E; Cozzarini, C; Di Muzio, N; Fazio, F; Gianolli, L; Giovacchini, G; Messa, C; Picchio, M; Rigatti, P; Scattoni, V, 2010) |
| "In 14 prostate cancer patients who had a final pathologic Gleason scores of i) (3 + 4 = 7, n = 7) and ii) (4 + 3 = 7, n = 7), the metabolite ratios (mean +/- SD) of (Cho + Cr)/Cit and (Cho + Cr)/Spm were calculated using the 2D JPRESS spectra as follows: i) (1." | 1.36 | Correlation of endorectal 2D JPRESS findings with pathological Gleason scores in prostate cancer patients. ( Gomez, AM; Margolis, DJ; McClure, T; Nagarajan, R; Raman, SS; Thomas, MA, 2010) |
| "Choline PET has the potential to determine whether a PDT-treated tumor responds to treatment within 48 h after therapy." | 1.36 | Choline PET for monitoring early tumor response to photodynamic therapy. ( Chiu, SM; Fei, B; Wang, H; Wu, C, 2010) |
| "For LN metastases greater than or equal to 5 mm in diameter, sensitivity, specificity, and positive and negative predictive values were 66%, 96%, 82%, and 92%, respectively." | 1.36 | 18F choline PET/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients. ( Beheshti, M; Broinger, G; Gruy, B; Imamovic, L; Janetschek, G; Langsteger, W; Nader, M; Stoiber, F; Vali, R; Waldenberger, P, 2010) |
| "The androgen-independent human prostate cancer cell line PC-3 was implanted subcutaneously into the flanks of 13 NMRI (nu/nu) mice." | 1.36 | [11C]Choline as pharmacodynamic marker for therapy response assessment in a prostate cancer xenograft model. ( Buck, AK; Herrmann, K; Krause, BJ; Nawroth, R; Schuster, T; Schwaiger, M; Senekowitsch-Schmidtke, R; Souvatzoglou, M; Treiber, U; Weber, AW; Weirich, G; Wester, HJ; Ziegler, SI, 2010) |
| "Sixteen prostate cancer patients were evaluated (7 for staging and 9 for restaging)." | 1.36 | Pilot comparison of F-fluorocholine and F-fluorodeoxyglucose PET/CT with conventional imaging in prostate cancer. ( Beauregard, JM; Degrado, TR; Hicks, RJ; Roselt, P; Williams, SG, 2010) |
| "Choline is an essential amino acid, which is needed for the synthesis of membrane phospholipids." | 1.36 | Colchicine must be stopped before imaging with [18F]-methylcholine PET/CT. ( Roef, MJ; van der Laken, CJ; van der Poel, H; Vogel, WV, 2010) |
| "C-11 choline PET/CT is a valuable noninvasive imaging technology in the diagnosis of PCa." | 1.35 | C-11 choline PET/CT imaging for differentiating malignant from benign prostate lesions. ( Jin, X; Li, J; Li, X; Liu, Q; Liu, S; Wang, M; Yao, S, 2008) |
| "(3)H-Choline uptake was reduced by 92-96% using HC-3 and unlabelled choline, by 63-69% using guanidine and by 20% using TEA." | 1.35 | Characterization of choline uptake in prostate cancer cells following bicalutamide and docetaxel treatment. ( Holzapfel, K; Krause, BJ; Müller, SA; Seidl, C; Senekowitsch-Schmidtke, R; Treiber, U, 2009) |
| "Relative risks of prostate cancer were estimated by conditional logistic regression." | 1.35 | One-carbon metabolism and prostate cancer risk: prospective investigation of seven circulating B vitamins and metabolites. ( Bergh, A; Hallmans, G; Hultdin, J; Johansson, M; Key, T; Midttun, O; Stattin, P; Ueland, PM; Van Guelpen, B; Vollset, SE, 2009) |
| "92 consecutive prostate cancer patients in biochemical progression following radical surgery (63) or radiation treatment (29) were studied with positron emission tomography (PET)." | 1.35 | [Usefulness of PET scans in diagnosing recurrent prostate cancer. Prostate with PSA level < 5 ng/ml]. ( Berián Polo, JM; Martínez-Monge, R; Richter, JA; Rincón Mayans, A; Rioja Zuazu, J; Rodríguez, M; Sansi, AS; Zudaire Bergera, JJ, 2009) |
| "Human PC-3 prostate cancer cells were engineered to express enhanced green fluorescent protein (EGFP) under hypoxic conditions." | 1.35 | Hypoxia regulates choline kinase expression through hypoxia-inducible factor-1 alpha signaling in a human prostate cancer model. ( Artemov, D; Bhujwalla, ZM; Glunde, K; Raman, V; Shah, T; Takagi, T; Vesuna, F; Winnard, PT, 2008) |
| "18F-choline uptake was defined as focal, multifocal or inhomogeneous." | 1.35 | The value of 18F-choline PET/CT in patients with elevated PSA-level and negative prostate needle biopsy for localisation of prostate cancer. ( Gallowitsch, HJ; Gomez-Segovia, I; Igerc, I; Kohlfürst, S; Kresnik, E; Lind, P; Matschnig, S, 2008) |
| "Although prostate cancer in TRAMP mice shares some metabolic features with that in humans, it differs with respect to choline phospholipid metabolism, which could impact upon the interpretation of results from biomarker or chemotherapy/chemoprevention studies." | 1.35 | Metabolic profiling of transgenic adenocarcinoma of mouse prostate (TRAMP) tissue by 1H-NMR analysis: evidence for unusual phospholipid metabolism. ( Edwards, RE; Farmer, PB; Gant, TW; Gescher, AJ; Greaves, P; Jones, DJ; Keun, HC; Steward, WP; Teahan, O; Teichert, F; Verschoyle, RD; Wilson, ID, 2008) |
| "Time-intensity curves were obtained for prostatic cancer and healthy PZ and CG from DCE-MRI." | 1.35 | Combined morphological, [1H]-MR spectroscopic and contrast-enhanced imaging of human prostate cancer with a 3-Tesla scanner: preliminary experience. ( Bonanno, E; Carlani, M; Finazzi Agrò, E; Mancino, S; Simonetti, G, 2008) |
| "Prevalence of prostate cancer in this selected patient population was 63." | 1.34 | Value of 11C-choline PET and PET/CT in patients with suspected prostate cancer. ( Albinger, W; Becker, HC; Dresel, S; Gildehaus, FJ; Scher, B; Scherr, M; Seitz, M; Souvatzogluou, M; Tiling, R; Wester, HJ, 2007) |
| "In all, 50 patients with prostate cancer who had had initial therapy (radical prostatectomy in 40, external beam radiation in three and interstitial brachytherapy in seven) had PET/CT using [(11)C]-choline in the presence of an increased or increasing prostate-specific antigen (PSA) level." | 1.34 | Evaluation of [11C]-choline positron-emission/computed tomography in patients with increasing prostate-specific antigen levels after primary treatment for prostate cancer. ( Blumstein, NM; Gschwend, JE; Hautmann, RE; Hohl, K; Kuefer, R; Möller, P; Mottaghy, FM; Reske, SN; Rinnab, L; Wiegel, T, 2007) |
| "A total of 17 patients with prostate cancer who had not yet received treatment for the disease underwent whole body PET following intravenous administration of 3." | 1.33 | Prostate cancer localization with 18fluorine fluorocholine positron emission tomography. ( Coel, MN; Ko, JP; Kwee, SA; Lim, J, 2005) |
| " The present study aimed to clarify the utility of 11C-choline PET for localising and evaluating cancer lesions in patients with prostate cancer by conducting a prospective comparison with magnetic resonance (MR) imaging combined with proton MR spectroscopy." | 1.33 | Prostate cancer: a comparative study of 11C-choline PET and MR imaging combined with proton MR spectroscopy. ( Endou, H; Inoue, T; Kubota, Y; Lee, J; Oka, T; Sasaki, T; Shizukuishi, K; Takahashi, N; Uemura, H; Yamaguchi, T, 2005) |
| "Delayed SUV(max) of bone metastases was significantly higher (p<0." | 1.33 | [18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients. ( Baresic, T; Borsatti, E; Bortolus, R; Canzonieri, V; Cimitan, M; Drigo, A; Garbeglio, A; Morassut, S; Trovò, MG, 2006) |
| "In 43 patients with known prostate cancer who had received positron emission tomography/computerized tomography before initial biopsy, we assessed sensitivity of positron emission tomography/computerized tomography for localization of nodules 5 mm or greater (those theoretically large enough for visualization) using radical prostatectomy histopathology as the reference standard." | 1.33 | 11C-choline positron emission tomography/computerized tomography for tumor localization of primary prostate cancer in comparison with 12-core biopsy. ( Bertaccini, A; Brunocilla, E; Canini, R; Castellucci, P; Corti, B; D'Errico Grigioni, A; Fanti, S; Farsad, M; Grigioni, WF; Manferrari, F; Martorana, G; Salizzoni, E; Schiavina, R, 2006) |
| "Prostate cancer is known for its difficulties in preoperative staging of pelvic lymph nodes by conventional imaging techniques." | 1.32 | Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET. ( de Jong, IJ; Elsinga, PH; Mensink, HJ; Pruim, J; Vaalburg, W, 2003) |
| "Dunning rat prostate cancer cells were injected into the prostate by open surgery." | 1.32 | Dynamic magnetic resonance tomography and proton magnetic resonance spectroscopy of prostate cancers in rats treated by radiotherapy. ( Fink, C; Grobholz, R; Heilmann, M; Huber, PE; Kiessling, F; Krix, M; Lichy, MP; Meding, J; Peschke, P; Schlemmer, HP, 2004) |
| "Visualization of prostate cancer with positron emission tomography (PET) using 2-[18F]-2-deoxy-D-glucose (FDG) as radiopharmaceutical is limited by the low uptake of FDG in the tumor and by radioactivity excreted into the bladder." | 1.31 | Visualization of prostate cancer with 11C-choline positron emission tomography. ( de Jong, IJ; Elsinga, PH; Mensink, HJ; Pruim, J; Vaalburg, W, 2002) |
| "The exact staging of prostate cancer is mandatory to allow selection of the appropriate primary therapy." | 1.31 | [The (11C) acetate positron emission tomography in prostatic carcinoma. New prospects in metabolic imaging]. ( Ackermann, R; Coenen, HH; Hautzel, H; Herzog, H; Krause, BJ; Müller-Gärtner, HW; Müller-Mattheis, V; Roden, W, 2002) |
| "Initial PET imaging studies in prostate cancer patients showed high uptake of FCH in advanced prostate carcinoma and detection of osseous and soft tissue metastases." | 1.31 | Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer. ( Baldwin, SW; Coleman, RE; DeGrado, TR; Orr, MD; Polascik, TJ; Price, DT; Robertson, CN; Wang, S, 2001) |
| "PET revealed FCH uptake in biopsy-proven recurrent brain tumor with little confounding uptake by normal brain tissues." | 1.31 | Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers. ( Baldwin, SW; Coleman, RE; DeGrado, TR; Friedman, HS; Liao, RP; Orr, MD; Price, DT; Reiman, R; Wang, S, 2001) |
| "PET was performed on 10 prostate cancer patients from the level of pelvis to the lower abdomen." | 1.30 | PET imaging of prostate cancer using carbon-11-choline. ( Hara, T; Kishi, H; Kosaka, N, 1998) |
| "Average SNRs of citrate in BPH and prostate cancer were 11." | 1.30 | In vivo differential diagnosis of prostate cancer and benign prostatic hyperplasia: localized proton magnetic resonance spectroscopy using external-body surface coil. ( Chung, DS; Kim, DY; Kim, JK; Kim, KB; Kim, OD; Lee, YH; Sung, NK, 1998) |
| "An estimate of the spatial extent of prostate cancer was determined by generating metabolite images in which this metabolite ratio significantly exceeded normal peripheral zone values in multiple contiguous sections." | 1.29 | Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. ( Carroll, P; Hricak, H; Kurhanewicz, J; Narayan, P; Nelson, SJ; Vigneron, DB, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.16) | 18.7374 |
| 1990's | 5 (0.79) | 18.2507 |
| 2000's | 124 (19.53) | 29.6817 |
| 2010's | 437 (68.82) | 24.3611 |
| 2020's | 68 (10.71) | 2.80 |
| Authors | Studies |
|---|---|
| Zattoni, F | 14 |
| Artioli, P | 2 |
| Burei, M | 2 |
| Chiaravalloti, A | 6 |
| Chierichetti, F | 2 |
| Donner, D | 2 |
| Panareo, S | 1 |
| Rambaldi, I | 2 |
| Schillaci, O | 13 |
| Dal Moro, F | 2 |
| Evangelista, L | 23 |
| Castello, A | 2 |
| Zuccotti, G | 1 |
| Bonatto, E | 1 |
| Florimonte, L | 2 |
| Castellani, M | 2 |
| Tayari, N | 2 |
| Wright, AJ | 3 |
| Heerschap, A | 9 |
| Albano, D | 3 |
| Volpi, G | 1 |
| Dondi, F | 2 |
| Giubbini, R | 7 |
| Bertagna, F | 8 |
| Urbano, N | 2 |
| Scimeca, M | 2 |
| Bonanno, E | 3 |
| Fan, Z | 1 |
| Ma, J | 1 |
| Pan, X | 1 |
| Zhao, L | 2 |
| Wu, Y | 1 |
| Lin, H | 1 |
| Zhao, Y | 2 |
| Jiang, H | 1 |
| Pan, T | 1 |
| Li, X | 2 |
| Wang, F | 1 |
| Wang, C | 1 |
| Calabrò, A | 1 |
| Bosio, G | 3 |
| Drera, E | 1 |
| Cegla, P | 2 |
| Scibisz-Dziedzic, K | 1 |
| Witkowska, K | 2 |
| Kubiak, A | 2 |
| Wierzchoslawska, E | 2 |
| Kycler, W | 1 |
| Chrapko, B | 1 |
| Czepczyński, R | 4 |
| Nyk, Ł | 1 |
| Kamecki, H | 1 |
| Krajewski, W | 1 |
| Małkiewicz, B | 1 |
| Szydełko, T | 1 |
| Kubis, M | 1 |
| Słojewski, M | 1 |
| Kryst, P | 1 |
| Poletajew, S | 1 |
| Malewski, W | 1 |
| Ma, W | 1 |
| Mao, J | 1 |
| Yang, J | 1 |
| Wang, T | 2 |
| Zhao, ZH | 1 |
| Ah-Thiane, L | 1 |
| Ferrer, L | 3 |
| Maucherat, B | 2 |
| Fleury, V | 2 |
| Le Thiec, M | 2 |
| Rusu, D | 3 |
| Rousseau, C | 5 |
| Langé, M | 1 |
| Magné, N | 2 |
| Zhou, K | 1 |
| Bellanger, M | 1 |
| Latorzeff, I | 2 |
| Pommier, P | 2 |
| Martin, E | 3 |
| Paumier, A | 1 |
| Béra, G | 1 |
| Supiot, S | 4 |
| Beheshti, M | 9 |
| Taimen, P | 1 |
| Kemppainen, J | 1 |
| Jambor, I | 1 |
| Müller, A | 1 |
| Loidl, W | 6 |
| Kähkönen, E | 1 |
| Käkelä, M | 1 |
| Berndt, M | 1 |
| Stephens, AW | 1 |
| Minn, H | 3 |
| Langsteger, W | 10 |
| Bjöersdorff, M | 2 |
| Puterman, C | 2 |
| Oddstig, J | 1 |
| Amidi, J | 2 |
| Zackrisson, S | 1 |
| Kjölhede, H | 5 |
| Bjartell, A | 4 |
| Wollmer, P | 1 |
| Trägårdh, E | 3 |
| Joy, A | 1 |
| Nagarajan, R | 3 |
| Saucedo, A | 1 |
| Iqbal, Z | 1 |
| Sarma, MK | 1 |
| Wilson, N | 1 |
| Felker, E | 1 |
| Reiter, RE | 1 |
| Raman, SS | 2 |
| Thomas, MA | 4 |
| Pizzuto, DA | 2 |
| Triumbari, EKA | 1 |
| Morland, D | 3 |
| Boldrini, L | 1 |
| Gatta, R | 1 |
| Treglia, G | 5 |
| Bientinesi, R | 1 |
| De Summa, M | 1 |
| De Risi, M | 1 |
| Caldarella, C | 2 |
| Scarciglia, E | 1 |
| Totaro, A | 1 |
| Annunziata, S | 2 |
| Andrews, JR | 1 |
| Ahmed, ME | 1 |
| Sharma, V | 1 |
| Britton, C | 1 |
| Stish, B | 1 |
| Phillips, R | 1 |
| Kendi, AT | 1 |
| Joshi, VB | 1 |
| Sood, A | 1 |
| Tollefson, MK | 3 |
| Boorjian, SA | 2 |
| Karnes, RJ | 9 |
| Kwon, ED | 8 |
| Dias, N | 1 |
| Colandrea, G | 1 |
| Botelho, F | 1 |
| Rodriguez-Sanchez, L | 1 |
| Barbé, Y | 1 |
| Macek, P | 1 |
| Cathelineau, X | 1 |
| Faudemer, J | 1 |
| Meriaux, E | 1 |
| Tillou, X | 1 |
| Aide, N | 2 |
| Urso, L | 1 |
| Nieri, A | 1 |
| Borgia, F | 1 |
| Malorgio, A | 1 |
| Bartolomei, M | 2 |
| Pitot, MA | 1 |
| Broski, SM | 1 |
| Thompson, SM | 1 |
| Woodrum, DA | 1 |
| Powell, GM | 1 |
| Tremblay, S | 1 |
| Alhogbani, M | 1 |
| Weickhardt, A | 1 |
| Davis, ID | 5 |
| Scott, AM | 5 |
| Hicks, RJ | 2 |
| Metser, U | 3 |
| Chua, S | 1 |
| Davda, R | 1 |
| Punwani, S | 1 |
| Payne, H | 1 |
| Tunariu, N | 2 |
| Ho, B | 2 |
| Young, S | 1 |
| Singbo, MNU | 1 |
| Bauman, G | 2 |
| Emmett, L | 3 |
| Pouliot, F | 1 |
| Houshmand, S | 1 |
| Lawhn-Heath, C | 2 |
| Behr, S | 1 |
| Panagiotidis, E | 1 |
| Fragkiadaki, V | 1 |
| Papathanasiou, N | 1 |
| Kypraios, C | 1 |
| Liatsikos, E | 1 |
| Klampatsas, A | 1 |
| Paschali, A | 1 |
| Exarhos, D | 1 |
| Zarokosta, F | 1 |
| Chatzipavlidou, V | 1 |
| Apostolopoulos, D | 1 |
| Datseris, I | 1 |
| Pretet, V | 1 |
| Moreau, A | 1 |
| Larrouquere, L | 1 |
| Mognetti, T | 1 |
| Kryza, D | 1 |
| Kitajima, K | 4 |
| Yamamoto, S | 2 |
| Nakanishi, Y | 2 |
| Yamada, Y | 2 |
| Hashimoto, T | 2 |
| Suzuki, T | 2 |
| Go, S | 1 |
| Kanematsu, A | 2 |
| Nojima, M | 2 |
| Fujiwara, M | 2 |
| Kaida, H | 1 |
| Tsurusaki, M | 1 |
| Kanda, T | 2 |
| Tamaki, Y | 1 |
| Yamakado, K | 2 |
| Ghafoor, S | 1 |
| Burger, IA | 2 |
| Vargas, AH | 1 |
| Siminiak, N | 1 |
| Wojciechowska, K | 1 |
| Miechowicz, I | 1 |
| Cholewiński, W | 2 |
| Ruchała, M | 1 |
| Witkowska-Patena, E | 3 |
| Giżewska, A | 3 |
| Dziuk, M | 3 |
| Miśko, J | 2 |
| Budzyńska, A | 1 |
| Walęcka-Mazur, A | 1 |
| Alberts, I | 1 |
| Sachpekidis, C | 1 |
| Fech, V | 1 |
| Rominger, A | 1 |
| Afshar-Oromieh, A | 3 |
| Polymeri, E | 1 |
| Sadik, M | 1 |
| Kaboteh, R | 1 |
| Borrelli, P | 1 |
| Enqvist, O | 1 |
| Ulén, J | 1 |
| Ohlsson, M | 1 |
| Poulsen, MH | 4 |
| Simonsen, JA | 1 |
| Hoilund-Carlsen, PF | 1 |
| Johnsson, ÅA | 1 |
| Edenbrandt, L | 1 |
| Pinto-Leite, T | 1 |
| Tixier, F | 1 |
| Upadhaya, T | 1 |
| Gallais, C | 1 |
| Perdrisot, R | 1 |
| Cheze Le Rest, C | 1 |
| Nguyen, BD | 2 |
| Heller, MT | 1 |
| Roarke, MC | 1 |
| Walker, SM | 1 |
| Lim, I | 1 |
| Lindenberg, L | 1 |
| Mena, E | 1 |
| Choyke, PL | 2 |
| Turkbey, B | 2 |
| D'Angelillo, RM | 3 |
| Fiore, M | 2 |
| Trodella, LE | 2 |
| Sciuto, R | 3 |
| Ippolito, E | 1 |
| Carnevale, A | 1 |
| Iurato, A | 1 |
| Miele, M | 1 |
| Trecca, P | 1 |
| Trodella, L | 3 |
| Greco, C | 3 |
| Ramella, S | 3 |
| Jiménez Londoño, GA | 2 |
| García Vicente, AM | 3 |
| Noriega Álvarez, E | 1 |
| Pena Pardo, FJ | 1 |
| Amo-Salas, M | 1 |
| López Guerrero, MA | 1 |
| Fúnez Mayorga, F | 1 |
| Soriano Castrejón, ÁM | 2 |
| Rowe, SP | 2 |
| Johnson, GB | 4 |
| Pomper, MG | 1 |
| Gorin, MA | 2 |
| Behr, SC | 2 |
| Chandrasekar, T | 1 |
| Reese, AC | 1 |
| Olivari, L | 1 |
| Riccardi, N | 1 |
| Rodari, P | 1 |
| Angheben, A | 1 |
| Salgarello, M | 2 |
| Soriano Castrejón, Á | 1 |
| Karahissarlian, V | 1 |
| Sargos, P | 2 |
| Blais, E | 1 |
| Cazeau, AL | 1 |
| Fontes, F | 1 |
| Petitpierre, F | 1 |
| Rigou, G | 2 |
| De Vaugelade, C | 1 |
| Mariey, A | 1 |
| Hindié, E | 3 |
| Thomas, L | 1 |
| Ravelli, I | 1 |
| Rensi, M | 3 |
| Capobianco, D | 1 |
| Borsatti, E | 5 |
| Baresic, T | 2 |
| Alongi, P | 3 |
| Bartolotta, TV | 2 |
| Farsad, M | 9 |
| Tredici, M | 1 |
| Trifirò, G | 1 |
| Brugola, E | 1 |
| Cecchin, D | 2 |
| Turpin, L | 1 |
| Pouliot, Q | 1 |
| Zhang, J | 1 |
| Glikman, M | 1 |
| Gomez, F | 1 |
| Talbot, JN | 7 |
| Montravers, F | 4 |
| Abecassis, JP | 1 |
| Ghazzar, N | 1 |
| Peyromaure, M | 2 |
| Giraud, P | 1 |
| Ceci, F | 15 |
| Castellucci, P | 36 |
| Polverari, G | 2 |
| Iagaru, A | 2 |
| Guglielmo, P | 1 |
| Pisu, N | 1 |
| Sanna, S | 1 |
| Pung, BLJ | 1 |
| Boero, M | 1 |
| Prandini, F | 1 |
| de Leiris, N | 3 |
| Leenhardt, J | 2 |
| Boussat, B | 1 |
| Montemagno, C | 1 |
| Seiller, A | 1 |
| Phan Sy, O | 1 |
| Roux, J | 1 |
| Laramas, M | 2 |
| Verry, C | 2 |
| Iriart, C | 1 |
| Fiard, G | 2 |
| Long, JA | 2 |
| Descotes, JL | 2 |
| Vuillez, JP | 2 |
| Riou, L | 3 |
| Djaileb, L | 3 |
| Telo, S | 1 |
| Fanti, S | 42 |
| Nanni, C | 19 |
| Lambertini, A | 1 |
| Picchio, M | 36 |
| Gianolli, L | 18 |
| Schiavina, R | 27 |
| Bianchi, L | 3 |
| Briganti, A | 13 |
| Mapelli, P | 11 |
| Farolfi, A | 2 |
| Khansa, Z | 1 |
| Neaimeh, N | 1 |
| Korek, M | 1 |
| Haidar, M | 1 |
| Bianchi, D | 1 |
| Rizzo, A | 1 |
| Bonacina, M | 1 |
| Zaniboni, A | 2 |
| Savelli, G | 2 |
| Aksoy, O | 1 |
| Pencik, J | 1 |
| Hartenbach, M | 3 |
| Moazzami, AA | 1 |
| Schlederer, M | 1 |
| Balber, T | 1 |
| Varady, A | 1 |
| Philippe, C | 1 |
| Baltzer, PA | 1 |
| Mazumder, B | 1 |
| Whitchurch, JB | 1 |
| Roberts, CJ | 1 |
| Haitel, A | 2 |
| Herac, M | 1 |
| Susani, M | 1 |
| Mitterhauser, M | 1 |
| Marculescu, R | 1 |
| Stangl-Kremser, J | 1 |
| Hassler, MR | 1 |
| Kramer, G | 2 |
| Shariat, SF | 1 |
| Turner, SD | 1 |
| Tichy, B | 1 |
| Oppelt, J | 1 |
| Pospisilova, S | 1 |
| Hartenbach, S | 2 |
| Tangermann, S | 1 |
| Egger, G | 1 |
| Neubauer, HA | 1 |
| Moriggl, R | 1 |
| Culig, Z | 1 |
| Greiner, G | 1 |
| Hoermann, G | 1 |
| Hacker, M | 4 |
| Heery, DM | 1 |
| Merkel, O | 1 |
| Kenner, L | 1 |
| Sollaku, S | 1 |
| Casciani, E | 1 |
| De Angelis, C | 1 |
| Frantellizzi, V | 1 |
| Gualdi, G | 1 |
| Ruggeri, V | 1 |
| Amrane, K | 1 |
| Le Pennec, R | 1 |
| Tissot, V | 1 |
| Schick, U | 3 |
| Abgral, R | 2 |
| Švec, P | 1 |
| Nový, Z | 1 |
| Kučka, J | 1 |
| Petřík, M | 1 |
| Sedláček, O | 1 |
| Kuchař, M | 1 |
| Lišková, B | 1 |
| Medvedíková, M | 1 |
| Kolouchová, K | 1 |
| Groborz, O | 1 |
| Loukotová, L | 1 |
| Konefał, RŁ | 1 |
| Hajdúch, M | 1 |
| Hrubý, M | 1 |
| Stefano, A | 1 |
| Comelli, A | 1 |
| Laudicella, R | 1 |
| Scalisi, S | 1 |
| Arnone, G | 1 |
| Barone, S | 1 |
| Spada, M | 1 |
| Purpura, P | 1 |
| Midiri, M | 1 |
| Lagalla, R | 1 |
| Russo, G | 1 |
| Salavati, A | 1 |
| Calais, J | 1 |
| Fendler, WP | 3 |
| Eiber, M | 11 |
| Hofman, MS | 2 |
| Hope, TA | 1 |
| Gravis, G | 1 |
| Autret, A | 1 |
| Guibert-Broudic, M | 1 |
| Dubergé, T | 1 |
| Zemmour, C | 1 |
| Carrier, P | 1 |
| Salem, N | 1 |
| Badinand, D | 1 |
| Cartier, L | 1 |
| Gross, E | 1 |
| Walz, J | 1 |
| Pignot, G | 1 |
| Brenot-Rossi, I | 3 |
| Anand, A | 1 |
| Soller, W | 1 |
| Jiborn, T | 1 |
| Giacomuzzi, F | 1 |
| Di Gregorio, F | 2 |
| Cassarino, G | 1 |
| Lauro, A | 1 |
| Morlacco, A | 1 |
| Sepulcri, M | 1 |
| Nguyen, AAL | 1 |
| Ietto, F | 1 |
| Lacognata, C | 1 |
| Zucchetta, P | 1 |
| Salah, H | 1 |
| Al-Mohammed, HI | 1 |
| Mayhoub, FH | 1 |
| Sulieman, A | 1 |
| Alkhorayef, M | 1 |
| Abolaban, FA | 1 |
| Khandaker, MU | 1 |
| Bradley, DA | 1 |
| Sörensen, J | 1 |
| Biscans, C | 1 |
| Vallée, M | 1 |
| Ingrand, P | 1 |
| Debiais-Delpech, C | 1 |
| Raynaud, N | 1 |
| Chalhoub, K | 1 |
| Guérif, S | 1 |
| Tu, SJ | 1 |
| Tran, VT | 1 |
| Teo, JM | 1 |
| Chong, WC | 1 |
| Tseng, JR | 1 |
| Mei, R | 1 |
| Zanoni, L | 5 |
| Latge, A | 1 |
| Heimburger, C | 1 |
| Severac, F | 1 |
| Meyer, N | 1 |
| Somme, F | 1 |
| Imperiale, A | 4 |
| Patra, A | 1 |
| Khasawneh, H | 1 |
| Suman, G | 1 |
| Nathan, MA | 7 |
| Packard, AT | 1 |
| Goenka, AH | 1 |
| Kanoun, S | 2 |
| Walker, P | 3 |
| Vrigneaud, JM | 1 |
| Depardon, E | 1 |
| Barbier, V | 1 |
| Humbert, O | 2 |
| Moulin, M | 1 |
| Créhange, G | 8 |
| Cormier, L | 6 |
| Loffroy, R | 1 |
| Brunotte, F | 6 |
| Cochet, A | 7 |
| Haroon, A | 2 |
| Syed, R | 2 |
| Endozo, R | 1 |
| Allie, R | 1 |
| Freeman, A | 2 |
| Emberton, M | 2 |
| Bomanji, J | 3 |
| Puche-Sanz, I | 2 |
| Triviño-Ibáñez, E | 1 |
| Vázquez-Alonso, F | 2 |
| Llamas-Elvira, JM | 3 |
| Cózar-Olmo, JM | 2 |
| Rodríguez-Fernández, A | 4 |
| Giovacchini, G | 21 |
| Giovannini, E | 4 |
| Leoncini, R | 2 |
| Riondato, M | 2 |
| Ciarmiello, A | 4 |
| Bonavina, MG | 1 |
| Bombardieri, E | 3 |
| Bouman-Wammes, EW | 1 |
| van Dodewaard-De Jong, JM | 1 |
| Dahele, M | 1 |
| Cysouw, MCF | 1 |
| Hoekstra, OS | 5 |
| van Moorselaar, RJA | 1 |
| Piet, MAH | 1 |
| Verberne, HJ | 1 |
| Bins, AD | 1 |
| Verheul, HMW | 1 |
| Slotman, BJ | 1 |
| Oprea-Lager, DE | 5 |
| Van den Eertwegh, AJM | 1 |
| Vadi, SK | 1 |
| Singh, B | 1 |
| Basher, RK | 1 |
| Watts, A | 1 |
| Sood, AK | 1 |
| Lal, A | 1 |
| Kakkar, N | 1 |
| Singh, SK | 1 |
| Herrmann, K | 9 |
| Hadaschik, B | 1 |
| Parekh, A | 1 |
| Hagan, I | 1 |
| Capaldi, L | 1 |
| Lyburn, I | 1 |
| Chaussé, G | 1 |
| Niazi, T | 1 |
| Abikhzer, GS | 1 |
| Probst, SM | 1 |
| Padhani, AR | 1 |
| Lecouvet, FE | 2 |
| Koh, DM | 1 |
| De Keyzer, F | 2 |
| Collins, DJ | 2 |
| Sala, E | 1 |
| Vargas, HA | 1 |
| Petralia, G | 1 |
| Schlemmer, HP | 3 |
| Tombal, B | 1 |
| de Bono, J | 1 |
| Lawrentschuk, N | 1 |
| Corfield, JM | 1 |
| Scott, A | 1 |
| Nehra, A | 1 |
| Parker, WP | 4 |
| Haloi, R | 3 |
| Park, SS | 3 |
| Mynderse, LA | 6 |
| Lowe, VJ | 7 |
| Davis, BJ | 5 |
| Quevedo, JF | 1 |
| Incerti, E | 10 |
| Gangemi, V | 1 |
| Deantoni, CL | 1 |
| Fallanca, F | 2 |
| Fodor, A | 6 |
| Baldari, S | 1 |
| Di Muzio, N | 7 |
| Franzese, C | 3 |
| Lopci, E | 6 |
| Di Brina, L | 3 |
| D'Agostino, GR | 4 |
| Navarria, P | 5 |
| Mancosu, P | 4 |
| Tomatis, S | 4 |
| Chiti, A | 9 |
| Scorsetti, M | 5 |
| El Kabbaj, O | 1 |
| Robin, P | 1 |
| Bourhis, D | 2 |
| Dissaux, G | 1 |
| Rosenfelder, N | 1 |
| Valeri, A | 1 |
| Fournier, G | 1 |
| Salaun, PY | 2 |
| Pradier, O | 1 |
| Malhaire, JP | 1 |
| Malamitsi, J | 1 |
| Efthymiadou, R | 1 |
| Pipikos, T | 1 |
| Vlachou, F | 1 |
| Prassopoulos, V | 1 |
| Cornelis, FH | 1 |
| Durack, JC | 1 |
| Morris, MJ | 1 |
| Scher, HI | 1 |
| Solomon, SB | 1 |
| Lorca, AM | 1 |
| Ghedini, P | 1 |
| Bossert, I | 1 |
| Graziani, T | 6 |
| Ambrosini, V | 5 |
| Massari, F | 1 |
| Nobili, E | 1 |
| Melotti, B | 1 |
| Musto, A | 1 |
| Zoboli, S | 1 |
| Antunovic, L | 2 |
| Kirienko, M | 6 |
| Mosconi, C | 1 |
| Ardizzoni, A | 2 |
| Golfieri, R | 1 |
| Li, R | 1 |
| Ravizzini, GC | 1 |
| Maurer, T | 6 |
| Cooperberg, MR | 1 |
| Alemozzaffar, M | 1 |
| Delacroix, SE | 1 |
| Chapin, BF | 1 |
| Dyrberg, E | 1 |
| Larsen, EL | 1 |
| Hendel, HW | 1 |
| Thomsen, HS | 1 |
| Berlin, A | 1 |
| Halankar, J | 1 |
| Murphy, G | 1 |
| Jhaveri, KS | 1 |
| Ghai, S | 2 |
| Tau, N | 2 |
| Ieria, FP | 1 |
| Isgrò, MA | 1 |
| Lanni, V | 1 |
| Bencivenga, G | 1 |
| Rufini, V | 1 |
| Giordano, A | 1 |
| Alabed, YZ | 1 |
| de la Riva-Pérez, PA | 1 |
| García-Gómez, FJ | 1 |
| Buján-Lloret, C | 1 |
| Calvo-Morón, MC | 1 |
| Castro-Montaño, J | 1 |
| Cuppari, L | 3 |
| Guttilla, A | 7 |
| Gardi, M | 1 |
| Agostini, A | 1 |
| Ruggera, L | 1 |
| Basso, U | 2 |
| Saladini, G | 4 |
| Mansi, L | 3 |
| Gillebert, Q | 1 |
| Huchet, V | 4 |
| Olivier, P | 1 |
| Courbon, F | 2 |
| Gontier, E | 1 |
| Nataf, V | 2 |
| Balogova, S | 4 |
| Gafita, A | 1 |
| Müller, J | 1 |
| Kranzbühler, B | 1 |
| Donati, OF | 1 |
| Eberli, D | 1 |
| Cozzarini, C | 5 |
| Palard-Novello, X | 1 |
| Blin, AL | 1 |
| Garin, E | 1 |
| Devillers, A | 1 |
| Querellou, S | 1 |
| Bourguet, P | 1 |
| Le Jeune, F | 1 |
| Saint-Jalmes, H | 1 |
| Schlenter, M | 1 |
| Berneking, V | 1 |
| Krenkel, B | 1 |
| Mottaghy, FM | 12 |
| Vögeli, TA | 1 |
| Eble, MJ | 4 |
| Pinkawa, M | 4 |
| Pietrzak, AK | 1 |
| Frood, R | 1 |
| Baren, J | 1 |
| McDermott, G | 1 |
| Bottomley, D | 1 |
| Patel, C | 1 |
| Scarsbrook, A | 1 |
| Lancia, A | 1 |
| Hoyer, M | 1 |
| Jereczek-Fossa, BA | 5 |
| Ost, P | 2 |
| Ingrosso, G | 1 |
| Cihoric, N | 1 |
| Vlaskou Badra, E | 1 |
| Tsikkinis, A | 1 |
| Prasad, V | 1 |
| Kroeze, S | 1 |
| Igrutinovic, I | 1 |
| Jeremic, B | 1 |
| Beck, M | 1 |
| Zschaeck, S | 1 |
| Wust, P | 1 |
| Ghadjar, P | 1 |
| Odawara, S | 1 |
| Kobayashi, K | 1 |
| Kamikonya, N | 1 |
| Fukushima, K | 1 |
| Linxweiler, J | 1 |
| Saar, M | 1 |
| Al-Kailani, Z | 1 |
| Janssen, M | 1 |
| Ezziddin, S | 1 |
| Stöckle, M | 1 |
| Siemer, S | 1 |
| Ohlmann, CH | 2 |
| Sathianathen, NJ | 1 |
| Butaney, M | 1 |
| Konety, BR | 1 |
| Franceschini, D | 3 |
| Dejust, S | 1 |
| Messaoud, L | 1 |
| Jallerat, P | 1 |
| Marical, V | 1 |
| Mazaheri, Y | 1 |
| Shukla-Dave, A | 4 |
| Goldman, DA | 1 |
| Moskowitz, CS | 1 |
| Takeda, T | 1 |
| Reuter, VE | 3 |
| Akin, O | 1 |
| Hricak, H | 7 |
| Guo, Y | 1 |
| Wang, L | 1 |
| Hu, J | 1 |
| Feng, D | 1 |
| Xu, L | 1 |
| Lépinoy, A | 2 |
| Silva, YE | 1 |
| Bertaut, A | 1 |
| Quivrin, M | 1 |
| Aubignac, L | 1 |
| Chan, R | 1 |
| Veit-Haibach, P | 2 |
| Samper Ots, P | 1 |
| Luis Cardo, A | 1 |
| Vallejo Ocaña, C | 1 |
| Cabeza Rodríguez, MA | 1 |
| Glaria Enríquez, LA | 1 |
| Couselo Paniagua, ML | 1 |
| Olivera Vegas, J | 1 |
| Obels, J | 1 |
| Kobus, T | 3 |
| Scheenen, TWJ | 1 |
| Borsò, E | 1 |
| Lazzeri, P | 1 |
| Duce, V | 1 |
| Conti, E | 1 |
| Ferretti, G | 1 |
| Vija Racaru, L | 1 |
| Gabiache, E | 1 |
| Fontaine, S | 1 |
| DʼAure, D | 1 |
| Mourey, L | 1 |
| Zerdoud, S | 1 |
| Gómez-de la Fuente, FJ | 1 |
| Martínez-Rodríguez, I | 2 |
| De Arcocha-Torres, M | 1 |
| Quirce, R | 2 |
| Jiménez-Bonilla, J | 2 |
| Martínez-Amador, N | 1 |
| Sánchez-Salmón, A | 1 |
| Lucas-Velázquez, B | 1 |
| Cuenca-Vera, O | 1 |
| Banzo, I | 2 |
| Barbaud, M | 1 |
| Frindel, M | 1 |
| Rauscher, A | 1 |
| Baumgartner, P | 1 |
| Colombié, M | 3 |
| Thierry-Morel, A | 1 |
| Kraeber-Bodéré, F | 2 |
| Campion, L | 3 |
| Vaugier, L | 1 |
| Palpacuer, C | 1 |
| Rio, E | 1 |
| Goineau, A | 3 |
| Pasquier, D | 1 |
| Buthaud, X | 1 |
| De Laroche, G | 2 |
| Beckendorf, V | 1 |
| Loos, G | 1 |
| Hasbini, A | 1 |
| Silva, M | 1 |
| Denis, F | 1 |
| Lagrange, JL | 1 |
| Huang, SM | 1 |
| Yin, L | 1 |
| Yue, JL | 1 |
| Li, YF | 1 |
| Yang, Y | 1 |
| Lin, ZC | 1 |
| Durmo, R | 1 |
| Trump, T | 1 |
| Luchey, AM | 1 |
| Hogg, J | 1 |
| Mattes, MD | 1 |
| Mujukian, A | 1 |
| Kay, M | 1 |
| Bonfiglio, R | 1 |
| Mapelli, SN | 1 |
| Catapano, CV | 1 |
| Carbone, GM | 1 |
| Ciuffa, S | 1 |
| Tavolozza, M | 6 |
| Mauriello, A | 1 |
| Triviño-Ibáñez, EM | 1 |
| Gómez-Río, M | 2 |
| Cózar Olmo, JM | 1 |
| Han, P | 1 |
| Bidulescu, A | 1 |
| Barber, JR | 1 |
| Zeisel, SH | 2 |
| Joshu, CE | 1 |
| Prizment, AE | 1 |
| Vitolins, MZ | 1 |
| Platz, EA | 1 |
| Iftode, C | 2 |
| Clerici, E | 1 |
| Tozzi, A | 2 |
| Lin, CY | 1 |
| Lee, MT | 1 |
| Lin, CL | 1 |
| Kao, CH | 1 |
| Gomez-Iturriaga, A | 1 |
| Casquero Ocio, F | 1 |
| Fernandez, I | 1 |
| Rodeño, E | 1 |
| Llarena, R | 1 |
| Garcia-Olaverri, J | 1 |
| Ortiz de Zarate, R | 1 |
| Cacicedo, J | 1 |
| Ahtamon, A | 1 |
| Bilbao, P | 1 |
| Zhou, J | 2 |
| Gou, Z | 1 |
| Wu, R | 1 |
| Yuan, Y | 1 |
| Yu, G | 1 |
| Achard, V | 1 |
| Lamanna, G | 2 |
| Denis, A | 1 |
| De Perrot, T | 2 |
| Mainta, IC | 1 |
| Ratib, O | 9 |
| Iselin, C | 2 |
| Miralbell, R | 12 |
| Garibotto, V | 4 |
| Zilli, T | 6 |
| Schollhammer, R | 1 |
| de Clermont Gallerande, H | 1 |
| Robert, G | 1 |
| Yacoub, M | 1 |
| Vimont, D | 1 |
| Fernandez, P | 3 |
| Morgat, C | 1 |
| Morassi, M | 1 |
| Cobelli, M | 1 |
| Stefanelli, A | 1 |
| Wetter, A | 4 |
| Lipponer, C | 3 |
| Nensa, F | 4 |
| Beiderwellen, K | 1 |
| Olbricht, T | 1 |
| Rübben, H | 3 |
| Bockisch, A | 3 |
| Schlosser, T | 2 |
| Heusner, TA | 1 |
| Lauenstein, TC | 3 |
| Colletti, PM | 9 |
| Rubello, D | 24 |
| Babu, MA | 1 |
| Spinner, RJ | 1 |
| Dyck, PJ | 1 |
| Amrami, KK | 1 |
| Kawashima, A | 3 |
| Howe, BM | 1 |
| Haim, S | 2 |
| Zakavi, R | 2 |
| Steinmair, M | 1 |
| Waldenberger, P | 3 |
| Kunit, T | 2 |
| Nader, M | 3 |
| Dost, RJ | 1 |
| Glaudemans, AW | 1 |
| Breeuwsma, AJ | 7 |
| de Jong, IJ | 10 |
| Schwarzenböck, SM | 4 |
| Kurth, J | 4 |
| Gocke, Ch | 1 |
| Kuhnt, T | 1 |
| Hildebrandt, G | 1 |
| Krause, BJ | 22 |
| Brogsitter, C | 1 |
| Zöphel, K | 3 |
| Kotzerke, J | 6 |
| Boschi, S | 6 |
| Pettinato, C | 4 |
| Brunocilla, E | 15 |
| Martorana, G | 20 |
| Borghesi, M | 6 |
| Vagnoni, V | 3 |
| Gacci, M | 3 |
| Umbehr, MH | 1 |
| Müntener, M | 1 |
| Hany, T | 2 |
| Sulser, T | 1 |
| Bachmann, LM | 1 |
| Murphy, RC | 3 |
| Chondrogiannis, S | 7 |
| Marzola, MC | 10 |
| Ferretti, A | 5 |
| Maffione, AM | 6 |
| Rampin, L | 5 |
| Grassetto, G | 5 |
| Calabria, F | 7 |
| Ragano-Caracciolo, C | 1 |
| Fuccio, C | 10 |
| Romagnoli, D | 2 |
| Malizia, C | 3 |
| Pinelli, L | 1 |
| Razzak, R | 1 |
| Yang, X | 1 |
| Pervez, N | 1 |
| Bédard, EL | 1 |
| Moore, RB | 1 |
| Shaw, A | 1 |
| Amanie, J | 1 |
| Roa, WH | 1 |
| Passoni, NM | 1 |
| Suardi, N | 4 |
| Abdollah, F | 3 |
| Messa, C | 19 |
| Freschi, M | 6 |
| Montorsi, F | 11 |
| Mamede, M | 3 |
| Fantini, L | 1 |
| Costa, S | 2 |
| Van den Bergh, L | 4 |
| Isebaert, S | 3 |
| Koole, M | 2 |
| Oyen, R | 4 |
| Joniau, S | 5 |
| Lerut, E | 4 |
| Deroose, CM | 4 |
| Van Poppel, H | 4 |
| Haustermans, K | 4 |
| de Vogel, S | 1 |
| Ulvik, A | 1 |
| Meyer, K | 1 |
| Ueland, PM | 2 |
| Nygård, O | 1 |
| Vollset, SE | 2 |
| Tell, GS | 1 |
| Gregory, JF | 1 |
| Tretli, S | 1 |
| Bjørge, T | 1 |
| Hodolič, M | 5 |
| Fettich, J | 4 |
| Gubina, B | 1 |
| Cimitan, M | 7 |
| Souvatzoglou, M | 17 |
| Takei, T | 2 |
| Fürst, S | 1 |
| Gaertner, F | 1 |
| Geinitz, H | 5 |
| Drzezga, A | 3 |
| Ziegler, S | 3 |
| Nekolla, SG | 1 |
| Rummeny, EJ | 4 |
| Schwaiger, M | 16 |
| Beer, AJ | 4 |
| Urso, C | 1 |
| Eccles, A | 1 |
| Challapalli, A | 3 |
| Khan, S | 1 |
| Barwick, T | 3 |
| Mangar, S | 3 |
| Wondergem, M | 1 |
| van der Zant, FM | 1 |
| van der Ploeg, T | 1 |
| Knol, RJ | 1 |
| Alongi, F | 4 |
| Liardo, RL | 2 |
| Villa, E | 2 |
| Comito, T | 2 |
| Ascolese, AM | 1 |
| Bellorofonte, C | 1 |
| Arturo, C | 1 |
| Granov, AM | 1 |
| Tiutin, LA | 1 |
| Ryzhkova, DV | 1 |
| Shkol'nik, MI | 1 |
| Andabekov, TT | 1 |
| Mostova, MI | 1 |
| Shatik, SV | 1 |
| Kostenikov, NA | 1 |
| Zaĭtsev, VV | 1 |
| Tlostanova, MS | 1 |
| Stanzhevskiĭ, AA | 1 |
| Panfilenko, AA | 1 |
| Arzumanov, AA | 1 |
| Metelëv, VV | 1 |
| Iliushchenko, IuR | 1 |
| Zechmann, CM | 3 |
| Malcher, A | 1 |
| Eder, M | 2 |
| Eisenhut, M | 2 |
| Linhart, HG | 1 |
| Holland-Letz, T | 1 |
| Hadaschik, BA | 1 |
| Giesel, FL | 1 |
| Debus, J | 1 |
| Haberkorn, U | 2 |
| Bergerat, JP | 1 |
| Saussine, C | 1 |
| Abu Eid, M | 1 |
| Kehrli, P | 1 |
| Namer, IJ | 3 |
| Heusch, P | 3 |
| Altenbernd, JC | 1 |
| Pöppel, T | 2 |
| Lauenstein, T | 1 |
| Nagarajah, J | 3 |
| Hausmann, D | 1 |
| Bittencourt, LK | 1 |
| Attenberger, UI | 1 |
| Sertdemir, M | 1 |
| Weidner, A | 1 |
| Büsing, KA | 1 |
| Brade, J | 1 |
| Wenz, F | 1 |
| Schoenberg, SO | 1 |
| Dinter, DJ | 1 |
| Buchegger, F | 6 |
| Allainmat, L | 1 |
| Jorcano, S | 4 |
| Vees, H | 5 |
| Rager, O | 4 |
| Steiner, C | 3 |
| Zaidi, H | 5 |
| Seimbille, Y | 2 |
| Gentile, G | 2 |
| Ahlgren, G | 3 |
| Almquist, H | 3 |
| Liedberg, F | 3 |
| Lyttkens, K | 3 |
| Ohlsson, T | 3 |
| Bratt, O | 3 |
| Cazaentre, T | 1 |
| Clivaz, F | 1 |
| Triponez, F | 1 |
| Weis, J | 3 |
| Ortiz-Nieto, F | 3 |
| Ahlström, H | 3 |
| Chang, JH | 4 |
| Lim Joon, D | 3 |
| Lee, ST | 4 |
| Hiew, CY | 2 |
| Esler, S | 2 |
| Gong, SJ | 4 |
| Wada, M | 2 |
| Clouston, D | 4 |
| O'Sullivan, R | 2 |
| Goh, YP | 2 |
| Tochon-Danguy, H | 1 |
| Chan, JG | 1 |
| Bolton, D | 4 |
| Khoo, V | 4 |
| Tomasi, G | 3 |
| O' Doherty, M | 1 |
| Contractor, K | 2 |
| Stewart, S | 1 |
| Al-Nahhas, A | 5 |
| Behan, K | 1 |
| Coombes, C | 1 |
| Aboagye, EO | 3 |
| Fabbri, C | 1 |
| Galassi, R | 1 |
| Moretti, A | 1 |
| Sintuzzi, E | 1 |
| Mautone, V | 1 |
| Sarti, G | 1 |
| Strigari, L | 1 |
| Benassi, M | 1 |
| Matteucci, F | 2 |
| von Eyben, FE | 2 |
| Kairemo, K | 3 |
| Cai, T | 1 |
| Siena, G | 1 |
| Minervini, A | 1 |
| Torshizi, MF | 1 |
| Bartolini, M | 1 |
| Giannì, G | 1 |
| Saieva, C | 2 |
| Ceroti, M | 2 |
| Detti, B | 2 |
| Livi, L | 2 |
| Pupi, A | 3 |
| Carini, M | 2 |
| Heck, MM | 2 |
| Retz, M | 2 |
| Nawroth, R | 5 |
| Kübler, H | 4 |
| Thalgott, M | 2 |
| Gramer, BM | 1 |
| Weirich, G | 9 |
| Rondak, IC | 1 |
| Gschwend, JE | 7 |
| Krause, B | 1 |
| Ceriani, L | 2 |
| Sadeghi, R | 1 |
| Giovanella, L | 2 |
| Petersen, H | 3 |
| Høilund-Carlsen, PF | 3 |
| Jakobsen, JS | 1 |
| Gerke, O | 3 |
| Karstoft, J | 1 |
| Steffansen, SI | 2 |
| Walter, S | 3 |
| Rodari, M | 2 |
| Bonora, M | 1 |
| Fanti, P | 1 |
| Fodor, C | 2 |
| Pepe, G | 2 |
| Zerini, D | 3 |
| Vischioni, B | 1 |
| Baroni, G | 1 |
| Matei, DV | 2 |
| De Cobelli, O | 2 |
| Orecchia, R | 3 |
| Concetti, S | 2 |
| Cevenini, M | 1 |
| Molinaroli, E | 1 |
| Mazzarotto, R | 3 |
| Ntreta, M | 1 |
| Lodi, F | 5 |
| Garcia-Parra, R | 2 |
| Schindler, C | 1 |
| Fazio, F | 10 |
| Froemming, AT | 2 |
| Hagen, CE | 1 |
| Takahashi, N | 2 |
| Cristina, I | 1 |
| Yoneyama, T | 1 |
| Tateishi, U | 2 |
| Terauchi, T | 2 |
| Inoue, T | 2 |
| Thörmer, G | 1 |
| Otto, J | 1 |
| Horn, LC | 1 |
| Garnov, N | 1 |
| Do, M | 1 |
| Franz, T | 1 |
| Stolzenburg, JU | 1 |
| Moche, M | 1 |
| Kahn, T | 1 |
| Busse, H | 1 |
| Ruchalla, E | 1 |
| Jilg, CA | 4 |
| Schultze-Seemann, W | 3 |
| Drendel, V | 1 |
| Vach, W | 4 |
| Wieser, G | 3 |
| Krauss, T | 2 |
| Jandausch, A | 1 |
| Hölz, S | 1 |
| Henne, K | 3 |
| Reske, SN | 13 |
| Grosu, AL | 7 |
| Weber, WA | 2 |
| Rischke, HC | 4 |
| Navarro-Pelayo Láinez, MM | 1 |
| Freesmeyer, M | 1 |
| Drescher, R | 1 |
| Winkens, T | 1 |
| Bertoli, M | 1 |
| Manenti, S | 1 |
| Salemme, M | 1 |
| Giammarile, F | 2 |
| Schlosser, TW | 2 |
| Pöppel, TD | 1 |
| Berardi, G | 2 |
| Busnardo, E | 4 |
| Crivellaro, C | 2 |
| Fiorino, C | 3 |
| Barizzi, J | 1 |
| Israel, I | 1 |
| Richter, D | 1 |
| Stritzker, J | 1 |
| van Ooschot, M | 1 |
| Donat, U | 1 |
| Buck, AK | 7 |
| Samnick, S | 2 |
| Bechtloff, W | 1 |
| Danz, B | 1 |
| Kraft, K | 1 |
| Klemenz, B | 1 |
| Sparwasser, C | 1 |
| Cueff, A | 1 |
| Maingon, P | 3 |
| Bosset, JF | 1 |
| De Bari, B | 1 |
| Lestrade, L | 1 |
| Clyne, M | 1 |
| Shen, G | 1 |
| Deng, H | 1 |
| Hu, S | 1 |
| Jia, Z | 1 |
| Scheffler, M | 1 |
| Lord, M | 2 |
| Pusztaszeri, M | 1 |
| Vallee, JP | 2 |
| Garcia, JR | 5 |
| Soler, M | 7 |
| Linero, D | 1 |
| Moragas, M | 6 |
| Riera, E | 5 |
| Lomeña, F | 5 |
| Piccardo, A | 2 |
| Paparo, F | 2 |
| Piccazzo, R | 2 |
| Picazzo, R | 1 |
| Naseri, M | 1 |
| Ricci, P | 1 |
| Marziano, A | 1 |
| Bacigalupo, L | 2 |
| Biscaldi, E | 1 |
| Rollandi, GA | 2 |
| Grillo-Ruggieri, F | 1 |
| Vag, T | 1 |
| Holzapfel, K | 4 |
| Sarkar, BK | 1 |
| Chakraborty, C | 1 |
| Sharma, AR | 1 |
| Bae, KJ | 1 |
| Sharma, G | 1 |
| Doss, GP | 1 |
| Dutta, D | 1 |
| Ding, S | 1 |
| Ganbold, B | 1 |
| Nam, JS | 1 |
| Lee, SS | 1 |
| Styles, C | 1 |
| Ferris, N | 1 |
| Mitchell, C | 1 |
| Murphy, D | 2 |
| Frydenberg, M | 1 |
| Mills, J | 1 |
| Pedersen, J | 1 |
| Bergen, N | 1 |
| Duchesne, G | 1 |
| Celli, M | 2 |
| Zbýň, Š | 1 |
| Krššák, M | 1 |
| Memarsadeghi, M | 1 |
| Gholami, B | 1 |
| Weber, M | 1 |
| Helbich, TH | 1 |
| Trattnig, S | 1 |
| Moser, E | 1 |
| Gruber, S | 1 |
| Beck, T | 1 |
| Meyer, PT | 1 |
| Garzon, JG | 1 |
| Bassa, P | 2 |
| Leyendecker, P | 1 |
| Matern, JF | 1 |
| Noël, G | 1 |
| Palumbo, B | 1 |
| Sivolella, S | 2 |
| Palumbo, I | 1 |
| Buresta, T | 1 |
| Radicchia, V | 1 |
| Fravolini, ML | 1 |
| Ferretti, F | 1 |
| Bellavita, R | 2 |
| Mearini, L | 1 |
| Scialpi, M | 1 |
| Aristei, C | 2 |
| Pelliccia, G | 1 |
| Schenck, M | 1 |
| Forsting, M | 1 |
| Cuccurullo, V | 2 |
| Papalia, R | 2 |
| Gallucci, M | 2 |
| Maini, CL | 2 |
| Leifert, A | 1 |
| Schnell, D | 1 |
| Kirste, S | 2 |
| Volegova-Neher, N | 2 |
| Schlager, D | 1 |
| Veronese, E | 1 |
| Massaro, A | 3 |
| Murphy, CR | 1 |
| Bergstralh, EJ | 1 |
| DiMonte, G | 1 |
| Cheville, JC | 1 |
| Gertz, J | 1 |
| Sachs, D | 2 |
| Treiber, U | 10 |
| Schuster, T | 7 |
| Senekowitsch-Schmidtke, R | 7 |
| Ziegler, SI | 4 |
| Henriksen, G | 2 |
| Wester, HJ | 10 |
| Bluemel, C | 3 |
| Vollmer, C | 1 |
| Droll, S | 1 |
| Wendl, C | 1 |
| Prokic, V | 1 |
| Molls, M | 2 |
| Walker, PM | 2 |
| Arteaga de Castro, CS | 1 |
| Boer, VO | 2 |
| Luttje, MP | 1 |
| van der Velden, TA | 1 |
| Bhogal, A | 1 |
| van Vulpen, M | 1 |
| Luijten, PR | 2 |
| van der Heide, UA | 1 |
| Klomp, DW | 4 |
| Cuberas, G | 1 |
| Rodado-Marina, S | 1 |
| Coronado-Poggio, M | 1 |
| García-Vicente, AM | 1 |
| García-Garzón, JR | 1 |
| Alonso-Farto, JC | 1 |
| de la Jara, AC | 1 |
| Maldonado-Suárez, A | 1 |
| Schiller, C | 1 |
| Stephens, A | 1 |
| Dinkelborg, L | 2 |
| Goldstein, J | 1 |
| Even-Sapir, E | 1 |
| Ben-Haim, S | 1 |
| Saad, A | 1 |
| Spieler, B | 1 |
| Davidson, T | 1 |
| Berger, R | 1 |
| Weiss, I | 1 |
| Appel, S | 1 |
| Lawrence, YR | 1 |
| Symon, Z | 1 |
| Pinaquy, JB | 3 |
| De Clermont-Galleran, H | 1 |
| Pasticier, G | 3 |
| Alberti, N | 1 |
| Mokrane, Y | 1 |
| van Kanten, MP | 1 |
| van Moorselaar, RJ | 4 |
| van den Eertwegh, AJ | 4 |
| van de Ven, PM | 2 |
| Bijnsdorp, IV | 1 |
| Geldof, AA | 1 |
| Gakis, G | 1 |
| Stenzl, A | 4 |
| Romera, N | 1 |
| Cozar, M | 1 |
| Escobar, M | 1 |
| Oyen, WJ | 1 |
| Mariani, G | 1 |
| Baseric, T | 2 |
| Bodanza, V | 1 |
| Volterrani, D | 1 |
| Cervino, AR | 2 |
| Gregianin, M | 1 |
| Puccini, G | 1 |
| Guidoccio, F | 1 |
| Simone, G | 1 |
| Di Pierro, GB | 1 |
| Rea, S | 1 |
| Ferriero, M | 1 |
| Guaglianone, S | 1 |
| Romagnoli, A | 1 |
| Monticone, M | 1 |
| Cevasco, L | 1 |
| Campodonico, F | 1 |
| Conzi, GM | 1 |
| Carmignani, G | 1 |
| Renard-Penna, R | 1 |
| Michaud, L | 3 |
| Bastide, C | 1 |
| Beuzeboc, P | 1 |
| Fromont, G | 1 |
| Hennequin, C | 2 |
| Mongiat-Artus, P | 2 |
| Rozet, F | 1 |
| Richaud, P | 1 |
| Salomon, L | 1 |
| Soulié, M | 1 |
| Tabrizipour, AI | 1 |
| Dunne, M | 1 |
| Stembrowicz-Nowakowska, Z | 1 |
| Buraczewska, A | 1 |
| Budiharto, T | 3 |
| Ameye, F | 2 |
| Bogaerts, K | 2 |
| Parrens, M | 1 |
| De Clermont, H | 3 |
| Allard, JB | 1 |
| Cornelis, F | 1 |
| Bagni, O | 1 |
| Filippi, L | 1 |
| Verwer, EE | 2 |
| Windhorst, AD | 1 |
| Schwarte, LA | 1 |
| Hendrikse, NH | 1 |
| Schuit, RC | 1 |
| Lammertsma, AA | 3 |
| Boellaard, R | 4 |
| Gandaglia, G | 2 |
| Matrone, F | 1 |
| Casciola, L | 1 |
| Cristallini, EG | 1 |
| Koo, PJ | 1 |
| David Crawford, E | 1 |
| Poncet, D | 1 |
| Arnoux, V | 1 |
| Rambeaud, JJ | 1 |
| Terrier, N | 1 |
| Boillot, B | 1 |
| Dubreuil, J | 1 |
| Lanchon, C | 1 |
| Carnicelli, D | 1 |
| Kim, YI | 1 |
| Cheon, GJ | 1 |
| Paeng, JC | 1 |
| Cho, JY | 1 |
| Kwak, C | 1 |
| Kang, KW | 1 |
| Chung, JK | 1 |
| Kim, EE | 1 |
| Lee, DS | 1 |
| Garai, I | 1 |
| Farkas, B | 1 |
| Oszlánszki, A | 1 |
| Berczi, C | 1 |
| Flaskó, T | 1 |
| Galuska, L | 1 |
| Bonfiglioli, R | 1 |
| Virgolini, IJ | 2 |
| Ng, SJ | 1 |
| Sinha, AK | 1 |
| Loi, HY | 1 |
| Khor, LK | 1 |
| Kuang, Y | 1 |
| Wu, L | 1 |
| Hirata, E | 1 |
| Miyazaki, K | 1 |
| Sato, M | 1 |
| Kwee, SA | 9 |
| Winter, A | 2 |
| Henke, RP | 2 |
| Wawroschek, F | 2 |
| Rasulova, N | 1 |
| Kiljunen, T | 1 |
| Partanen, K | 1 |
| Kangasmäki, A | 1 |
| Joensuu, T | 1 |
| Porreca, A | 1 |
| Pultrone, CV | 1 |
| Angelo, P | 1 |
| Chessa, F | 1 |
| Mengoni, F | 1 |
| Dababneh, H | 1 |
| Chan, J | 1 |
| Syndikus, I | 1 |
| Mahmood, S | 1 |
| Bell, L | 1 |
| Vinjamuri, S | 1 |
| Sadot-Lebouvier, S | 1 |
| Kobe, C | 1 |
| Maintz, D | 1 |
| Fischer, T | 1 |
| Chang, DH | 1 |
| Agrawal, K | 1 |
| Sajjan, RS | 1 |
| Gavra, M | 1 |
| Fraioli, F | 1 |
| Carril, JM | 1 |
| Heidenreich, A | 4 |
| Laffon, E | 1 |
| Marthan, R | 1 |
| Fersino, S | 1 |
| Giaj Levra, N | 1 |
| Mazzola, R | 1 |
| Ricchetti, F | 1 |
| Fiorentino, A | 1 |
| Ruggieri, R | 1 |
| Malfatti, V | 1 |
| Cavalleri, S | 1 |
| Morigi, JJ | 2 |
| Stricker, PD | 1 |
| van Leeuwen, PJ | 1 |
| Tang, R | 1 |
| Nguyen, Q | 1 |
| Hruby, G | 1 |
| Fogarty, G | 1 |
| Jagavkar, R | 1 |
| Kneebone, A | 1 |
| Hickey, A | 1 |
| Tarlinton, L | 1 |
| Bailly, C | 1 |
| Rousseau, T | 1 |
| Mathieu, C | 1 |
| Rousseau, N | 1 |
| Baskin, A | 1 |
| Amzalag, G | 1 |
| Quero, L | 1 |
| Vercellino, L | 1 |
| de Kerviler, E | 1 |
| Culine, S | 1 |
| Merlet, P | 1 |
| Ravery, V | 1 |
| Meria, P | 1 |
| Desgrandchamps, F | 1 |
| Di Biagio, D | 2 |
| Abbatiello, P | 1 |
| Gallo, G | 1 |
| Cascini, GL | 2 |
| Keum, N | 1 |
| Lee, DH | 1 |
| Marchand, N | 1 |
| Oh, H | 1 |
| Liu, H | 1 |
| Aune, D | 1 |
| Greenwood, DC | 1 |
| Giovannucci, EL | 2 |
| Golubić, AT | 1 |
| Mutvar, A | 1 |
| Žuvić, M | 1 |
| Huić, D | 1 |
| Hernández-Argüello, M | 1 |
| Quiceno, H | 1 |
| Pascual, I | 1 |
| Solorzano, JL | 1 |
| Benito, A | 1 |
| Collantes, M | 1 |
| Rodríguez-Fraile, M | 1 |
| Pardo, J | 1 |
| Richter, JA | 3 |
| Ouyang, Q | 1 |
| Duan, Z | 1 |
| Lei, J | 1 |
| Jiao, G | 1 |
| van der Laak, JA | 1 |
| Maas, MC | 1 |
| Hambrock, T | 2 |
| Bruggink, CC | 1 |
| Hulsbergen-van de Kaa, CA | 3 |
| Scheenen, TW | 6 |
| Minozzi, S | 1 |
| Balduzzi, S | 1 |
| Oyen, W | 1 |
| Schmeja, P | 1 |
| Kundt, G | 1 |
| Berndt, S | 1 |
| Graham, K | 1 |
| How Kit, N | 1 |
| Dugué, AE | 1 |
| Sevin, E | 1 |
| Allouache, N | 1 |
| Lesaunier, F | 1 |
| Joly, F | 1 |
| Wahart, A | 1 |
| Guy, JB | 1 |
| Vallard, A | 1 |
| Geissler, B | 1 |
| Ben Mrad, M | 1 |
| Falk, AT | 1 |
| Prevot, N | 1 |
| Rancoule, C | 1 |
| Chargari, C | 1 |
| Schober, P | 1 |
| Awwad, HM | 2 |
| Stoeckle, M | 1 |
| Aziz, R | 1 |
| Geisel, J | 2 |
| Obeid, R | 2 |
| Pasqualetti, F | 2 |
| Panichi, M | 1 |
| Sainato, A | 1 |
| Galli, L | 1 |
| Cocuzza, P | 1 |
| Ferrazza, P | 1 |
| Coraggio, G | 2 |
| Pasqualetti, G | 1 |
| Derosa, L | 1 |
| Sollini, M | 2 |
| Mannelli, L | 1 |
| Ortori, S | 1 |
| Monzani, F | 1 |
| Ricci, S | 1 |
| Fabrini, MG | 1 |
| Erba, PA | 2 |
| Orunesu, E | 1 |
| Longari, V | 1 |
| Cortelezzi, A | 1 |
| Reske, S | 2 |
| Stief, C | 3 |
| Thalmann, GN | 2 |
| Eiberger, AK | 1 |
| Lalire, P | 1 |
| Zalzali, M | 1 |
| Garbar, C | 1 |
| Bruna-Muraille, C | 1 |
| Pultrone, C | 1 |
| Ferrari, M | 1 |
| Rigatti, P | 7 |
| Fonti, C | 1 |
| Hegemann, NS | 1 |
| Wenter, V | 1 |
| Spath, S | 1 |
| Kusumo, N | 1 |
| Li, M | 1 |
| Bartenstein, P | 3 |
| Belka, C | 1 |
| Ganswindt, U | 2 |
| Krebs, M | 1 |
| Polat, B | 1 |
| Linke, F | 1 |
| Lapa, C | 1 |
| Lassmann, M | 1 |
| Riedmiller, H | 1 |
| Czernin, J | 1 |
| Bley, T | 1 |
| Kropf, S | 1 |
| Pasquale, R | 1 |
| Piert, M | 4 |
| Montgomery, J | 1 |
| Kunju, LP | 1 |
| Siddiqui, J | 3 |
| Rogers, V | 1 |
| Rajendiran, T | 1 |
| Johnson, TD | 2 |
| Shao, X | 1 |
| Davenport, MS | 1 |
| Pfister, D | 1 |
| Porres, D | 1 |
| Heidegger, I | 1 |
| Knuechel, R | 1 |
| Steib, F | 1 |
| Behrendt, FF | 2 |
| Verburg, FA | 2 |
| Rybalov, MA | 1 |
| De Iong, IY | 1 |
| Breusma, AI | 1 |
| Al'-Shukri, SKh | 1 |
| Borovets, SY | 1 |
| Jacob, M | 1 |
| Delfort, F | 1 |
| Heliette, C | 1 |
| Renard, D | 1 |
| Tan, H | 1 |
| Joseph, D | 1 |
| Loh, NK | 1 |
| McCarthy, M | 2 |
| Leong, E | 1 |
| Siew, T | 2 |
| Segard, T | 1 |
| Morandeau, L | 2 |
| Trevenen, M | 1 |
| Francis, RJ | 1 |
| Dell'Oca, I | 1 |
| Mangili, P | 1 |
| Pasetti, M | 1 |
| Calandrino, R | 1 |
| Di Muzio, NG | 1 |
| Lavalaye, J | 1 |
| Lam, MG | 1 |
| Verzijlbergen, JF | 1 |
| Krijger, GC | 1 |
| Vis, R | 1 |
| de Keizer, B | 1 |
| Jadvar, H | 4 |
| Schwarz, T | 1 |
| Seidl, C | 3 |
| Schiemann, M | 1 |
| Lima, GM | 1 |
| Morganti, AG | 1 |
| Lapa, P | 1 |
| Silva, R | 1 |
| Saraiva, T | 1 |
| Figueiredo, A | 1 |
| Ferreira, R | 1 |
| Costa, G | 1 |
| Lima, JP | 1 |
| Lensing, C | 1 |
| Keil, S | 1 |
| Liu, J | 1 |
| Chen, Z | 1 |
| Liu, L | 1 |
| Guo, G | 1 |
| Wang, D | 1 |
| Sobol, I | 2 |
| Zaid, HB | 2 |
| Mandoliti, G | 1 |
| Pasini, F | 1 |
| Silveira, MB | 1 |
| Ferreira, SM | 1 |
| Nascimento, LT | 1 |
| Costa, FM | 1 |
| Mendes, BM | 1 |
| Ferreira, AV | 1 |
| Malamut, C | 1 |
| Silva, JB | 1 |
| Dezortova, M | 1 |
| Jiru, F | 1 |
| Skoch, A | 1 |
| Capek, V | 1 |
| Ryznarova, Z | 1 |
| Vik, V | 1 |
| Hajek, M | 1 |
| Novara, G | 1 |
| Lowe, V | 1 |
| von Below, C | 1 |
| Tolf, A | 1 |
| Wassberg, C | 1 |
| Häggman, M | 2 |
| Ladjevardi, S | 1 |
| Schwenck, J | 1 |
| Rempp, H | 1 |
| Reischl, G | 3 |
| Kruck, S | 1 |
| Nikolaou, K | 1 |
| Pfannenberg, C | 2 |
| la Fougère, C | 1 |
| Knieling, A | 1 |
| Steiger, K | 1 |
| Esposito, I | 1 |
| Perri, M | 1 |
| Roncali, M | 1 |
| Boni, R | 1 |
| Lazzeri, E | 1 |
| Galeandro, M | 1 |
| Paiar, F | 1 |
| Versari, A | 1 |
| Olivier, KR | 1 |
| Choo, R | 2 |
| Welch, TJ | 1 |
| Evans, JD | 2 |
| Harmsen, WS | 1 |
| Moreira, DM | 1 |
| Gettman, MT | 1 |
| Vadrucci, M | 1 |
| Gilardi, L | 1 |
| Grana, CM | 1 |
| Ahmed, HU | 1 |
| Cathcart, P | 1 |
| Almuhaideb, A | 1 |
| Kayani, I | 1 |
| Dickson, J | 1 |
| Kirkham, A | 1 |
| Conde-Moreno, AJ | 1 |
| Herrando-Parreño, G | 1 |
| Muelas-Soria, R | 1 |
| Ferrer-Rebolleda, J | 1 |
| Broseta-Torres, R | 1 |
| Cozar-Santiago, MP | 1 |
| García-Piñón, F | 1 |
| Ferrer-Albiach, C | 1 |
| Bellomo, G | 1 |
| Marcocci, F | 1 |
| Bianchini, D | 1 |
| Mezzenga, E | 1 |
| D'Errico, V | 1 |
| Menghi, E | 1 |
| Zannoli, R | 1 |
| Sarnelli, A | 1 |
| Bossi, A | 1 |
| Mottet, N | 1 |
| Blanchard, P | 1 |
| Touijer, KA | 1 |
| Beauregard, JM | 2 |
| Beaulieu, A | 1 |
| Couñago, F | 1 |
| Recio, M | 1 |
| Maldonado, A | 1 |
| Del Cerro, E | 1 |
| Díaz-Gavela, AA | 1 |
| Thuissard, IJ | 1 |
| Sanz-Rosa, D | 1 |
| Marcos, FJ | 1 |
| Olaciregui, K | 1 |
| Mateo, M | 1 |
| Cerezo, L | 1 |
| Fossati, N | 1 |
| Stish, BJ | 1 |
| Olivier, K | 1 |
| Welch, BT | 1 |
| Pisansky, TM | 1 |
| Van den Broeck, B | 1 |
| De Maeseneer, D | 1 |
| De Gersem, R | 1 |
| De Man, K | 1 |
| Tabouret-Viaud, C | 1 |
| Vees, HJ | 1 |
| Sonni, I | 1 |
| Baratto, L | 1 |
| Baum, RP | 1 |
| DeGrado, T | 1 |
| Müller, SA | 2 |
| Nakagomi, K | 2 |
| Goto, S | 2 |
| Torizuka, T | 2 |
| Swanson, MG | 2 |
| Keshari, KR | 2 |
| Tabatabai, ZL | 2 |
| Simko, JP | 2 |
| Shinohara, K | 3 |
| Carroll, PR | 3 |
| Zektzer, AS | 1 |
| Kurhanewicz, J | 10 |
| Hlavcak, P | 1 |
| Bergman, A | 1 |
| Lange, T | 1 |
| Velan, SS | 1 |
| Raman, S | 1 |
| Gomez, A | 1 |
| Margolis, D | 2 |
| Swart, S | 1 |
| Raylman, RR | 1 |
| Schulte, RF | 1 |
| Boesiger, P | 1 |
| Tuncel, M | 2 |
| Stollfuss, J | 1 |
| Rinnab, L | 4 |
| Simon, J | 2 |
| Volkmer, BG | 2 |
| de Petriconi, R | 1 |
| Hautmann, RE | 4 |
| Wittbrodt, M | 1 |
| Egghart, G | 1 |
| Moeller, P | 1 |
| Blumstein, N | 2 |
| Kuefer, R | 2 |
| Liu, Q | 2 |
| Wang, M | 1 |
| Jin, X | 1 |
| Yao, S | 1 |
| Liu, S | 1 |
| Li, J | 1 |
| Zuhayra, M | 1 |
| Alfteimi, A | 1 |
| Papp, L | 1 |
| Lützen, U | 1 |
| Lützen, A | 1 |
| Von Forstner, C | 1 |
| Meller, B | 1 |
| Henze, E | 1 |
| Luboldt, W | 1 |
| Küfer, R | 2 |
| Toussaint, TL | 1 |
| Kluge, A | 1 |
| Seemann, MD | 1 |
| Luboldt, HJ | 1 |
| Samanes Gajate, AM | 1 |
| Zakian, KL | 4 |
| Ackerstaff, E | 2 |
| Koutcher, JA | 6 |
| Franceschelli, A | 3 |
| Sanguedolce, F | 2 |
| Bertaccini, A | 3 |
| Manferrari, F | 4 |
| Garofalo, M | 1 |
| Rocca, C | 1 |
| Franchi, R | 2 |
| Brame, RS | 1 |
| Zaider, M | 1 |
| Zelefsky, MJ | 1 |
| Scardino, PT | 2 |
| van Asten, JJ | 1 |
| Cuijpers, V | 1 |
| Hulsbergen-van de Kaa, C | 1 |
| Soede-Huijbregts, C | 1 |
| Witjes, JA | 1 |
| Verhofstad, A | 1 |
| Wang, XZ | 1 |
| Wang, B | 1 |
| Gao, ZQ | 1 |
| Liu, JG | 1 |
| Liu, ZQ | 1 |
| Niu, QL | 1 |
| Sun, ZK | 1 |
| Yuan, YX | 1 |
| Near, J | 1 |
| Romagnoli, C | 1 |
| Bartha, R | 1 |
| Steiner, Ch | 1 |
| Wissmeyer, M | 2 |
| Berrebi, O | 1 |
| Kossovsky, MP | 1 |
| Khan, HG | 1 |
| Cronauer, MV | 1 |
| Hohl, K | 3 |
| Belloli, S | 1 |
| Jachetti, E | 1 |
| Moresco, RM | 1 |
| Lecchi, M | 1 |
| Valtorta, S | 1 |
| Hess Michelini, R | 1 |
| Bellone, M | 1 |
| Rahbar, K | 1 |
| Fuchs, M | 1 |
| Kemper, S | 1 |
| Juergens, KU | 1 |
| Weckesser, M | 1 |
| Stegger, L | 1 |
| Emonds, KM | 2 |
| Swinnen, JV | 2 |
| Mortelmans, L | 2 |
| Raina, K | 1 |
| Serkova, NJ | 1 |
| Agarwal, R | 1 |
| Lindholm, P | 1 |
| Seppänen, M | 1 |
| Johansson, M | 1 |
| Van Guelpen, B | 1 |
| Hultdin, J | 1 |
| Bergh, A | 1 |
| Key, T | 1 |
| Midttun, O | 1 |
| Hallmans, G | 1 |
| Stattin, P | 1 |
| Jacobs, MA | 1 |
| Ouwerkerk, R | 1 |
| Petrowski, K | 1 |
| Macura, KJ | 1 |
| Pascali, G | 1 |
| D'Antonio, L | 1 |
| Bovone, P | 1 |
| Gerundini, P | 1 |
| August, T | 1 |
| Coel, MN | 7 |
| Ly, BH | 1 |
| Lim, J | 3 |
| Rodríguez, M | 2 |
| Rioja, J | 1 |
| Peñuelas, I | 1 |
| Martí-Climent, J | 1 |
| Garrastachu, P | 1 |
| Quincoces, G | 1 |
| Zudaire, J | 1 |
| García-Velloso, MJ | 1 |
| Santi, I | 3 |
| Rizzello, A | 1 |
| Schmuecking, M | 1 |
| Boltze, C | 1 |
| Geyer, H | 1 |
| Salz, H | 1 |
| Schilling, B | 1 |
| Wendt, TG | 1 |
| Kloetzer, KH | 1 |
| Marx, C | 1 |
| Vande Berg, BC | 1 |
| Malghem, J | 1 |
| Omoumi, P | 1 |
| Simoni, P | 1 |
| Attieh, C | 1 |
| Piroth, MD | 3 |
| Holy, R | 3 |
| Nussen, S | 2 |
| Klotz, J | 3 |
| Hawickhorst, R | 1 |
| Schäfer, W | 1 |
| Coradeschi, E | 2 |
| Bettinardi, V | 2 |
| Scattoni, V | 7 |
| Giusti, S | 1 |
| Caramella, D | 1 |
| Fruzzetti, E | 1 |
| Lazzereschi, M | 1 |
| Tognetti, A | 1 |
| Bartolozzi, C | 1 |
| Park, H | 3 |
| Khan, A | 2 |
| Hussain, H | 3 |
| Chenevert, T | 3 |
| Wood, D | 3 |
| Johnson, T | 1 |
| Shah, RB | 2 |
| Meyer, C | 1 |
| Wang, H | 2 |
| Senthamizhchelvan, S | 1 |
| Le, HC | 1 |
| Lupu, M | 1 |
| Kotedia, K | 1 |
| Rosen, N | 1 |
| Solit, D | 1 |
| Pruim, J | 8 |
| van den Bergh, AC | 1 |
| Leliveld, AM | 4 |
| Nijman, RJ | 2 |
| Dierckx, RA | 3 |
| Gomez, AM | 1 |
| Margolis, DJ | 1 |
| McClure, T | 1 |
| Rioja Zuazu, J | 1 |
| Rincón Mayans, A | 1 |
| Sansi, AS | 1 |
| Zudaire Bergera, JJ | 1 |
| Martínez-Monge, R | 1 |
| Berián Polo, JM | 1 |
| Riches, SF | 1 |
| Payne, GS | 1 |
| Morgan, VA | 1 |
| Sandhu, S | 1 |
| Fisher, C | 1 |
| Germuska, M | 1 |
| Thompson, A | 1 |
| deSouza, NM | 1 |
| Steuber, T | 1 |
| Schlomm, T | 1 |
| Heinzer, H | 1 |
| Zacharias, M | 1 |
| Ahyai, S | 1 |
| Chun, KF | 1 |
| Haese, A | 1 |
| Klutmann, S | 1 |
| Köllermann, J | 1 |
| Sauter, G | 1 |
| Mester, J | 1 |
| Mikecz, P | 1 |
| Fisch, M | 1 |
| Huland, H | 1 |
| Graefen, M | 2 |
| Salomon, G | 2 |
| Cicciò, C | 1 |
| Carlani, M | 2 |
| Caracciolo, CR | 2 |
| Danieli, R | 2 |
| Orlacchio, A | 2 |
| Simonetti, G | 3 |
| Fei, B | 1 |
| Wu, C | 1 |
| Chiu, SM | 1 |
| Le, C | 1 |
| van de Weijer, EP | 1 |
| Pos, FJ | 1 |
| Vogel, WV | 2 |
| Bouchelouche, K | 2 |
| Svolgaard, B | 1 |
| Marcussen, N | 2 |
| Svolgaard, N | 2 |
| Ogren, M | 1 |
| Geertsen, U | 2 |
| Imamovic, L | 1 |
| Broinger, G | 2 |
| Vali, R | 3 |
| Stoiber, F | 2 |
| Gruy, B | 1 |
| Janetschek, G | 3 |
| Meyer, CR | 2 |
| Shah, R | 1 |
| Seo, J | 1 |
| Uphoff, J | 1 |
| Garcia Parra, R | 1 |
| Kirilova, A | 1 |
| Damyanovich, A | 1 |
| Crook, J | 1 |
| Jezioranski, J | 1 |
| Wallace, K | 1 |
| Pintilie, M | 1 |
| Watanabe, H | 1 |
| Kanematsu, M | 1 |
| Kondo, H | 1 |
| Kako, N | 1 |
| Yamamoto, N | 1 |
| Yamada, T | 1 |
| Goshima, S | 1 |
| Hoshi, H | 1 |
| Bae, KT | 1 |
| Verma, S | 1 |
| Rajesh, A | 1 |
| Fütterer, JJ | 3 |
| Pang, Y | 1 |
| Ganter, C | 1 |
| Gaa, J | 1 |
| Weber, AW | 1 |
| Mertens, K | 1 |
| Slaets, D | 1 |
| Lambert, B | 1 |
| Acou, M | 1 |
| De Vos, F | 1 |
| Goethals, I | 1 |
| Allegri, V | 2 |
| Pettinato, V | 2 |
| Al-Saffar, NM | 1 |
| Jackson, LE | 1 |
| Raynaud, FI | 1 |
| Clarke, PA | 1 |
| Ramírez de Molina, A | 1 |
| Lacal, JC | 1 |
| Workman, P | 1 |
| Leach, MO | 1 |
| Parfait, S | 2 |
| Liegard, M | 1 |
| Ben Salem, D | 1 |
| Funes de la Vega, M | 1 |
| Bonnetain, F | 2 |
| Mirjolet, C | 2 |
| Teahan, O | 2 |
| Bevan, CL | 1 |
| Waxman, J | 1 |
| Keun, HC | 2 |
| Salonia, A | 1 |
| Landoni, C | 3 |
| De Waele, A | 1 |
| Van Binnebeek, S | 1 |
| Williams, SG | 1 |
| Degrado, TR | 8 |
| Roselt, P | 1 |
| Montini, GC | 2 |
| Campbell, A | 1 |
| Lenzo, N | 1 |
| Spry, N | 1 |
| Vivian, J | 1 |
| Arteaga, CS | 1 |
| van Asten, J | 1 |
| Krohn, T | 2 |
| Weibrecht, M | 1 |
| García-Martín, ML | 1 |
| Adrados, M | 1 |
| Ortega, MP | 1 |
| Fernández González, I | 1 |
| López-Larrubia, P | 1 |
| Viaño, J | 2 |
| García-Segura, JM | 2 |
| Roef, MJ | 1 |
| van der Poel, H | 1 |
| van der Laken, CJ | 1 |
| Dundee, PE | 1 |
| Hutton, AC | 1 |
| Eden, CG | 1 |
| Bossi Zanetti, I | 1 |
| Rumsby, M | 1 |
| Schmitt, J | 1 |
| Sharrard, M | 1 |
| Rodrigues, G | 1 |
| Stower, M | 1 |
| Maitland, N | 1 |
| Beltramo, G | 1 |
| Fariselli, L | 1 |
| Santoro, L | 1 |
| Vavassori, A | 1 |
| Gherardi, F | 1 |
| Ascione, C | 1 |
| Bossi-Zanetti, I | 1 |
| Mauro, R | 1 |
| Bregantin, A | 1 |
| Bianchi, LC | 1 |
| Mottaghy, F | 2 |
| Panebianco, V | 1 |
| Sciarra, A | 1 |
| Lisi, D | 1 |
| Galati, F | 1 |
| Buonocore, V | 1 |
| Catalano, C | 1 |
| Gentile, V | 1 |
| Laghi, A | 1 |
| Passariello, R | 1 |
| Barentsz, JO | 4 |
| Schroeder, RP | 1 |
| van Weerden, WM | 2 |
| Krenning, EP | 1 |
| Bangma, CH | 1 |
| Berndsen, S | 1 |
| Grievink-de Ligt, CH | 1 |
| Groen, HC | 1 |
| Reneman, S | 1 |
| de Blois, E | 1 |
| Breeman, WA | 1 |
| de Jong, M | 1 |
| Muacevic, A | 1 |
| Kufeld, M | 1 |
| Rist, C | 1 |
| Wowra, B | 1 |
| Staehler, M | 1 |
| Schwarzenboeck, S | 1 |
| Bundschuh, RA | 2 |
| Kuebler, H | 1 |
| Hoefler, H | 1 |
| Gschwend, J | 1 |
| Würschmidt, F | 1 |
| Petersen, C | 1 |
| Wahl, A | 1 |
| Dahle, J | 1 |
| Kretschmer, M | 1 |
| Joon, DL | 1 |
| Hamilton, CS | 2 |
| Gauthier, M | 1 |
| Peller, PJ | 1 |
| Pürschel, A | 1 |
| Thamm, R | 1 |
| Zimmermann, F | 1 |
| Profitos, MB | 1 |
| Vanderhoydonc, F | 1 |
| Nuyts, J | 1 |
| Paycha, F | 2 |
| Egrot, C | 2 |
| Kerrou, K | 4 |
| Pascal, O | 1 |
| Cussenot, O | 3 |
| Zengerling, F | 1 |
| Schrader, AJ | 1 |
| Schrader, M | 1 |
| Jentzmik, F | 1 |
| Abuhilal, M | 1 |
| Simeone, C | 1 |
| Rossini, P | 1 |
| Pizzocaro, C | 1 |
| Orlando, E | 1 |
| Finamanti, M | 1 |
| Biasiotto, G | 1 |
| Rodella, C | 1 |
| Cosciani Cunico, S | 1 |
| Tsachres, H | 1 |
| Iman, R | 1 |
| Delos Santos, L | 1 |
| Vigneron, DB | 6 |
| Da Pozzo, LF | 1 |
| Tutolo, M | 1 |
| Villa, L | 1 |
| Gallina, A | 1 |
| Capitanio, U | 1 |
| Colombo, R | 1 |
| Guazzoni, G | 1 |
| Belhocine, T | 1 |
| Kovacs, M | 1 |
| Ward, A | 1 |
| Rachinsky, I | 1 |
| Kukuk, D | 1 |
| Raguin, O | 1 |
| Wiehr, S | 1 |
| Judenhofer, MS | 1 |
| Calaminus, C | 1 |
| Honndorf, VS | 1 |
| Quintanilla-Martinez, L | 1 |
| Schönberger, T | 1 |
| Duchamp, O | 2 |
| Machulla, HJ | 2 |
| Pichler, BJ | 1 |
| Spinapolice, EG | 1 |
| Buydens, LM | 1 |
| Bansal, A | 2 |
| Harris, RA | 1 |
| Winkler, M | 1 |
| Hellawell, G | 1 |
| Hazell, S | 1 |
| Kenny, LM | 1 |
| Tadrous, P | 1 |
| Coombes, RC | 1 |
| Rietbergen, DD | 1 |
| van der Hiel, B | 1 |
| Vogel, W | 1 |
| Stokkel, MP | 1 |
| Dirscherl, T | 1 |
| Rickhey, M | 1 |
| Bogner, L | 1 |
| Graute, V | 1 |
| Jansen, N | 1 |
| Ubleis, C | 1 |
| Seitz, M | 3 |
| Scherr, MK | 2 |
| Thieme, S | 1 |
| Cumming, P | 1 |
| Klanke, K | 1 |
| Tiling, R | 2 |
| Tavola, F | 2 |
| Janzen, T | 2 |
| Giussani, A | 2 |
| Facchinetti, D | 1 |
| Veronese, I | 1 |
| Uusijärvi-Lizana, H | 2 |
| Mattsson, S | 2 |
| Hoeschen, C | 2 |
| Cantone, MC | 2 |
| Shabbeer, S | 1 |
| Williams, SA | 1 |
| Simons, BW | 1 |
| Herman, JG | 1 |
| Carducci, MA | 1 |
| Finazzi Agrò, E | 2 |
| Miano, R | 1 |
| Witney, TH | 1 |
| Alam, IS | 1 |
| Turton, DR | 1 |
| Smith, G | 1 |
| Carroll, L | 1 |
| Brickute, D | 1 |
| Twyman, FJ | 1 |
| Nguyen, QD | 1 |
| Awais, RO | 1 |
| Hossain, M | 1 |
| Schirmer, T | 1 |
| Richardson, T | 1 |
| Chen, L | 1 |
| Buyyounouski, MK | 1 |
| Ma, CM | 1 |
| Bormans, G | 1 |
| Djukic, V | 1 |
| Corral, NE | 1 |
| Caffaro, M | 1 |
| Winz, OH | 1 |
| Geethanath, S | 1 |
| Baek, HM | 1 |
| Ganji, SK | 1 |
| Ding, Y | 1 |
| Maher, EA | 1 |
| Sims, RD | 1 |
| Choi, C | 1 |
| Lewis, MA | 1 |
| Kodibagkar, VD | 1 |
| Kwee, S | 1 |
| Song, MA | 1 |
| Cheng, I | 1 |
| Loo, L | 1 |
| Tiirikainen, M | 1 |
| Parra, RG | 1 |
| Kragelj, B | 1 |
| Goldsmith, SJ | 1 |
| Rybalov, M | 3 |
| Rosati, S | 1 |
| Veltman, NC | 1 |
| Soyka, JD | 1 |
| Muster, MA | 1 |
| Schmid, DT | 1 |
| Seifert, B | 1 |
| Zaugg, K | 1 |
| Seifert, HH | 1 |
| Strobel, K | 1 |
| Schaefer, NG | 1 |
| Husarik, DB | 2 |
| Hany, TF | 3 |
| Fortuin, AS | 1 |
| Deserno, WM | 1 |
| Meijer, HJ | 1 |
| Jager, GJ | 1 |
| Takahashi, S | 1 |
| Debats, OA | 1 |
| Schick, C | 1 |
| van Oort, I | 1 |
| Witjes, AJ | 1 |
| Hoogeveen, YL | 1 |
| van Lin, EN | 2 |
| Valentini, AL | 1 |
| Gui, B | 1 |
| Mattiucci, G | 1 |
| Clementi, V | 1 |
| Di Molfetta, IV | 1 |
| Bonomo, P | 1 |
| Mantini, G | 1 |
| Olbert, PJ | 1 |
| Heinis, J | 1 |
| Hofmann, R | 1 |
| Hegele, A | 1 |
| Evans-Axelsson, S | 1 |
| Ulmert, D | 1 |
| Örbom, A | 1 |
| Peterson, P | 1 |
| Nilsson, O | 1 |
| Wennerberg, J | 1 |
| Strand, J | 1 |
| Wingårdh, K | 1 |
| Olsson, T | 1 |
| Hagman, Z | 1 |
| Tolmachev, V | 1 |
| Lilja, H | 1 |
| Strand, SE | 1 |
| Bertilsson, H | 2 |
| Tessem, MB | 2 |
| Flatberg, A | 1 |
| Viset, T | 1 |
| Gribbestad, I | 1 |
| Angelsen, A | 2 |
| Halgunset, J | 1 |
| Zankl, M | 1 |
| Sydoff, M | 1 |
| Leide-Svegborn, S | 1 |
| Söderberg, M | 1 |
| Magnani, P | 1 |
| Guidalotti, PL | 1 |
| Gavaruzzi, G | 1 |
| Anderson, NJ | 1 |
| Gu, CN | 1 |
| Hunt, CH | 1 |
| Lehman, VT | 1 |
| Diehn, FE | 1 |
| Schwartz, KM | 1 |
| Eckel, LJ | 1 |
| Aguilo, JJ | 1 |
| Marco, V | 1 |
| Valls, E | 3 |
| Henninger, B | 1 |
| Vesco, P | 1 |
| Putzer, D | 1 |
| Kendler, D | 1 |
| Loizides, A | 1 |
| Bale, RJ | 1 |
| Dipasquale, G | 1 |
| Chouiter, A | 1 |
| Velazquez, M | 1 |
| Namy, S | 1 |
| Tilki, D | 1 |
| Reich, O | 1 |
| Graser, A | 1 |
| Silchinger, J | 1 |
| Becker, AJ | 1 |
| Khoder, W | 1 |
| Stief, CG | 1 |
| Richman, EL | 1 |
| Kenfield, SA | 1 |
| Stampfer, MJ | 1 |
| Willett, WC | 1 |
| Chan, JM | 1 |
| Schwarzenböck, S | 2 |
| Muzzio, PC | 1 |
| Moritz, S | 1 |
| Kull, T | 1 |
| Provent, P | 1 |
| Tizon, X | 1 |
| Genne, P | 1 |
| Vincent, AD | 1 |
| Gerritsen, WR | 1 |
| Eriksson, J | 1 |
| Mitchell, CR | 1 |
| Rangel, LJ | 1 |
| Hung, JC | 1 |
| Núñez García, A | 1 |
| Cordero García, JM | 1 |
| Palomar Muñoz, A | 1 |
| Scoccianti, S | 1 |
| Cipressi, S | 1 |
| Cassani, S | 1 |
| Villari, D | 1 |
| Vaggelli, L | 1 |
| Pertici, M | 1 |
| Nicita, G | 1 |
| Biti, G | 1 |
| Marcolongo, A | 1 |
| Selnaes, KM | 1 |
| Gribbestad, IS | 1 |
| Wright, A | 1 |
| Garcia, G | 1 |
| Cabral, JF | 1 |
| Rust, E | 1 |
| Flores-Turk, G | 1 |
| Renard, C | 1 |
| Hubele, F | 1 |
| Detour, J | 1 |
| Lang, H | 1 |
| Gangi, A | 1 |
| Wendl, CM | 1 |
| Yue, K | 1 |
| Marumoto, A | 1 |
| Binesh, N | 1 |
| Elsinga, PH | 3 |
| Vaalburg, W | 4 |
| Mensink, HJ | 3 |
| Matarrese, M | 2 |
| De Cobelli, F | 2 |
| Maschio, AD | 1 |
| Kaji, Y | 1 |
| Wada, A | 1 |
| Imaoka, I | 1 |
| Matsuo, M | 1 |
| Terachi, T | 1 |
| Kobashi, Y | 1 |
| Sugimura, K | 2 |
| Fujii, M | 1 |
| Maruyama, K | 1 |
| Takizawa, O | 1 |
| Hautzel, H | 1 |
| Müller-Mattheis, V | 1 |
| Herzog, H | 1 |
| Roden, W | 1 |
| Coenen, HH | 1 |
| Ackermann, R | 1 |
| Müller-Gärtner, HW | 1 |
| Glatting, G | 3 |
| van den Hoff, J | 1 |
| Messer, P | 1 |
| Neumaier, B | 4 |
| Sironi, S | 1 |
| Brioschi, M | 1 |
| Del Maschio, A | 1 |
| Rocco, F | 1 |
| Mueller-Lisse, UG | 3 |
| Scherr, M | 2 |
| Swindle, P | 1 |
| McCredie, S | 1 |
| Russell, P | 1 |
| Himmelreich, U | 1 |
| Khadra, M | 1 |
| Lean, C | 1 |
| Mountford, C | 1 |
| Eberhardt, S | 1 |
| Kleinman, S | 1 |
| Muruganandham, M | 1 |
| Sircar, K | 1 |
| Kattan, MW | 1 |
| Kumar, R | 1 |
| Kumar, M | 1 |
| Jagannathan, NR | 1 |
| Gupta, NP | 1 |
| Hemal, AK | 1 |
| Dyke, JP | 1 |
| Spees, WM | 1 |
| Matei, C | 1 |
| Chen, Y | 1 |
| Mao, X | 1 |
| Shungu, DC | 1 |
| Sutinen, E | 1 |
| Nurmi, M | 1 |
| Roivainen, A | 1 |
| Varpula, M | 1 |
| Tolvanen, T | 1 |
| Lehikoinen, P | 1 |
| Kiessling, F | 1 |
| Huber, PE | 1 |
| Grobholz, R | 1 |
| Heilmann, M | 1 |
| Meding, J | 1 |
| Lichy, MP | 1 |
| Fink, C | 1 |
| Krix, M | 1 |
| Peschke, P | 1 |
| Bieg, C | 1 |
| Schmiedl, O | 1 |
| Solbach, C | 1 |
| Zheng, QH | 1 |
| Gardner, TA | 1 |
| Raikwar, S | 1 |
| Kao, C | 1 |
| Stone, KL | 1 |
| Martinez, TD | 1 |
| Mock, BH | 1 |
| Fei, X | 1 |
| Wang, JQ | 1 |
| Hutchins, GD | 1 |
| Herz, M | 1 |
| Hauser, A | 1 |
| Ko, JP | 1 |
| Jongen, MM | 1 |
| Suurmeijer, AJ | 1 |
| Yoshida, S | 1 |
| Futatsubashi, M | 1 |
| Kim, DH | 1 |
| Xing, L | 1 |
| Daniel, B | 1 |
| Spielman, D | 1 |
| Cunningham, CH | 2 |
| Marjanska, M | 1 |
| Chen, AP | 2 |
| Xu, D | 2 |
| Hurd, RE | 2 |
| Garwood, M | 1 |
| Pauly, JM | 2 |
| Gambarota, G | 1 |
| Weiland, E | 1 |
| Yamaguchi, T | 1 |
| Lee, J | 1 |
| Uemura, H | 1 |
| Sasaki, T | 1 |
| Oka, T | 1 |
| Shizukuishi, K | 1 |
| Endou, H | 1 |
| Kubota, Y | 1 |
| Corti, B | 4 |
| Canini, R | 3 |
| Grigioni, W | 1 |
| Marengo, M | 1 |
| Salizzoni, E | 3 |
| Monetti, N | 2 |
| Heinisch, M | 1 |
| Fogelman, I | 1 |
| Wei, H | 1 |
| Sesterhenn, I | 1 |
| Yun, D | 1 |
| Taouli, B | 1 |
| Maeda, T | 1 |
| Komiyama, M | 1 |
| Fujimoto, H | 1 |
| Watanabe, S | 1 |
| Moriyama, N | 1 |
| Arai, Y | 1 |
| Kakizoe, T | 1 |
| Bortolus, R | 1 |
| Morassut, S | 1 |
| Canzonieri, V | 1 |
| Garbeglio, A | 1 |
| Drigo, A | 1 |
| Trovò, MG | 1 |
| Blumstein, NM | 4 |
| Gottfried, HW | 1 |
| Finsterbusch, F | 1 |
| Kocot, D | 1 |
| Möller, P | 2 |
| Perner, S | 1 |
| Grigioni, WF | 3 |
| D'Errico Grigioni, A | 1 |
| Carvajal, L | 1 |
| Karpodinis, K | 1 |
| Scher, B | 1 |
| Albinger, W | 1 |
| Becker, HC | 1 |
| Souvatzogluou, M | 1 |
| Gildehaus, FJ | 1 |
| Dresel, S | 1 |
| Häcker, A | 1 |
| Jeschke, S | 1 |
| Leeb, K | 1 |
| Prammer, K | 1 |
| Ziegerhofer, J | 1 |
| Sega, W | 1 |
| Gutman, F | 3 |
| Aflalo-Hazan, V | 1 |
| Grahek, D | 2 |
| Hara, T | 3 |
| Hom, JJ | 1 |
| Coakley, FV | 1 |
| Lu, Y | 1 |
| Qayyum, A | 1 |
| Westphalen, AC | 1 |
| Schmitt, LD | 1 |
| Ciernik, IF | 1 |
| Brown, DW | 1 |
| Schmid, D | 1 |
| Egli, P | 1 |
| Davis, JB | 1 |
| Schöder, H | 1 |
| Bochner, B | 1 |
| Oyama, N | 1 |
| Roscigno, M | 1 |
| Da Pozzo, L | 1 |
| Bocciardi, A | 1 |
| Albrecht, S | 1 |
| Khan, H | 1 |
| Husarik, D | 1 |
| Soloviev, D | 1 |
| Heijmink, SW | 1 |
| Heesakkers, RA | 1 |
| Kerrouche, N | 1 |
| Gattegno, B | 1 |
| Thibault, P | 1 |
| Coleman, RE | 4 |
| Testa, C | 1 |
| Lodi, R | 1 |
| Tonon, C | 1 |
| Coe, M | 1 |
| Barbiroli, B | 1 |
| Weber, C | 1 |
| Kelm, BM | 1 |
| Zamecnik, P | 1 |
| Hendricks, D | 1 |
| Waldherr, R | 1 |
| Hamprecht, FA | 1 |
| Delorme, S | 1 |
| Bachert, P | 1 |
| Ikinger, U | 1 |
| Wiegel, T | 1 |
| Praus, C | 1 |
| Dubs, M | 1 |
| John, H | 1 |
| Giger, OT | 1 |
| Gelet, A | 1 |
| Cservenyàk, T | 1 |
| Glunde, K | 1 |
| Shah, T | 1 |
| Winnard, PT | 1 |
| Raman, V | 1 |
| Takagi, T | 1 |
| Vesuna, F | 1 |
| Artemov, D | 1 |
| Bhujwalla, ZM | 2 |
| Tamburrini, O | 1 |
| Igerc, I | 1 |
| Kohlfürst, S | 1 |
| Gallowitsch, HJ | 1 |
| Matschnig, S | 1 |
| Kresnik, E | 1 |
| Gomez-Segovia, I | 1 |
| Lind, P | 1 |
| Schilling, D | 1 |
| Wagner, PH | 1 |
| Böttcher, P | 1 |
| Merseburger, AS | 1 |
| Aschoff, P | 1 |
| Bares, R | 1 |
| Corvin, S | 1 |
| Pelosi, E | 1 |
| Arena, V | 1 |
| Skanjeti, A | 1 |
| Pirro, V | 1 |
| Douroukas, A | 1 |
| Mancini, M | 1 |
| Chun, FK | 1 |
| Teichert, F | 1 |
| Verschoyle, RD | 1 |
| Greaves, P | 1 |
| Edwards, RE | 1 |
| Jones, DJ | 1 |
| Wilson, ID | 1 |
| Farmer, PB | 1 |
| Steward, WP | 1 |
| Gant, TW | 1 |
| Gescher, AJ | 1 |
| Fitz, F | 1 |
| Foglman, I | 1 |
| Mancino, S | 1 |
| Saini, MS | 1 |
| Van Etten, RL | 1 |
| Narayan, P | 1 |
| Carroll, P | 1 |
| Nelson, SJ | 2 |
| Parivar, F | 1 |
| Kosaka, N | 2 |
| Kishi, H | 2 |
| Kim, JK | 1 |
| Kim, DY | 1 |
| Lee, YH | 1 |
| Sung, NK | 1 |
| Chung, DS | 1 |
| Kim, OD | 1 |
| Kim, KB | 1 |
| Sánchez-Chapado, M | 1 |
| Ibarburen, C | 1 |
| Angulo, JC | 1 |
| González, J | 1 |
| Rodríguez-Vallejo, JM | 1 |
| Stanka, M | 1 |
| Eltze, E | 1 |
| Semjonow, A | 1 |
| Sievert, KD | 1 |
| Maier, A | 1 |
| Pfleiderer, B | 1 |
| Prang, J | 1 |
| Volkmer, B | 1 |
| Guhlmann, A | 1 |
| Kleinschmidt, K | 1 |
| Hautmann, R | 1 |
| Zakian, K | 1 |
| Wang, S | 2 |
| Baldwin, SW | 2 |
| Orr, MD | 2 |
| Robertson, CN | 2 |
| Polascik, TJ | 2 |
| Price, DT | 3 |
| Pflug, BR | 1 |
| Nelson, JB | 1 |
| Liao, RP | 2 |
| Friedman, HS | 1 |
| Reiman, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Two Bed SPECT/CT Versus Planar Bone Scintigraphy in Detection of Osseous Metastases in Patients With Genitourinary Malignancies[NCT05597215] | 70 participants (Anticipated) | Observational | 2022-12-31 | Not yet recruiting | |||
| Randomized Assessment of Patients With Clinically Suspected Prostate Cancer After Multiparametric Metabolic Hybrid Imaging to Evaluate Its Potential Clinical Domain: A Prospective, Randomized, Multi-arm, Multi-treatment Clinical Trial[NCT02659527] | Phase 3 | 220 participants (Actual) | Interventional | 2016-01-31 | Completed | ||
| A Multi-center, Open-label, Single Arm Phase III Clinical Trial for the Diagnostic Efficacy Assessment and Safety Evaluation by [18F]Florastamin PET/CT Imaging Examination in Patients With Suspected Recurrent or Metastatic Prostate Cancer[NCT05936658] | Phase 3 | 89 participants (Anticipated) | Interventional | 2023-05-08 | Recruiting | ||
| Phase III Multicentre Prospective Comparative Study of Detection Rate of 18F-JK-PSMA-7 and of 18F-fluorocholine in Patients With Biochemical Recurrence of Prostate Cancer After Previous Treatment With Curative Intent[NCT05622162] | Phase 3 | 106 participants (Anticipated) | Interventional | 2022-11-30 | Not yet recruiting | ||
| Pilot Comparative Study of PET/MR and PET/CT With Different Tracers (18F-FDG and 68Gallium Citrate) in the Diagnosis of Periprosthetic Joint Infection[NCT02855190] | 30 participants (Anticipated) | Interventional | 2016-01-31 | Recruiting | |||
| [NCT02964351] | 120 participants (Anticipated) | Observational | 2016-12-31 | Not yet recruiting | |||
| All-in-One Prostate Cancer Staging With MRI[NCT06071195] | 400 participants (Anticipated) | Observational | 2021-12-22 | Recruiting | |||
| PRISMA-PET - Primary Staging of Prostate Cancer: A Randomized Controlled Trial Comparing 18F-PSMA-1007 PET/CT to Conventional Imaging[NCT05123300] | 448 participants (Anticipated) | Interventional | 2021-10-04 | Recruiting | |||
| A Phase II Study to Evaluate Axumin PET/CT for Risk Stratification for Laser Focal Therapy of Intermediate Risk Localized Prostate Cancer[NCT03373006] | Phase 2 | 20 participants (Actual) | Interventional | 2018-02-27 | Completed | ||
| Determination of the Diagnostic Detection Rate of Axumin (Fluciclovine) PET/CT Utilizing the High Resolution Digital Philips Vereos Scanner, in Patients With Biochemical Recurrence After Radical Prostatectomy[NCT04234399] | 22 participants (Actual) | Observational | 2020-03-01 | Active, not recruiting | |||
| Investigation of the Magnitude of Uptake, Retention, and Spatial Distribution Pattern of 18F-Choline in Comparison With MRI and Histology Obtained From Prostate Cancer Biopsies[NCT01751737] | 63 participants (Actual) | Interventional | 2012-11-30 | Completed | |||
| Molecular Imaging of Prostate Cancer Using Radiofluorinated PSMA Ligand[NCT04266392] | Early Phase 1 | 20 participants (Actual) | Interventional | 2019-12-16 | Completed | ||
| WHOLE-BODY DIFFUSION-WEIGHTED MAGNETIC RESONANCE IMAGING (WB-DW-MRI) VS CHOLINE-POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY (CHOLINE- PET/CT) for Selecting Treatments in Recurrent Prostate Cancer[NCT02858128] | 46 participants (Actual) | Observational | 2014-10-31 | Completed | |||
| Dose Intensification With a Focal Boost to Dominant Intraprostatic Lesion Using Volumetric Modulated Arc Therapy /Image Guided Radiotherapy in Patients With Localized Prostate Cancer[NCT03030625] | 30 participants (Actual) | Interventional | 2017-03-13 | Active, not recruiting | |||
| F-choline PET in Early Response Assessment for Castration Resistant Prostatic Cancer Treated by Abiraterone Acetate or Enzalutamide[NCT01981707] | Phase 2/Phase 3 | 12 participants (Actual) | Interventional | 2013-12-31 | Terminated (stopped due to enrollment default) | ||
| Feasibility of 11C-acetate in the Monitoring of Treatment Response Following Radiotherapy in Patients With Hepatocellular Carcinoma[NCT02549755] | Phase 2 | 1 participants (Actual) | Interventional | 2015-09-30 | Terminated (stopped due to Poor enrollment) | ||
| BEACON - A Phase I/II Study of High-dose-rate Brachytherapy and External Beam and Short-term Androgen Deprivation COmbined for the Treatment of Men With Fluciclovine PET Pelvic Nodal Uptake in Locally Recurrent Prostate Cancer After Prior Definitive Radio[NCT03553602] | Phase 1/Phase 2 | 24 participants (Anticipated) | Interventional | 2018-05-29 | Recruiting | ||
| Evaluation of [18F] Fluorocholine PET/CT for Detection of Regional Lymph Node Metastases From Prostate Cancer[NCT00670527] | 205 participants (Anticipated) | Interventional | 2008-01-31 | Recruiting | |||
| Clinical Value of [18]Fluoroethylcholine Positron-Emission-Tomography Combined With Endorectal Magnetic Resonance Imaging by Software Fusion for Pre-therapeutic Staging of Prostate Cancer[NCT00520546] | Phase 3 | 44 participants (Actual) | Interventional | 2007-12-31 | Completed | ||
| Cancer Localization in the Prostate With F-18 Fluorocholine Positron Emission Tomography[NCT01310192] | Phase 1 | 20 participants (Actual) | Interventional | 2004-06-30 | Completed | ||
| Multi-paramEtric Imaging to Assess Treatment REsponse After Stereotactic Radiosurgery of Brain Metastases[NCT04626206] | 12 participants (Anticipated) | Observational | 2020-12-31 | Not yet recruiting | |||
| Trans-Rectal Placement of Prostatic Fiducial Markers Under MR-Guidance in Patients Receiving External Beam Radiotherapy for Prostate Cancer: A Pilot Study[NCT00061347] | Phase 1 | 15 participants (Actual) | Interventional | 2003-05-23 | Completed | ||
| Evaluation of 11 C-Choline PET-CT for Detection of Hepatocellular Carcinoma[NCT01377220] | Phase 2 | 30 participants (Anticipated) | Interventional | 2011-06-30 | Not yet recruiting | ||
| A Phase 1 Pilot Study of 99mTc-MIP-1404 Single Photon Emission Computed Tomography (SPECT)/CT Imaging in Men With Prostate Cancer Undergoing Prostatectomy and/or Pelvic Lymph Node Dissection (PLND)[NCT01572701] | Phase 1 | 8 participants (Actual) | Interventional | 2012-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Biochemical disease-free survival according to the Phoenix definition (PSA >2 ng/mL above the currently observed PSA nadir. Defined as the time from enrollment to progression of biochemical disease, or death from any cause, or censoring at the date of the last contact. (NCT03030625)
Timeframe: 5 years
| Intervention | Participants (Count of Participants) |
|---|---|
| IGRT/VMAT Focal Therapy Boost to DIL | 30 |
Acute and late rectal and urinary complications defined as the number of participants with treatment-related adverse events assessed by Common Terminology Criteria for Adverse Events CTCAE v4.0 and Radiation- Therapy Oncology Group/ European Organization for Research and Treatment of Cancer RTOG/EORTC scales (been 0: no toxicity and 4: most severe toxicity). (NCT03030625)
Timeframe: 5 years
| Intervention | Participants (Count of Participants) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Acute rectal72073577 | Acute urinary72073577 | Late rectal72073577 | Late urinary72073577 | |||||||||||||
| Grade 0 | Grade >2 | Grade 1 | Grade 2 | |||||||||||||
| IGRT/VMAT Focal Therapy Boost to DIL | 28 | |||||||||||||||
| IGRT/VMAT Focal Therapy Boost to DIL | 2 | |||||||||||||||
| IGRT/VMAT Focal Therapy Boost to DIL | 0 | |||||||||||||||
| IGRT/VMAT Focal Therapy Boost to DIL | 11 | |||||||||||||||
| IGRT/VMAT Focal Therapy Boost to DIL | 13 | |||||||||||||||
| IGRT/VMAT Focal Therapy Boost to DIL | 6 | |||||||||||||||
| IGRT/VMAT Focal Therapy Boost to DIL | 27 | |||||||||||||||
| IGRT/VMAT Focal Therapy Boost to DIL | 3 | |||||||||||||||
PET positive lesions (n=128) were measured on its own and evaluated as malignant just as hypointense lesions on MRI. In PET/MRI analysis, MRI suspect lesions without FEC uptake were considered not to be malignant. PET positive lesions in central periurethral zone with inhomogenous signal intensity and sharp edges on MRI images were also considered to be benign. PET positive lesions in the peripheral zone without a hypointense correlate on MRI were considered to be malignant. Sensitivity, specificity, accuracy, negative and positive predictive values were determined. (NCT00520546)
Timeframe: within < 2 weeks after PET/MRI
| Intervention | lesions (Number) | |||||
|---|---|---|---|---|---|---|
| True positive | False positive | True negative | False negative | Total true | Total false | |
| FEC-PET | 59 | 26 | 19 | 24 | 78 | 50 |
| Magnetic Resonance Imaging (MRI) | 40 | 27 | 18 | 43 | 58 | 70 |
| PET/MRI | 55 | 8 | 37 | 28 | 92 | 36 |
PET positive lesions in patients with Gleason >6(3+3),n=43 were measured on its own and evaluated as malignant just as hypointense lesions on MRI. In PET/MRI analysis, MRI suspect lesions without FEC uptake were considered not to be malignant. PET positive lesions in central periurethral zone with inhomogenous signal intensity and sharp edges on MRI images were also considered to be benign. PET positive lesions in the peripheral zone without a hypointense correlate on MRI were considered to be malignant. Sensitivity, specificity, accuracy, negative & positive predictive values were determined. (NCT00520546)
Timeframe: within < 2 weeks after PET/MRI
| Intervention | lesions (Number) | |||||
|---|---|---|---|---|---|---|
| True positive | False positive | True negative | False negative | Total true | Total false | |
| FEC-PET | 27 | 5 | 8 | 3 | 35 | 8 |
| Magnetic Resonance Imaging (MRI) | 22 | 9 | 4 | 8 | 26 | 17 |
| PET/MRI | 27 | 1 | 11 | 4 | 38 | 5 |
PET positive lesions were measured on its own and evaluated as malignant just as hypointense lesions on MRI. In PET/MRI analysis, MRI suspect lesions without FEC uptake were considered not to be malignant. PET positive lesions in central periurethral zone with inhomogenous signal intensity and sharp edges on MRI images were also considered to be benign. PET positive lesions in the peripheral zone without a hypointense correlate on MRI were considered to be malignant. Sensitivity, specificity, accuracy, negative and positive predictive values were determined without malign lesions <=5mm. (NCT00520546)
Timeframe: within < 2 weeks after PET/MRI
| Intervention | lesions (Number) | |||||
|---|---|---|---|---|---|---|
| True positive | False positive | True negative | False negative | Total true | Total false | |
| FEC-PET | 48 | 24 | 18 | 8 | 66 | 32 |
| Magnetic Resonance Imaging (MRI) | 37 | 26 | 16 | 19 | 53 | 45 |
| PET/MRI | 48 | 8 | 32 | 10 | 80 | 18 |
PET positive lesions were measured on its own and evaluated as malignant just as hypointense lesions on MRI. In PET/MRI analysis, MRI suspect lesions without FEC uptake were considered not to be malignant. PET positive lesions in central periurethral zone with inhomogenous signal intensity and sharp edges on MRI images were also considered to be benign. PET positive lesions in the peripheral zone without a hypointense correlate on MRI were considered to be malignant. At least 1 histological confirmed cancer lesion has to be detected by each of the 3 methods to be patient based true positive. (NCT00520546)
Timeframe: within < 2 weeks after PET/MRI
| Intervention | participants (Number) | |||||
|---|---|---|---|---|---|---|
| True Positive | False Positive | True Negative | False Negative | Total True | Total False | |
| [18F]Fluoroethylcholine Positron-Emission-Tomography (FEC-PET) | 36 | 1 | 0 | 1 | 36 | 2 |
| Magnetic Resonance Imaging (MRI) | 26 | 1 | 0 | 11 | 27 | 11 |
| PositronEmissionTomography/MagneticResonanceImaging (PET/MRI) | 35 | 0 | 1 | 2 | 36 | 2 |
84 reviews available for choline and Prostatic Neoplasms
| Article | Year |
|---|---|
Comparing the diagnostic performance of radiotracers in prostate cancer biochemical recurrence: a systematic review and meta-analysis.
Topics: Choline; Gallium Radioisotopes; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomograp | 2022 |
Accuracy of PET-choline in nodal staging of localized very high-risk prostate cancer.
Topics: Choline; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Staging; Pos | 2022 |
PSMA PET imaging in the diagnosis and management of prostate cancer.
Topics: Choline; Humans; Male; Molecular Targeted Therapy; Neoplasm Staging; Positron Emission Tomography Co | 2023 |
Multimodality Imaging of Prostate Cancer.
Topics: Aged; Antigens, Surface; Carboxylic Acids; Choline; Cyclobutanes; Disease Progression; Fluorodeoxygl | 2019 |
Positron emission tomography (PET) radiotracers for prostate cancer imaging.
Topics: Choline; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; | 2020 |
Recent updates and developments in PET imaging of prostate cancer.
Topics: Choline; Humans; Male; Positron-Emission Tomography; Prostatic Neoplasms | 2020 |
Prostate imaging: Contribution of PET PSMA and MRI.
Topics: Adenocarcinoma; Aged; Antigens, Surface; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Glut | 2020 |
Clinical application of Fluciclovine PET, choline PET and gastrin-releasing polypeptide receptor (bombesin) targeting PET in prostate cancer.
Topics: Amino Acids; Antigens, Surface; Bombesin; Choline; Gastrins; Humans; Male; Positron Emission Tomogra | 2020 |
Prostate-specific Membrane Antigen PET in Prostate Cancer.
Topics: Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutanes; Fluorodeoxyglucose F18; Humans; Magne | 2021 |
PET/CT Variants and Pitfalls in Prostate Cancer: What You Might See on PET and Should Never Forget.
Topics: Choline; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomograph | 2021 |
Atypical Metastases in the Abdomen and Pelvis From Biochemically Recurrent Prostate Cancer:
Topics: Abdominal Cavity; Abdominal Neoplasms; Carbon Radioisotopes; Choline; Humans; Male; Multimodal Imagi | 2022 |
PET and PET/CT with radiolabeled choline in prostate cancer: a critical reappraisal of 20 years of clinical studies.
Topics: Choline; Humans; Isotope Labeling; Male; Neoplasm Staging; Positron Emission Tomography Computed Tom | 2017 |
Therapy assessment in prostate cancer using choline and PSMA PET/CT.
Topics: Antigens, Surface; Choline; Glutamate Carboxypeptidase II; Humans; Male; Positron Emission Tomograph | 2017 |
Rationale for Modernising Imaging in Advanced Prostate Cancer.
Topics: Choline; Humans; Magnetic Resonance Imaging; Male; Neoplasm Metastasis; Positron Emission Tomography | 2017 |
Is choline-based PET imaging still relevant in recurrent prostate cancer?
Topics: Aged; Aged, 80 and over; Choline; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Em | 2017 |
The use of PET/CT in prostate cancer.
Topics: Carboxylic Acids; Choline; Cyclobutanes; Humans; Male; Multimodal Imaging; Neoplasm Recurrence, Loca | 2018 |
The future of choline PET in the era of prostate specific membrane antigen.
Topics: Antigens, Surface; Choline; Glutamate Carboxypeptidase II; Humans; Isotope Labeling; Male; Neoplasm | 2019 |
Oligorecurrent prostate cancer limited to lymph nodes: getting our ducks in a row : Nodal oligorecurrent prostate cancer.
Topics: Choline; Fluorine Radioisotopes; Gallium Isotopes; Gallium Radioisotopes; Humans; Lymphatic Metastas | 2019 |
The utility of PET-based imaging for prostate cancer biochemical recurrence: a systematic review and meta-analysis.
Topics: Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutanes; Gallium Isotopes; Gallium Radioisotop | 2019 |
Diagnostic performance of choline PET/CT for the detection of bone metastasis in prostate cancer: A systematic review and meta-analysis.
Topics: Bone Neoplasms; Choline; Humans; Male; Positron Emission Tomography Computed Tomography; Prostatic N | 2018 |
Direct comparison of choline PET/CT and MRI in the diagnosis of lymph node metastases in patients with prostate cancer.
Topics: Aged; Choline; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Positron | 2018 |
Comparing the Staging/Restaging Performance of 68Ga-Labeled Prostate-Specific Membrane Antigen and 18F-Choline PET/CT in Prostate Cancer: A Systematic Review and Meta-analysis.
Topics: Choline; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Oligopeptides; Positron | 2019 |
Comparison of PSMA-PET/CT, choline-PET/CT, NaF-PET/CT, MRI, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a systematic review and meta-analysis.
Topics: Bone Neoplasms; Choline; Gallium Isotopes; Gallium Radioisotopes; Humans; Magnetic Resonance Imaging | 2019 |
Choline PET or PET/CT and biochemical relapse of prostate cancer: a systematic review and meta-analysis.
Topics: Aged; Aged, 80 and over; Androgens; Choline; Humans; Male; Middle Aged; Multimodal Imaging; Positron | 2013 |
Role of choline PET/CT in guiding target volume delineation for irradiation of prostate cancer.
Topics: Choline; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Positro | 2013 |
18F-Choline, 11C-choline and 11C-acetate PET/CT: comparative analysis for imaging prostate cancer patients.
Topics: Acetates; Carbon; Choline; Humans; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tom | 2013 |
11C-choline PET/CT and PSA kinetics.
Topics: Carbon Radioisotopes; Choline; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Prost | 2013 |
The dilemma of localizing disease relapse after radical treatment for prostate cancer: which is the value of the actual imaging techniques?
Topics: Bone Neoplasms; Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutanes; Fluorine Radioisotope | 2013 |
The role of 11C-choline and 18F-fluorocholine positron emission tomography (PET) and PET/CT in prostate cancer: a systematic review and meta-analysis.
Topics: Choline; Humans; Kallikreins; Likelihood Functions; Male; Multimodal Imaging; Neoplasm Staging; Odds | 2013 |
Choline PET/CT for imaging prostate cancer: an update.
Topics: Choline; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Recurr | 2013 |
A literature review of 18F-fluoride PET/CT and 18F-choline or 11C-choline PET/CT for detection of bone metastases in patients with prostate cancer.
Topics: Bone Neoplasms; Carbon Radioisotopes; Choline; Fluorides; Fluorine Radioisotopes; Humans; Male; Mult | 2013 |
Meta-analysis of (11)C-choline and (18)F-choline PET/CT for management of patients with prostate cancer.
Topics: Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Humans; Male; Positron-Emission Tomography; P | 2014 |
Relationship between prostate-specific antigen kinetics and detection rate of radiolabelled choline PET/CT in restaging prostate cancer patients: a meta-analysis.
Topics: Carbon Radioisotopes; Choline; Databases, Factual; Fluorine Radioisotopes; Humans; Kinetics; Male; P | 2014 |
The role of positron emission tomography/computed tomography imaging with radiolabeled choline analogues in prostate cancer.
Topics: Choline; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Co | 2014 |
Choline-PET in prostate cancer management: the point of view of the radiation oncologist.
Topics: Biomarkers, Tumor; Bone Neoplasms; Choline; Gamma Rays; Humans; Male; Neoplasm Recurrence, Local; Po | 2014 |
Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis.
Topics: Bone Neoplasms; Choline; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Observer Vari | 2014 |
Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis.
Topics: Bone Neoplasms; Choline; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Observer Vari | 2014 |
Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis.
Topics: Bone Neoplasms; Choline; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Observer Vari | 2014 |
Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis.
Topics: Bone Neoplasms; Choline; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Observer Vari | 2014 |
Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis.
Topics: Bone Neoplasms; Choline; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Observer Vari | 2014 |
Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis.
Topics: Bone Neoplasms; Choline; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Observer Vari | 2014 |
Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis.
Topics: Bone Neoplasms; Choline; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Observer Vari | 2014 |
Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis.
Topics: Bone Neoplasms; Choline; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Observer Vari | 2014 |
Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis.
Topics: Bone Neoplasms; Choline; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Observer Vari | 2014 |
Novel biomarker for prostate cancer diagnosis by MRS.
Topics: Biomarkers, Tumor; Choline; Citric Acid; Creatine; Humans; Inositol; Magnetic Resonance Spectroscopy | 2014 |
New acquisition protocol of 18F-choline PET/CT in prostate cancer patients: review of the literature about methodology and proposal of standardization.
Topics: Adult; Aged; Aged, 80 and over; Choline; Humans; Lymph Nodes; Male; Middle Aged; Positron-Emission T | 2014 |
[Multimodality MRI and PET for restaging prostate cancer after biochemical failure of the treatment].
Topics: Adenocarcinoma; Brachytherapy; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Fluorodeoxyglu | 2014 |
[Imagery of treated prostate cancer].
Topics: Choline; Fluorine Radioisotopes; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neopl | 2015 |
¹⁸F-fluoromethylcholine or ¹⁸F-fluoroethylcholine pet for prostate cancer imaging: which is better? A literature revision.
Topics: Choline; Diagnostic Imaging; Humans; Male; Prostatic Neoplasms; Tissue Distribution | 2015 |
¹⁸F-NaF PET/CT and ¹¹C-Choline PET/CT for the initial detection of metastatic disease in prostate cancer: overview and potential utilization.
Topics: Bone Neoplasms; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Humans; Male; Multimodal Imag | 2014 |
State of the art of PET/CT with 11-choline and 18F-fluorocholine in the diagnosis and follow-up of localized and locally advanced prostate cancer.
Topics: Choline; Follow-Up Studies; Humans; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission To | 2015 |
Is choline PET useful for identifying intraprostatic tumour lesions? A literature review.
Topics: Choline; Humans; Image Processing, Computer-Assisted; Male; Multimodal Imaging; Positron-Emission To | 2015 |
Initial prostate cancer diagnosis and disease staging--the role of choline-PET-CT.
Topics: Choline; Humans; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prostatic | 2015 |
Bio-Distribution, Imaging Protocols and Diagnostic Accuracy of PET with Tracers of Lipogenesis in Imaging Prostate Cancer: a Comparison between 11C-Choline, 18FFluoroethylcholine and 18F-Methylcholine.
Topics: Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Humans; Lipogenesis; Male; Neoplasm Metastasi | 2015 |
Egg intake and cancers of the breast, ovary and prostate: a dose-response meta-analysis of prospective observational studies.
Topics: Breast Neoplasms; Cholesterol; Choline; Databases, Factual; Diet; Dose-Response Relationship, Drug; | 2015 |
PET/CT with (11)C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data.
Topics: Carbon Radioisotopes; Choline; Humans; Male; Positron-Emission Tomography; Prostatic Neoplasms; Recu | 2016 |
New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.
Topics: Antigens, Surface; Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutanes; Gallium Radioisoto | 2016 |
Acquisition with (11)C-choline and (18)F-fluorocholine PET/CT for patients with biochemical recurrence of prostate cancer: a systematic review and meta-analysis.
Topics: Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Humans; Image Processing, Computer-Assisted; | 2016 |
Positron emission tomography in imaging evaluation of staging, restaging, treatment response, and prognosis in prostate cancer.
Topics: Acetates; Carbon; Choline; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Staging; Positron-Emission | 2016 |
Influence of Four Radiotracers in PET/CT on Diagnostic Accuracy for Prostate Cancer: A Bivariate Random-Effects Meta-Analysis.
Topics: Acetates; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Mal | 2016 |
Rapidly changing landscape of PET/CT imaging in prostate cancer.
Topics: Antigens, Surface; Choline; Glutamate Carboxypeptidase II; Humans; Male; Neoplasm Recurrence, Local; | 2016 |
Radiolabeled choline PET/CT before salvage lymphadenectomy dissection: a systematic review and meta-analysis.
Topics: Choline; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Positr | 2016 |
11C- or 18F-Choline PET/CT for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer.
Topics: Choline; Diagnosis, Differential; Evidence-Based Medicine; Humans; Image Enhancement; Male; Neoplasm | 2016 |
PET imaging for lymph node dissection in prostate cancer.
Topics: Acetates; Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutanes; Edetic Acid; Fluorodeoxyglu | 2017 |
Molecular imaging for prostate cancer: Performance analysis of
Topics: Choline; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Molecular Imaging; Olig | 2017 |
Imaging of Prostate Cancer Using Gallium-68-Labeled Bombesin.
Topics: Antigens, Surface; Bombesin; Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutanes; Fluorode | 2017 |
1H magnetic resonance spectroscopy of prostate cancer: biomarkers for tumor characterization.
Topics: Biomarkers, Tumor; Choline; Citrates; Humans; Magnetic Resonance Spectroscopy; Male; Polyamines; Pro | 2008 |
Molecular imaging of prostate cancer.
Topics: Animals; Antigens, Neoplasm; Bombesin; Cell Line, Tumor; Choline; Dideoxynucleosides; Dihydrotestost | 2009 |
Diffusion-weighted imaging with apparent diffusion coefficient mapping and spectroscopy in prostate cancer.
Topics: Biomarkers, Tumor; Choline; Citrates; Contrast Media; Creatine; Diagnosis, Differential; Diffusion M | 2008 |
Prostate MRI and 3D MR spectroscopy: how we do it.
Topics: Choline; Citrates; Creatine; Diagnosis, Differential; Humans; Image Enhancement; Image Interpretatio | 2010 |
PET with (18)F-labelled choline-based tracers for tumour imaging: a review of the literature.
Topics: Brain Neoplasms; Choline; Humans; Liver Neoplasms; Male; Neoplasms; Positron-Emission Tomography; Pr | 2010 |
Choline PET/CT for prostate cancer: main clinical applications.
Topics: Choline; Humans; Kinetics; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; | 2011 |
The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer.
Topics: Carbon Radioisotopes; Choline; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron- | 2011 |
Prostate cancer: PET with 18F-FDG, 18F- or 11C-acetate, and 18F- or 11C-choline.
Topics: Acetates; Aged; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Human | 2011 |
Prostate cancer: PET with 18F-FDG, 18F- or 11C-acetate, and 18F- or 11C-choline.
Topics: Acetates; Aged; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Human | 2011 |
Prostate cancer: PET with 18F-FDG, 18F- or 11C-acetate, and 18F- or 11C-choline.
Topics: Acetates; Aged; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Human | 2011 |
Prostate cancer: PET with 18F-FDG, 18F- or 11C-acetate, and 18F- or 11C-choline.
Topics: Acetates; Aged; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Human | 2011 |
The role of PET/computed tomography scan in the management of prostate cancer.
Topics: Acetates; Choline; Fluorides; Humans; Male; Neoplasm Staging; Positron-Emission Tomography; Prostati | 2011 |
Imaging of prostate cancer with PET/CT and radioactively labeled choline derivates.
Topics: Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Humans; Image Processing, Computer-Assisted; | 2013 |
Prostate-specific antigen kinetics and choline PET/CT in patients with biochemical relapse after primary treatment for prostate cancer.
Topics: Choline; Humans; Kinetics; Male; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic | 2011 |
The utility of 11C-choline PET/CT for imaging prostate cancer: a pictorial guide.
Topics: Carbon Radioisotopes; Choline; Humans; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radi | 2011 |
[Diagnostic relevance of choline-PET / CT in patients with prostate cancer].
Topics: Bone Neoplasms; Carbon Radioisotopes; Choline; Disease Progression; Fluorine Radioisotopes; Humans; | 2012 |
18F-fluorocholine for prostate cancer imaging: a systematic review of the literature.
Topics: Choline; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplas | 2012 |
18F-fluorocholine for prostate cancer imaging: a systematic review of the literature.
Topics: Choline; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplas | 2012 |
18F-fluorocholine for prostate cancer imaging: a systematic review of the literature.
Topics: Choline; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplas | 2012 |
18F-fluorocholine for prostate cancer imaging: a systematic review of the literature.
Topics: Choline; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplas | 2012 |
[Choline PET/CT in the diagnosis of primary and recurrent prostate cancer. Are there evidence-based indications?].
Topics: Choline; Clinical Trials as Topic; Evidence-Based Medicine; Humans; Male; Multimodal Imaging; Neopla | 2012 |
The role of choline in prostate cancer.
Topics: Biomarkers, Tumor; Cell Hypoxia; Choline; Humans; Male; Phospholipids; Prostatic Neoplasms; Signal T | 2012 |
Utility of choline positron emission tomography/computed tomography for lymph node involvement identification in intermediate- to high-risk prostate cancer: a systematic literature review and meta-analysis.
Topics: Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Humans; Lymph Nodes; Lymphatic Metastasis; Ma | 2013 |
[1H magnetic resonance spectroscopy of the prostate].
Topics: Biopsy; Choline; Citrates; Creatine; Follow-Up Studies; Humans; Imaging, Three-Dimensional; Magnetic | 2003 |
The role of fluorodeoxyglucose, 18F-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast.
Topics: Bone Neoplasms; Breast Neoplasms; Choline; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeo | 2006 |
[MR spectroscopic imaging for evaluation of prostate cancer].
Topics: Adenocarcinoma; Biomarkers; Biopsy; Choline; Citrates; Humans; Magnetic Resonance Imaging; Magnetic | 2006 |
[Clinical usefulness of positron emission tomography in prostate cancer].
Topics: Bone Neoplasms; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recu | 2007 |
Proton MR spectroscopy of the prostate.
Topics: Biopsy; Choline; Citric Acid; Creatine; Diagnosis, Differential; Humans; Imaging, Three-Dimensional; | 2007 |
Cancer imaging with fluorine-18-labeled choline derivatives.
Topics: Brain Neoplasms; Carcinoma, Hepatocellular; Choline; Esophageal Neoplasms; Female; Fluorine Radioiso | 2007 |
[Nuclear imaging of prostate cancer: current status].
Topics: Carbon Radioisotopes; Choline; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Magnetic Re | 2007 |
Is there a role for positron emission tomography imaging in the early evaluation of prostate cancer relapse?
Topics: Adenocarcinoma; Carbon Radioisotopes; Choline; Clinical Trials as Topic; Humans; Lymphatic Metastasi | 2008 |
Magnetic resonance spectroscopic studies of the prostate.
Topics: Adenocarcinoma; Choline; Citric Acid; Humans; Magnetic Resonance Spectroscopy; Male; Neoplasm Stagin | 2000 |
33 trials available for choline and Prostatic Neoplasms
| Article | Year |
|---|---|
Value of
Topics: Bombesin; Choline; Gallium Radioisotopes; Humans; Male; Multiparametric Magnetic Resonance Imaging; | 2023 |
Comparison of 18F-PSMA-1007 and 18F-Choline PET/CT in prostate cancer patients with biochemical recurrence: a phase 3, prospective, multicenter, randomized study.
Topics: Choline; Gallium Radioisotopes; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomograp | 2023 |
Head-to-Head Comparison of 18F-Prostate-Specific Membrane Antigen-1007 and 18F-Fluorocholine PET/CT in Biochemically Relapsed Prostate Cancer.
Topics: Aged; Aged, 80 and over; Choline; Humans; Male; Middle Aged; Niacinamide; Oligopeptides; Positron Em | 2019 |
Qualitative and quantitative reproducibility of [18]fluoromethycholine PET/computed tomography in prostate cancer.
Topics: Aged; Aged, 80 and over; Choline; Humans; Male; Middle Aged; Positron Emission Tomography Computed T | 2020 |
Spectrum of metastatic and nonmetastatic skeletal findings with dual-phase 18F-FECH PET/CT in patients with biochemical relapse of prostate cancer.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choline; Humans; Male; Middle Aged; Positron Emission Tomog | 2017 |
Early Toxicity of a Phase 2 Trial of Combined Salvage Radiation Therapy and Hormone Therapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer (OLIGOPELVIS GETUG P07).
Topics: Aged; Androgen Antagonists; Choline; Digestive System; Dose Fractionation, Radiation; Fluorine Radio | 2019 |
Impact of 18F-choline PET/CT in prostate cancer patients with biochemical recurrence: influence of androgen deprivation therapy and correlation with PSA kinetics.
Topics: Aged; Androgens; Choline; Humans; Kinetics; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emi | 2013 |
Diagnostic accuracy of 18F choline PET/CT using time-of-flight reconstruction algorithm in prostate cancer patients with biochemical recurrence.
Topics: Algorithms; Choline; Humans; Image Processing, Computer-Assisted; Male; Multimodal Imaging; Neoplasm | 2014 |
First imaging results of an intraindividual comparison of (11)C-acetate and (18)F-fluorocholine PET/CT in patients with prostate cancer at early biochemical first or second relapse after prostatectomy or radiotherapy.
Topics: Acetates; Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Humans; Ma | 2014 |
Diffusion-weighted MRI, 11C-choline PET and 18F-fluorodeoxyglucose PET for predicting the Gleason score in prostate carcinoma.
Topics: Adenocarcinoma; Aged; Biopsy; Carbon Radioisotopes; Choline; Diffusion Magnetic Resonance Imaging; F | 2014 |
Combined PET/MRI improves diagnostic accuracy in patients with prostate cancer: a prospective diagnostic trial.
Topics: Aged; Choline; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal | 2014 |
Value of fused 18F-Choline-PET/MRI to evaluate prostate cancer relapse in patients showing biochemical recurrence after EBRT: preliminary results.
Topics: Aged; Aged, 80 and over; Choline; Humans; Male; Neoplasm Recurrence, Local; Positron-Emission Tomogr | 2014 |
Dual-phase 11C-choline PET/computed tomography in the early evaluation of prostate cancer recurrence.
Topics: Aged; Carbon Radioisotopes; Choline; Feasibility Studies; Half-Life; Humans; Male; Multimodal Imagin | 2015 |
BAY 1075553 PET-CT for Staging and Restaging Prostate Cancer Patients: Comparison with [18F] Fluorocholine PET-CT (Phase I Study).
Topics: Aged; Aged, 80 and over; Bone Marrow; Choline; Fluorodeoxyglucose F18; Glutarates; Humans; Lymphatic | 2015 |
Repeatability of Quantitative 18F-Fluoromethylcholine PET/CT Studies in Prostate Cancer.
Topics: Aged; Choline; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prostati | 2016 |
(18)F-FACBC (anti1-amino-3-(18)F-fluorocyclobutane-1-carboxylic acid) versus (11)C-choline PET/CT in prostate cancer relapse: results of a prospective trial.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutan | 2016 |
(18)F-FACBC (anti1-amino-3-(18)F-fluorocyclobutane-1-carboxylic acid) versus (11)C-choline PET/CT in prostate cancer relapse: results of a prospective trial.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutan | 2016 |
(18)F-FACBC (anti1-amino-3-(18)F-fluorocyclobutane-1-carboxylic acid) versus (11)C-choline PET/CT in prostate cancer relapse: results of a prospective trial.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutan | 2016 |
(18)F-FACBC (anti1-amino-3-(18)F-fluorocyclobutane-1-carboxylic acid) versus (11)C-choline PET/CT in prostate cancer relapse: results of a prospective trial.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutan | 2016 |
18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies.
Topics: Adenocarcinoma; Aged; Choline; Humans; Image-Guided Biopsy; Magnetic Resonance Imaging; Male; Middle | 2016 |
Whole-body diffusion-weighted magnetic resonance imaging (WB-DW-MRI) vs choline-positron emission tomography-computed tomography (choline-PET/CT) for selecting treatments in recurrent prostate cancer.
Topics: Aged; Aged, 80 and over; Choline; Diffusion Magnetic Resonance Imaging; Humans; Male; Middle Aged; N | 2017 |
(18)F-Choline PET/CT imaging of RECIST measurable lesions in hormone refractory prostate cancer.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Case-Control Studies; Choline; Hormones; Humans; Male; Midd | 2009 |
Dynamic MRI and CAD vs. choline MRS: where is the detection level for a lesion characterisation in prostate cancer?
Topics: Aged; Biopsy; Choline; Diagnosis, Computer-Assisted; Humans; Magnetic Resonance Imaging; Magnetic Re | 2009 |
Detection of aggressive primary prostate cancer with 11C-choline PET/CT using multimodality fusion techniques.
Topics: Aged; Algorithms; Biomarkers, Tumor; Carbon Radioisotopes; Choline; Gene Expression Regulation, Neop | 2009 |
Preoperative detection of prostate cancer: a comparison with 11C-choline PET, 18F-fluorodeoxyglucose PET and MR imaging.
Topics: Adenocarcinoma; Aged; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Humans; Magnetic Resona | 2010 |
¹⁸F-Fluoromethylcholine (FCH) PET imaging in patients with castration-resistant prostate cancer: prospective comparison with standard imaging.
Topics: Aged; Aged, 80 and over; Choline; Follow-Up Studies; Humans; Male; Middle Aged; Orchiectomy; Positro | 2011 |
Prostate cancer: 1HMRS-DCEMR at 3T versus [(18)F]choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP).
Topics: Aged; Choline; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Age | 2012 |
[18F]fluoroethylcholine-PET/CT imaging for radiation treatment planning of recurrent and primary prostate cancer with dose escalation to PET/CT-positive lymph nodes.
Topics: Aged; Carcinoma; Choline; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Sta | 2011 |
Detection of recurrent prostate cancer with 18F-fluorocholine PET/CT in relation to PSA level at the time of imaging.
Topics: Aged; Aged, 80 and over; Choline; Disease Progression; Humans; Male; Middle Aged; Multimodal Imaging | 2012 |
11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer.
Topics: Aftercare; Aged; Aged, 80 and over; Biopsy, Needle; Brachytherapy; Choline; Cohort Studies; Humans; | 2003 |
11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer.
Topics: Aftercare; Aged; Aged, 80 and over; Biopsy, Needle; Brachytherapy; Choline; Cohort Studies; Humans; | 2003 |
11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer.
Topics: Aftercare; Aged; Aged, 80 and over; Biopsy, Needle; Brachytherapy; Choline; Cohort Studies; Humans; | 2003 |
11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer.
Topics: Aftercare; Aged; Aged, 80 and over; Biopsy, Needle; Brachytherapy; Choline; Cohort Studies; Humans; | 2003 |
Kinetics of [(11)C]choline uptake in prostate cancer: a PET study.
Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Humans; Image Interpretation, Computer-Assis | 2004 |
In vivo uptake of [11C]choline does not correlate with cell proliferation in human prostate cancer.
Topics: Aged; Carbon Radioisotopes; Cell Proliferation; Choline; Humans; Male; Middle Aged; Positron-Emissio | 2005 |
Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET.
Topics: Adult; Aged; Aged, 80 and over; Choline; Humans; Image Enhancement; Image Interpretation, Computer-A | 2006 |
Imaging prostate cancer with 11C-choline PET/CT.
Topics: Aged; Biopsy; Carbon Radioisotopes; Choline; Humans; Image Processing, Computer-Assisted; Male; Midd | 2006 |
Detection of pelvic lymph node metastases in patients with clinically localized prostate cancer: comparison of [18F]fluorocholine positron emission tomography-computerized tomography and laparoscopic radioisotope guided sentinel lymph node dissection.
Topics: Aged; Choline; Humans; Laparoscopy; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomog | 2006 |
Detection of bone metastases in patients with prostate cancer by 18F fluorocholine and 18F fluoride PET-CT: a comparative study.
Topics: Adult; Bone Neoplasms; Choline; Fluorine Radioisotopes; Humans; Male; Positron-Emission Tomography; | 2008 |
518 other studies available for choline and Prostatic Neoplasms
| Article | Year |
|---|---|
Detection rate of 18F-Choline positron emission tomography/computed tomography in patients with non-metastatic hormone sensitive and castrate resistant prostate cancer.
Topics: Choline; Hormones; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed T | 2023 |
An Incidental Uptake of 18F-Choline in Paraganglioma.
Topics: Choline; Humans; Male; Middle Aged; Paraganglioma; Paraganglioma, Extra-Adrenal; Positron Emission T | 2022 |
Absolute choline tissue concentration mapping for prostate cancer localization and characterization using 3D
Topics: Choline; Humans; Magnetic Resonance Spectroscopy; Male; Prostate; Prostatic Neoplasms; Water | 2022 |
COVID-19 Vaccination Manifesting as Unilateral Lymphadenopathies Detected by 18F-Choline PET/CT.
Topics: Aged; Choline; COVID-19; COVID-19 Vaccines; Humans; Lymphadenopathy; Male; Neoplasm Recurrence, Loca | 2022 |
Preclinical Investigation of Radiopharmaceuticals: An Accurate and Multidisciplinary Approach.
Topics: Animals; Cell Line, Tumor; Choline; Fluorine Radioisotopes; Humans; Male; Mice; Mice, Inbred NOD; Mi | 2022 |
Crosstalk of FGFR1 signaling and choline metabolism promotes cell proliferation and survival in prostate cancer cells.
Topics: Cell Line, Tumor; Cell Proliferation; Choline; Humans; Male; Prostate; Prostatic Neoplasms; Receptor | 2022 |
Incidental Finding of Testicular Seminoma by 18F-Choline PET/CT in a Prostate Cancer Patient.
Topics: Aged, 80 and over; Choline; Humans; Incidental Findings; Male; Positron Emission Tomography Computed | 2022 |
Detection of a second primary cancer in a 18F-fluorocholine PET/CT - multicentre retrospective analysis on a group of 1345 prostate cancer patients.
Topics: Choline; Humans; Male; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; | 2022 |
Diagnostic Performance of Preoperative Choline-PET/CT in Patients Undergoing Salvage Lymph Node Dissection for Recurrent Prostate Cancer: A Multicenter Experience.
Topics: Choline; Humans; Lymph Node Excision; Male; Neoplasm Recurrence, Local; Positron Emission Tomography | 2022 |
Vaccine-Related Lymph Nodes: The Emerging Pitfalls of 18F-Fluorocholine and 68Ga-PSMA-11 PET/CT in the Era of COVID-19 Vaccination.
Topics: Ad26COVS1; Choline; Cohort Studies; COVID-19; COVID-19 Vaccines; Fluorodeoxyglucose F18; Gallium Iso | 2022 |
[Intermediate-risk prostate cancer treated with exclusive external irradiation: Focus on anatomical sites of recurrence in two French trials].
Topics: Choline; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; | 2022 |
Detection of lymph node metastases in patients with prostate cancer: Comparing conventional and digital [
Topics: Choline; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Staging; Positron Emission Tomogr | 2022 |
Dictionary learning compressed sensing reconstruction: pilot validation of accelerated echo planar J-resolved spectroscopic imaging in prostate cancer.
Topics: Choline; Echo-Planar Imaging; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Magnet | 2022 |
Topics: Choline; Humans; Male; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; | 2022 |
Metastasis-directed Therapy Without Androgen Deprivation Therapy in Solitary Oligorecurrent Prostate Cancer.
Topics: Androgen Antagonists; Androgens; Choline; Humans; Lymphatic Metastasis; Male; Neoplasm Recurrence, L | 2022 |
Normalization of Liver Physiological Uptake as a Response Marker to Treatment in Prostate Cancer Liver Metastases Appearing as Photopenic on Baseline 18F-Fluorocholine PET/CT.
Topics: Bone Neoplasms; Choline; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Co | 2023 |
Superscan-Like Pattern on 18F-Choline PET/CT in a Patient With Essential Thrombocythemia.
Topics: Choline; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; | 2023 |
Nodular Fasciitis: False Positive on 18F-Piflufolastat and 11C-Choline PET/CT.
Topics: Carbon Radioisotopes; Choline; Fasciitis; Fibroma; Fluorine Radioisotopes; Humans; Male; Positron Em | 2023 |
Influence of molecular imaging on patient selection for treatment intensification prior to salvage radiation therapy for prostate cancer: a post hoc analysis of the PROPS trial.
Topics: Androgen Antagonists; Choline; Humans; Male; Neoplasm Recurrence, Local; Patient Selection; Positron | 2023 |
A False-Positive Bone Oligometastatic Prostate Cancer in 18 F-Choline PET/CT : Be Aware of Chronic Vascular Pitfalls.
Topics: Aged; Choline; Humans; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; | 2023 |
Evaluation of Treatment Response in Prostate Cancer and Renal Cell Carcinoma Patients Using 11C-choline PET/CT Findings.
Topics: Aged; Carbon Radioisotopes; Carcinoma, Renal Cell; Choline; Female; Humans; Male; Middle Aged; Neopl | 2019 |
18F-choline positron emission tomography/computed tomography for the detection of prostate cancer relapse: assessment of maximum standardized uptake value correlation with prostate-specific antigen levels.
Topics: Aged; Biological Transport; Choline; Humans; Male; Positron Emission Tomography Computed Tomography; | 2019 |
PSMA-negative prostate cancer and the continued value of choline-PET/CT.
Topics: Aged, 80 and over; Antigens, Surface; Choline; Glutamate Carboxypeptidase II; Humans; Male; Positron | 2020 |
Deep learning-based quantification of PET/CT prostate gland uptake: association with overall survival.
Topics: Adult; Aged; Aged, 80 and over; Choline; Deep Learning; Fluorine Radioisotopes; Humans; Image Interp | 2020 |
Nodular Fat-Sparing Hepatic Parenchyma as 11C-Choline-Avid Finding on PET/CT.
Topics: Adipose Tissue; Aged; Carbon Radioisotopes; Choline; Diagnosis, Differential; Humans; Liver; Male; M | 2020 |
18F-choline PET/CT driven salvage radiotherapy in prostate cancer patients: up-date analysis with 5-year median follow-up.
Topics: Aged; Aged, 80 and over; Choline; Disease Progression; Follow-Up Studies; Humans; Male; Middle Aged; | 2020 |
18F-choline PET/computed tomography and clinical parameters in the detection of significant prostate cancer in patients with increased prostate-specific antigen levels and previous negative biopsies.
Topics: Aged; Aged, 80 and over; Biopsy; Choline; Humans; Male; Middle Aged; Positron Emission Tomography Co | 2020 |
Editorial Comment.
Topics: Carbon Radioisotopes; Choline; Gallium Isotopes; Gallium Radioisotopes; Humans; Lymph Node Excision; | 2020 |
Editorial Comment.
Topics: Carbon Radioisotopes; Choline; Gallium Isotopes; Gallium Radioisotopes; Humans; Lymph Node Excision; | 2020 |
Peyronie Disease as an Example of Nononcological, Inflammatory Uptake of 18F-Fluorocholine in Patient With Prostate Cancer.
Topics: Aged; Choline; Humans; Inflammation; Male; Middle Aged; Penile Induration; Positron Emission Tomogra | 2020 |
COVID-19 pneumonia: increased choline uptake with 18F-choline PET/CT.
Topics: Choline; Coronavirus Infections; COVID-19; Disease Progression; Humans; Inflammation; Lung; Macropha | 2020 |
Incidental COVID-19 Pneumonia on 18F-Fluorocholine PET/CT.
Topics: Betacoronavirus; Choline; Coronavirus Infections; COVID-19; Humans; Male; Middle Aged; Pandemics; Pn | 2020 |
Diagnostic performance of imaging techniques for detecting of local recurrence after prostate brachytherapy.
Topics: Aged; Biopsy; Brachytherapy; Choline; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplas | 2020 |
10-Year Clinical Experience With 18F-Choline PET/CT: An Italian Multicenter Retrospective Assessment of 3343 Patients.
Topics: Aged; Aged, 80 and over; Choline; Humans; Male; Middle Aged; Neoplasm Grading; Positron Emission Tom | 2020 |
Topics: Adenocarcinoma; Aged; Betacoronavirus; Choline; Convalescence; Coronavirus Infections; COVID-19; Flu | 2020 |
Incidental Finding on 11C-Choline-PET/CT of Hepatocellular Carcinoma Recurrence in a Prostate Cancer Patient With Negative Abdominal CT Scan.
Topics: Aged; Carbon Radioisotopes; Carcinoma, Hepatocellular; Choline; Humans; Incidental Findings; Liver N | 2020 |
Incidental double neurinoma detected by 18F-choline PET/CT scan in a prostate cancer patient.
Topics: Aged; Choline; Humans; Incidental Findings; Male; Neurilemmoma; Positron Emission Tomography Compute | 2020 |
Does whole-body bone SPECT/CT provide additional diagnostic information over [18F]-FCH PET/CT for the detection of bone metastases in the setting of prostate cancer biochemical recurrence?
Topics: Aged; Bone Neoplasms; Choline; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomo | 2020 |
Negative 11C-choline PET/computed tomography imaging in restaging of patients with prostate cancer with serum prostate-specific antigen values >20 ng/mL.
Topics: Aged; Carbon Radioisotopes; Choline; False Negative Reactions; Humans; Male; Middle Aged; Neoplasm S | 2020 |
Can SUVmax of 68Ga-labeled PSMA Ligand and 18F-choline PET/CT Be Used to Predict the Radiation Dose in Prostate Cancer Patients?
Topics: Choline; Diagnostic Reference Levels; Fluorine Radioisotopes; Gallium Isotopes; Gallium Radioisotope | 2021 |
Penile Metastasis From Prostate Cancer Detected by 18F-Fluorocholine PET/CT.
Topics: Aged; Choline; Humans; Male; Middle Aged; Penile Neoplasms; Positron Emission Tomography Computed To | 2021 |
Thyroid and androgen receptor signaling are antagonized by μ-Crystallin in prostate cancer.
Topics: Cell Line, Tumor; Choline; Cohort Studies; Crystallins; Down-Regulation; Gene Expression Profiling; | 2021 |
Seminal Vesicle Urinary Reflux After TURP Mimicking Vesicular Invasion From Prostate Cancer on 18F-Choline PET/CT.
Topics: Aged; Choline; Diagnosis, Differential; Humans; Male; Middle Aged; Neoplasm Invasiveness; Positron E | 2021 |
Aggressive Bone Metastatic Prostate Cancer With Periosteal Reaction in 18F-Choline PET/CT.
Topics: Aged; Bone Neoplasms; Choline; Humans; Male; Osteogenesis; Positron Emission Tomography Computed Tom | 2021 |
Incidental Findings of a Vestibular Schwannoma on 18F-Choline PET/CT.
Topics: Aged; Bone Neoplasms; Brain; Choline; Humans; Incidental Findings; Magnetic Resonance Imaging; Male; | 2021 |
Iodinated Choline Transport-Targeted Tracers.
Topics: Animals; Apoptosis; Cell Proliferation; Choline; Fluorine Radioisotopes; Humans; Iodine Radioisotope | 2020 |
Radiomics analysis of 18F-Choline PET/CT in the prediction of disease outcome in high-risk prostate cancer: an explorative study on machine learning feature classification in 94 patients.
Topics: Artificial Intelligence; Choline; Humans; Machine Learning; Male; Neoplasm Recurrence, Local; Positr | 2021 |
11C-Choline PET/CT Depiction of Rectal Gastrointestinal Stromal Tumor.
Topics: Carbon Radioisotopes; Choline; Gastrointestinal Stromal Tumors; Humans; Male; Positron Emission Tomo | 2021 |
Prognostic Risk Classification for Biochemical Relapse-Free Survival in Oligometastatic Recurrent Prostate Cancer Determined by Choline PET.
Topics: Androgen Antagonists; Choline; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomograph | 2021 |
A retrospective study assessing the accuracy of [18F]-fluorocholine PET/CT for primary staging of lymph node metastases in intermediate and high-risk prostate cancer patients undergoing robotic-assisted laparoscopic prostatectomy with extended lymph node
Topics: Choline; Humans; Laparoscopy; Lymph Node Excision; Lymphatic Metastasis; Male; Neoplasm Staging; Pos | 2021 |
Skeletal Muscle Metastases in HCC Revealed by 18F-Choline PET/CT.
Topics: Aged; Carcinoma, Hepatocellular; Choline; Humans; Liver Neoplasms; Male; Muscle, Skeletal; Neoplasm | 2021 |
Comparison of MRI, PET, and 18F-choline PET/MRI in patients with oligometastatic recurrent prostate cancer.
Topics: Choline; Humans; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Positron Emission Tom | 2021 |
ASSESSMENT OF PATIENT'S RADIATION EXPOSURES RESULTED FROM PET/CT 18F-FCH AND 68GA-PSMA PROCEDURES.
Topics: Choline; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Positron Emission Tomography Compute | 2021 |
Fluorocholine PET in N-staging of primary prostate cancer - a nail in the coffin?
Topics: Choline; Humans; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals | 2021 |
Comparison between MRI and choline-PET trans-perineal target biopsies and saturation biopsies for detection and topography of intra-prostatic recurrence after primary radiation therapy for prostate cancer.
Topics: Biopsy; Choline; Humans; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Positron Emis | 2021 |
Utility of radiomic zones for risk classification and clinical outcome predictions using supervised machine learning during simultaneous
Topics: Choline; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Prostatic Neoplasms | 2021 |
Impact of pelvic dynamic acquisition on final reading of
Topics: Adenocarcinoma; Choline; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Em | 2022 |
Topics: Aged; Biopsy; Choline; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Middle | 2017 |
Role of PET-CT with
Topics: Aged; Aged, 80 and over; Choline; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Em | 2017 |
Clinical results and economic considerations of
Topics: Choline; Edetic Acid; Fluorine Radioisotopes; Gallium Isotopes; Gallium Radioisotopes; Humans; Isoto | 2017 |
Benefits of Using Stereotactic Body Radiotherapy in Patients With Metachronous Oligometastases of Hormone-Sensitive Prostate Cancer Detected by [18F]fluoromethylcholine PET/CT.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents, Hormonal; Choline; Combined Mo | 2017 |
18F-Fluorocholine PET/CT Complementing the Role of Dynamic Contrast-Enhanced MRI for Providing Comprehensive Diagnostic Workup in Prostate Cancer Patients With Suspected Relapse Following Radical Prostatectomy.
Topics: Aged; Choline; Contrast Media; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Stagi | 2017 |
Incidental Papillary Bladder Carcinoma on 18F-Fluoromethylcholine PET/CT Undertaken to Evaluate Prostate Malignancy.
Topics: Aged; Carcinoma, Papillary; Choline; Humans; Incidental Findings; Male; Positron Emission Tomography | 2017 |
Biopsy-Proven Diffuse Mediastinal Prostate Cancer Metastases Negative on 18F-Fluorocholine, Diagnosed on 68Ga-PSMA and 18F-PSMA PET/CT.
Topics: Aged; Biopsy; Choline; Edetic Acid; Fluorine Radioisotopes; Gallium Isotopes; Gallium Radioisotopes; | 2017 |
Identification of Recurrence Sites Following Post-Prostatectomy Treatment for Prostate Cancer Using
Topics: Aged; Choline; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal | 2018 |
11C-Choline PET/CT based Helical Tomotherapy as Treatment Approach for Bone Metastases in Recurrent Prostate Cancer Patients.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Choline; Humans; Lymphatic Metastasis | 2017 |
11C-Choline-Pet Guided Stereotactic Body Radiation Therapy for Lymph Node Metastases in Oligometastatic Prostate Cancer.
Topics: Aged; Carbon Radioisotopes; Choline; Disease-Free Survival; Humans; Kallikreins; Kaplan-Meier Estima | 2017 |
Target definition in salvage postoperative radiotherapy for prostate cancer: 18F-fluorocholine PET/CT assessment of local recurrence.
Topics: Aged; Choline; Fluorine Radioisotopes; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positr | 2018 |
Internal Auditory Canal Tumor as an Incidental Finding on a Choline PET/CT Scan in a Prostate Cancer Patient.
Topics: Aged, 80 and over; Bone Neoplasms; Choline; Humans; Incidental Findings; Male; Neuroma, Acoustic; Po | 2017 |
Effective Prostate-Specific Membrane Antigen-Based 18F-DCFPyL-Guided Cryoablation of a Single Positive Site in a Patient Believed to Be More Metastatic on 11C-Choline PET/CT.
Topics: Aged; Antigens, Surface; Carbon Radioisotopes; Choline; Cryosurgery; Glutamate Carboxypeptidase II; | 2017 |
Management of biochemically recurrent prostate cancer: molecular imaging perspective.
Topics: Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutanes; Humans; Male; Molecular Imaging; Neop | 2018 |
Editorial Comment.
Topics: Carbon Radioisotopes; Choline; Humans; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; | 2018 |
Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis.
Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Humans; Liver Neoplasms; Male; Middle Aged; | 2018 |
Diagnostic bone imaging in patients with prostate cancer: patient experience and acceptance of NaF-PET/CT, choline-PET/CT, whole-body MRI, and bone SPECT/CT.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choline; Humans; Magnetic Resonance Imaging; Male; Middle A | 2018 |
Topics: Aged; Aged, 80 and over; Choline; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Mi | 2018 |
Lung uptake of fluorine-18 fluoroethyl-choline PET-CT in patients with prostate cancer.
Topics: Aged; Biological Transport; Choline; Humans; Lung; Male; Positron Emission Tomography Computed Tomog | 2019 |
Prostate Cancer Lytic Bone Metastases Imaged With 18F-Fluorocholine PET/CT.
Topics: Aged; Bone Neoplasms; Choline; Humans; Male; Neoplasm Staging; Palliative Care; Positron Emission To | 2018 |
Virchow Node From Prostate Carcinoma by 18F-Choline PET/CT.
Topics: Aged; Choline; Humans; Lymph Nodes; Male; Positron Emission Tomography Computed Tomography; Prostati | 2018 |
Oligometastatic recurrent prostate cancer detects by fluorine-18-choline positron emission tomography/computed tomography in patients with prostate-specific antigen levels of up to 5 ng/ml.
Topics: Aged; Androgens; Choline; Humans; Male; Neoplasm Metastasis; Positron Emission Tomography Computed T | 2018 |
18F-fluorocholine PET/CT in patients with occult biochemical recurrence of prostate cancer: Detection rate, impact on management and adequacy of impact. A prospective multicentre study.
Topics: Aged; Aged, 80 and over; Choline; Fluorine Radioisotopes; Humans; Male; Middle Aged; Multimodal Imag | 2018 |
18F-Choline PET/MR Can Detect and Delineate Local Recurrence After High-Intensity Focused Ultrasound Therapy of Prostate Cancer.
Topics: Choline; Extracorporeal Shockwave Therapy; Humans; Magnetic Resonance Imaging; Male; Multimodal Imag | 2018 |
The relationship between local recurrences and distant metastases in prostate cancer: can
Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Humans; Male; Middle Aged; Neoplasm Metastas | 2018 |
Comparison of choline influx from dynamic
Topics: Aged; Aged, 80 and over; Biological Transport; Choline; Humans; Kinetics; Male; Middle Aged; Positro | 2018 |
Intensity-modulated radiotherapy of prostate cancer with simultaneous integrated boost after molecular imaging with 18F-choline-PET/CT : Clinical results and quality of life.
Topics: Aged; Aged, 80 and over; Choline; Follow-Up Studies; Humans; Male; Middle Aged; Molecular Imaging; P | 2018 |
Detection of the Prostate Cancer Bone Metastases: Is It Feasible to Compare 18F-fluorocholine PET/CT, 18F-fluorodeoxyglucose PET/CT and 99mTc-methyl Diphosphonate Bone Scintigraphy?
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hu | 2018 |
Diagnostic performance of a streamlined
Topics: Aged; Aged, 80 and over; Choline; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Em | 2018 |
Ectopic Salivary Gland in a Patient With Prostate Cancer at 18F-Choline PET/CT: An Incidental Finding.
Topics: Aged; Choline; Choristoma; Humans; Incidental Findings; Male; Positron Emission Tomography Computed | 2018 |
Clinical trials involving positron emission tomography and prostate cancer: an analysis of the ClinicalTrials.gov database.
Topics: Choline; Clinical Trials as Topic; Databases, Factual; Humans; Male; Positron-Emission Tomography; P | 2018 |
Diagnostic Performance of 11C-choline PET/CT and FDG PET/CT in Prostate Cancer.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Huma | 2018 |
Robotic salvage lymph node dissection for nodal-only recurrences after radical prostatectomy: Perioperative and early oncological outcomes.
Topics: Aged; Aged, 80 and over; Choline; Follow-Up Studies; Humans; Lymph Node Excision; Lymph Nodes; Male; | 2018 |
Role of 11C-choline PET/CT in radiation therapy planning of patients with prostate cancer.
Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Humans; Male; Middle Aged; Positron Emission | 2018 |
Hepatic Metastases From Prostatic Adenocarcinoma Without Elevated 18F-Choline Activity.
Topics: Adenocarcinoma; Aged; Biological Transport; Choline; Humans; Liver Neoplasms; Male; Positron Emissio | 2018 |
Characterization of prostate cancer with MR spectroscopic imaging and diffusion-weighted imaging at 3 Tesla.
Topics: Adult; Aged; Area Under Curve; Biopsy; Choline; Creatine; Diffusion Magnetic Resonance Imaging; Huma | 2019 |
Salvage extended field or involved field nodal irradiation in
Topics: Aged; Aged, 80 and over; Choline; Humans; Male; Middle Aged; Positron Emission Tomography Computed T | 2019 |
18F-Choline and 18F-FDG PET/CT in a Patient With Diffuse Large B-Cell Lymphoma and Recurrent Prostate Cancer.
Topics: Aged, 80 and over; Choline; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; P | 2018 |
Comparison of MRI Sequences in Whole-Body PET/MRI for Staging of Patients With High-Risk Prostate Cancer.
Topics: Choline; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Staging; Positron Em | 2019 |
Diagnostic performance of
Topics: Aged; Choline; Fluorine Radioisotopes; Follow-Up Studies; Humans; Male; Neoplasm Grading; Neoplasm R | 2019 |
Simple and broadly applicable automatic quality control for 3D
Topics: Algorithms; Choline; Humans; Image Processing, Computer-Assisted; Lipids; Magnetic Resonance Spectro | 2019 |
Sensitivity of fluorine-18-fluoromethylcholine PET/CT to prostate-specific antigen over different plasma levels: a retrospective study in a cohort of 192 patients with prostate cancer.
Topics: Aged; Aged, 80 and over; Choline; Humans; Male; Middle Aged; Positron Emission Tomography Computed T | 2019 |
Pleural Mesothelioma Detects by 18F-Choline PET/CT in a Patient With Biochemical Recurrence of Prostate Cancer.
Topics: Aged; Choline; Humans; Male; Mesothelioma; Pleural Neoplasms; Positron Emission Tomography Computed | 2019 |
Incidental Finding of Intrathyroid Metastases of Prostatic Cancer on 18F-Choline PET/CT.
Topics: Aged, 80 and over; Choline; Humans; Incidental Findings; Male; Positron Emission Tomography Computed | 2019 |
Effect of positive carbon-11-choline PET/CT results in the therapeutic management of prostate cancer biochemical relapse.
Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Humans; Male; Middle Aged; Positron Emission | 2019 |
68Ga-PSMA-11 PET-CT study in prostate cancer patients with biochemical recurrence and non-contributive 18F-Choline PET-CT: Impact on therapeutic decision-making and biomarker changes.
Topics: Aged; Aged, 80 and over; Choline; Decision Making; Edetic Acid; Gallium Isotopes; Gallium Radioisoto | 2019 |
18F-choline PET/CT incidental thyroid uptake in patients studied for prostate cancer.
Topics: Aged; Aged, 80 and over; Choline; Humans; Incidental Findings; Male; Middle Aged; Prostatic Neoplasm | 2019 |
Intramedullary Reactive Fibrosis as Mimic of Prostate Cancer Bone Metastasis on 11C-Choline Positron Emission and Computed Tomography.
Topics: Bone and Bones; Bone Neoplasms; Carbon Radioisotopes; Choline; Fibrosis; Humans; Male; Middle Aged; | 2019 |
Indeterminate single bone lesion on multimodality imaging of prostate cancer.
Topics: Adenocarcinoma; Aged; Bone Neoplasms; Choline; Diagnosis, Differential; Diphosphonates; Disease Prog | 2019 |
Prostate Osteoblast-Like Cells: A Reliable Prognostic Marker of Bone Metastasis in Prostate Cancer Patients.
Topics: Bone Neoplasms; Calcification, Physiologic; Calcinosis; Cell Differentiation; Cell Shape; Choline; E | 2018 |
Usefulness of 18F-fluorocoline PET/CT in prostate cancer patients with biochemical recurrence: Influence of PSA kinetics and hormone therapy.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Choline; Humans; Male; Middle Aged; Neoplasm Recurren | 2019 |
Dietary choline and betaine intakes and risk of total and lethal prostate cancer in the Atherosclerosis Risk in Communities (ARIC) Study.
Topics: Betaine; Choline; Cohort Studies; Diet; Humans; Male; Middle Aged; Proportional Hazards Models; Pros | 2019 |
Reirradiation of Locally Recurrent Prostate Cancer With Volumetric Modulated Arc Therapy.
Topics: Aged; Aged, 80 and over; Choline; Dose Fractionation, Radiation; Feasibility Studies; Humans; Male; | 2019 |
18F-Prostate-Specific Membrane Antigen 1007 and 18F-FCH PET/CT in Local Recurrence of Prostate Cancer.
Topics: Aged; Choline; Fluorine Radioisotopes; Humans; Male; Neoplasm Recurrence, Local; Niacinamide; Oligop | 2019 |
Outcomes after a first and/or second salvage treatment in patients with oligometastatic prostate cancer recurrence detected by (18-F) choline PET-CT.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Bone Neoplasms; Carcinoma; Choline; Fluori | 2019 |
Recurrent prostate cancer after radical prostatectomy: restaging performance of 18F-choline hybrid PET/MRI.
Topics: Aged; Aged, 80 and over; Choline; Fluorine Radioisotopes; Humans; Magnetic Resonance Imaging; Male; | 2019 |
68Ga-PSMA-617 Compared With 68Ga-RM2 and 18F-FCholine PET/CT for the Initial Staging of High-Risk Prostate Cancer.
Topics: Aged; Choline; Dipeptides; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Male; Neop | 2019 |
18F-Fluorocholine Uptake by a Head and Neck Meningeal Inflammatory Pseudotumor.
Topics: Choline; Granuloma, Plasma Cell; Humans; Male; Meninges; Middle Aged; Neck; Positron Emission Tomogr | 2019 |
Simultaneous 18F choline positron emission tomography/magnetic resonance imaging of the prostate: initial results.
Topics: Aged; Choline; Feasibility Studies; Fluorine Radioisotopes; Humans; Magnetic Resonance Imaging; Male | 2013 |
Recurrent prostatic adenocarcinoma with perineural spread to the lumbosacral plexus and sciatic nerve: comparing high resolution MRI with torso and endorectal coils and F-18 FDG and C-11 choline PET/CT.
Topics: Adenocarcinoma; Aged, 80 and over; Biopsy; Choline; Fluorodeoxyglucose F18; Humans; Lumbosacral Plex | 2013 |
Influence of androgen deprivation therapy on choline PET/CT in recurrent prostate cancer.
Topics: Androgen Antagonists; Androgens; Choline; Humans; Male; Multimodal Imaging; Neoplasm Recurrence, Loc | 2013 |
Comparison of 18F-FACBC and 11C-choline PET/CT in patients with radically treated prostate cancer and biochemical relapse: preliminary results.
Topics: Aged; Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutanes; Humans; Limit of Detection; Mal | 2013 |
Role of ¹⁸F-choline PET/CT in suspicion of relapse following definitive radiotherapy for prostate cancer.
Topics: Aged; Aged, 80 and over; Brachytherapy; Choline; Humans; Male; Middle Aged; Multimodal Imaging; Posi | 2013 |
Evaluation of extraprostatic disease in the staging of prostate cancer by F-18 choline PET/CT: can PSA and PSA density help in patient selection?
Topics: Aged; Aged, 80 and over; Choline; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; P | 2013 |
11C-choline PET/CT scan in patients with prostate cancer treated with intermittent ADT: a sequential PET/CT study.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Carbon Radioisotopes; Choline; Humans; Male; Multimod | 2013 |
Incidental 11C-choline PET/CT brain uptake due to meningioma in a patient studied for prostate cancer: correlation with MRI and imaging fusion.
Topics: Aged; Brain; Carbon Radioisotopes; Choline; Humans; Magnetic Resonance Imaging; Male; Meningeal Neop | 2013 |
The biodistribution and pharmacokinetic evaluation of choline-bound gold nanoparticles in a human prostate tumor xenograft model.
Topics: Animals; Cell Line, Tumor; Cell Survival; Choline; Gold; Humans; Male; Metal Nanoparticles; Mice; Ph | 2013 |
Utility of [11C]choline PET/CT in guiding lesion-targeted salvage therapies in patients with prostate cancer recurrence localized to a single lymph node at imaging: results from a pathologically validated series.
Topics: Aged; Androgen Antagonists; Carbon Radioisotopes; Choline; Humans; Lymph Node Excision; Lymph Nodes; | 2014 |
The role of 11C-choline PET imaging in the early detection of recurrence in surgically treated prostate cancer patients with very low PSA level <0.5 ng/mL.
Topics: Carbon Radioisotopes; Choline; Early Detection of Cancer; Humans; Logistic Models; Male; Middle Aged | 2013 |
Does 11C-choline PET-CT contribute to multiparametric MRI for prostate cancer localisation?
Topics: Aged; Carbon Radioisotopes; Choline; Humans; Image Enhancement; Image Interpretation, Computer-Assis | 2013 |
Sarcosine and other metabolites along the choline oxidation pathway in relation to prostate cancer--a large nested case-control study within the JANUS cohort in Norway.
Topics: Betaine; Biomarkers, Tumor; Case-Control Studies; Choline; Chromatography, Liquid; Cohort Studies; G | 2014 |
Metastatic prostate cancer proven by 18F-FCH PET/CT staging scan in patient with normal PSA but high PSA doubling time.
Topics: Choline; Fluorine Radioisotopes; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission | 2013 |
Comparison of integrated whole-body [11C]choline PET/MR with PET/CT in patients with prostate cancer.
Topics: Aged; Carbon Radioisotopes; Choline; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimod | 2013 |
Incidental detection of Leydig cell tumor via fluorine-18-Choline PET/CT in a patient with recurrent prostate cancer disease.
Topics: Choline; Fluorine Radioisotopes; Humans; Incidental Findings; Leydig Cell Tumor; Male; Neoplasm Recu | 2013 |
Thyroid lymphoma incidentally detected by 18F-fluorocholine (FCH) PET/CT.
Topics: Choline; Fluorine Radioisotopes; Humans; Incidental Findings; Lymphoma; Male; Middle Aged; Multimoda | 2013 |
11C choline PET guided salvage radiotherapy with volumetric modulation arc therapy and hypofractionation for recurrent prostate cancer after HIFU failure: preliminary results of tolerability and acute toxicity.
Topics: Aged; Aged, 80 and over; Choline; Diarrhea; Dose Fractionation, Radiation; Humans; Male; Middle Aged | 2014 |
[First experience of using positron emission tomography with 11C-choline in prostate cancer (PC)].
Topics: Aged; Carbon Radioisotopes; Choline; Diagnosis, Differential; Humans; Male; Middle Aged; Positron-Em | 2013 |
Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer.
Topics: Aged; Aged, 80 and over; Antigens, Surface; Choline; Gallium Radioisotopes; Glutamate Carboxypeptida | 2014 |
Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer.
Topics: Aged; Aged, 80 and over; Antigens, Surface; Choline; Gallium Radioisotopes; Glutamate Carboxypeptida | 2014 |
Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer.
Topics: Aged; Aged, 80 and over; Antigens, Surface; Choline; Gallium Radioisotopes; Glutamate Carboxypeptida | 2014 |
Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer.
Topics: Aged; Aged, 80 and over; Antigens, Surface; Choline; Gallium Radioisotopes; Glutamate Carboxypeptida | 2014 |
Writing PET into existence.
Topics: Antigens, Surface; Choline; Glutamate Carboxypeptidase II; Humans; Male; Multimodal Imaging; Positro | 2014 |
Isolated cerebellar metastasis from prostate adenocarcinoma diagnosed by 18F-fluorocholine PET/CT: a rare but not impossible complication.
Topics: Adenocarcinoma; Aged; Cerebellar Neoplasms; Choline; Humans; Male; Multimodal Imaging; Positron-Emis | 2014 |
Evaluation of the PET component of simultaneous [(18)F]choline PET/MRI in prostate cancer: comparison with [(18)F]choline PET/CT.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choline; Humans; Lymphatic Metastasis; Magnetic Resonance I | 2014 |
18F-FACBC compared with 11C-choline PET/CT in patients with biochemical relapse after radical prostatectomy: a prospective study in 28 patients.
Topics: Aged; Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutanes; Humans; Male; Middle Aged; Neop | 2014 |
¹⁸F-fluorocholine PET/CT compared with extended pelvic lymph node dissection in high-risk prostate cancer.
Topics: Aged; Biomarkers, Tumor; Choline; Cohort Studies; Fluorine Radioisotopes; Humans; Lymph Node Excisio | 2014 |
False-positive result in 18F-fluorocholine PET/CT due to incidental and ectopic parathyroid hyperplasia.
Topics: Choline; False Positive Reactions; Humans; Hyperplasia; Incidental Findings; Male; Middle Aged; Mult | 2014 |
MR spectroscopy of the prostate at 3T: measurements of relaxation times and quantification of prostate metabolites using water as an internal reference.
Topics: Adult; Aged; Biomarkers, Tumor; Body Water; Choline; Citric Acid; Creatine; Humans; Magnetic Resonan | 2013 |
Exploring the potential of [11C]choline-PET/CT as a novel imaging biomarker for predicting early treatment response in prostate cancer.
Topics: Androgens; Carbon Radioisotopes; Choline; Humans; Male; Multimodal Imaging; Neoadjuvant Therapy; Pos | 2014 |
Radiation dosimetry of 18F-fluorocholine PET/CT studies in prostate cancer patients.
Topics: Aged; Aged, 80 and over; Choline; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Organs at R | 2014 |
Prostate-specific antigen kinetics parameters are predictive of positron emission tomography features worsening in patients with biochemical relapse after prostate cancer treatment with radical intent: Results from a longitudinal cohort study.
Topics: Aged; Choline; Cohort Studies; Disease Progression; Humans; Kallikreins; Longitudinal Studies; Male; | 2014 |
Prospective comparison of computed tomography, diffusion-weighted magnetic resonance imaging and [11C]choline positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Diffusion Magnetic Resonance Imaging; | 2014 |
Spine metastases in prostate cancer: comparison of technetium-99m-MDP whole-body bone scintigraphy, [(18) F]choline positron emission tomography(PET)/computed tomography (CT) and [(18) F]NaF PET/CT.
Topics: Aged; Aged, 80 and over; Choline; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Pr | 2014 |
[11C]choline PET/CT impacts treatment decision making in patients with prostate cancer referred for radiotherapy.
Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Decision Making; Disease Management; Humans; | 2014 |
First case of 18F-FACBC PET/CT-guided salvage retroperitoneal lymph node dissection for disease relapse after radical prostatectomy for prostate cancer and negative 11C-choline PET/CT: new imaging techniques may expand pioneering approaches.
Topics: Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutanes; Humans; Lymph Node Excision; Lymphati | 2014 |
11C-choline PET/CT detects the site of relapse in the majority of prostate cancer patients showing biochemical recurrence after EBRT.
Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Humans; Male; Middle Aged; Multimodal Imagin | 2014 |
[Focus: Prostate cancer and PET-choline].
Topics: Bone Neoplasms; Choline; Fluorine Radioisotopes; Humans; Male; Positron-Emission Tomography; Prostat | 2014 |
(18)F-choline PET/CT pitfalls in image interpretation: an update on 300 examined patients with prostate cancer.
Topics: Aged; Aged, 80 and over; Biological Transport; Choline; Fluorine Radioisotopes; Humans; Image Interp | 2014 |
11C-choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy.
Topics: Androgen Antagonists; Carbon Radioisotopes; Choline; Disease-Free Survival; Humans; Image Processing | 2014 |
Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil.
Topics: Aged; Aged, 80 and over; Area Under Curve; Carbon Radioisotopes; Choline; Humans; Image Processing, | 2014 |
What is the role of [11C]choline PET/CT in decision making strategy before post-operative salvage radiation therapy in prostate cancer patients?
Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Decision Making; Humans; Male; Middle Aged; | 2014 |
Correlation of metabolic tumor volume and 11C-choline uptake with the pathology of prostate cancer: evaluation by use of simultaneously recorded MR and PET images.
Topics: Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Humans; Magnetic Resonance Imaging; M | 2014 |
The optimal timing to perform 18F/11C-choline PET/CT in patients with suspicion of relapse of prostate cancer: trigger PSA versus PSA velocity and PSA doubling time.
Topics: Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Humans; Male; Neoplasm Recurrence, Local; Pos | 2014 |
Non-invasive estimation of prostate cancer aggressiveness using diffusion-weighted MRI and 3D proton MR spectroscopy at 3.0 T.
Topics: Aged; Biomarkers, Tumor; Choline; Diffusion Magnetic Resonance Imaging; Humans; Image Interpretation | 2015 |
[Prostate carcinoma--18F-choline-PET/CT for relapse].
Topics: Androgens; Choline; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Prostate-Specifi | 2014 |
Detection of lymph node metastasis in patients with nodal prostate cancer relapse using (18)F/(11)C-choline positron emission tomography/computerized tomography.
Topics: Aged; Carbon Radioisotopes; Choline; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Neoplas | 2014 |
Unexpected diagnosis of peripheral schwannoma on 18F-fluoroethylcholine PET/CT for localization of prostate cancer recurrence and biopsy under real-time PET/ultrasound fusion guidance.
Topics: Aged; Choline; Humans; Image Processing, Computer-Assisted; Image-Guided Biopsy; Incidental Findings | 2014 |
Incidental 11C-choline PET/CT uptake due to esophageal carcinoma in a patient studied for prostate cancer.
Topics: Aged; Carbon Radioisotopes; Carcinoma; Choline; Esophageal Neoplasms; Humans; Incidental Findings; M | 2014 |
Is the detection rate of 18F-choline PET/CT influenced by androgen-deprivation therapy?
Topics: Aged; Aged, 80 and over; Androgens; Choline; Humans; Image Interpretation, Computer-Assisted; Male; | 2014 |
Quantitative evaluation of bone metastases from prostate cancer with simultaneous [18F] choline PET/MRI: combined SUV and ADC analysis.
Topics: Aged; Aged, 80 and over; Biological Transport; Bone Neoplasms; Carbon Radioisotopes; Choline; Diffus | 2014 |
(11)C-Choline PET/CT as a guide to radiation treatment planning of lymph-node relapses in prostate cancer patients.
Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Feasibility Studies; Humans; Lymphatic Metas | 2014 |
Squamous cell carcinoma of the tonsil incidentally detected by 18F-choline PET/CT.
Topics: Carcinoma, Squamous Cell; Choline; Humans; Incidental Findings; Male; Middle Aged; Multimodal Imagin | 2015 |
PET imaging with [⁶⁸Ga]NOTA-RGD for prostate cancer: a comparative study with [¹⁸F]fluorodeoxyglucose and [¹⁸F]fluoroethylcholine.
Topics: Affinity Labels; Animals; Biological Transport; Cell Line, Tumor; Choline; Coordination Complexes; F | 2014 |
Pattern of occult nodal relapse diagnosed with (18)F-fluoro-choline PET/CT in prostate cancer patients with biochemical failure after prostate-only radiotherapy.
Topics: Choline; Fluorine Radioisotopes; Humans; Kallikreins; Lymph Nodes; Lymphatic Metastasis; Male; Multi | 2014 |
Prostate cancer: combined FEC-PET/MRI improves diagnostic accuracy.
Topics: Choline; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; | 2014 |
Potential of hybrid ¹⁸F-fluorocholine PET/MRI for prostate cancer imaging.
Topics: Aged; Choline; Feasibility Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimoda | 2014 |
11C-Choline PET/CT in the primary diagnosis of prostate cancer: impact on treatment planning.
Topics: Aged; Biopsy; Bone Neoplasms; Carbon Radioisotopes; Choline; Humans; Lymphatic Metastasis; Male; Mid | 2015 |
Preoperative lymph node staging in patients with primary prostate cancer: comparison and correlation of quantitative imaging parameters in diffusion-weighted imaging and 11C-choline PET/CT.
Topics: Aged; Carbon Radioisotopes; Choline; Diffusion Magnetic Resonance Imaging; Humans; Lymph Nodes; Lymp | 2014 |
Multiparametric 3T MRI in the evaluation of intraglandular prostate cancer: correlation with histopathology.
Topics: Adult; Aged; Biomarkers, Tumor; Choline; Creatine; Humans; Image Interpretation, Computer-Assisted; | 2014 |
Early biochemical relapse after radical prostatectomy: which prostate cancer patients may benefit from a restaging 11C-Choline PET/CT scan before salvage radiation therapy?
Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Humans; Male; Middle Aged; Multimodal Imagin | 2014 |
Technical Note: evaluation of the uncertainties in (choline + creatine)/citrate ratios measured by proton MR spectroscopic imaging in patients suspicious for prostate cancer.
Topics: Adult; Aged; Algorithms; Biomarkers, Tumor; Choline; Citric Acid; Creatine; Humans; Magnetic Resonan | 2014 |
Furosemide diminishes ¹⁸F-fluoroethylcholine uptake in prostate cancer in vivo.
Topics: Aged; Biological Transport; Choline; Fluorodeoxyglucose F18; Furosemide; Humans; Male; Neoplasm Meta | 2014 |
Incidental diagnosis of diffuse large B-cell lymphoma by 11C-choline PET/CT in a patient with biochemical recurrence of prostate cancer.
Topics: Aged; Carbon Radioisotopes; Choline; Humans; Incidental Findings; Lymphoma, Large B-Cell, Diffuse; M | 2014 |
Intense 18F-choline uptake after minor head injury: misleading PET/CT result in a patient with biochemical relapse of prostate adenocarcinoma.
Topics: Adenocarcinoma; Choline; Diagnostic Errors; Humans; Male; Middle Aged; Multimodal Imaging; Positron- | 2014 |
Influence of hormonal therapy in prostate cancer patients undergoing [18F]fluoromethyl choline PET/CT: a retrospective study.
Topics: Aged; Aged, 80 and over; Biological Transport; Choline; Hormones; Humans; Male; Middle Aged; Positro | 2016 |
Combined PET imaging and diffusion-weighted imaging of intermediate and high-risk primary prostate carcinomas with simultaneous [18F] choline PET/MRI.
Topics: Aged; Aged, 80 and over; Biopsy; Choline; Diagnostic Imaging; Diffusion Magnetic Resonance Imaging; | 2014 |
Is radiocholine PET/CT already clinically useful in patients with prostate cancer?
Topics: Carbon Radioisotopes; Choline; Humans; Male; Prostatectomy; Prostatic Neoplasms; Radionuclide Imagin | 2014 |
¹⁸F-choline positron emission tomography/computed tomography-driven high-dose salvage radiation therapy in patients with biochemical progression after radical prostatectomy: feasibility study in 60 patients.
Topics: Aged; Aged, 80 and over; Choline; Disease Progression; Feasibility Studies; Fluorine Radioisotopes; | 2014 |
Toxicity and quality of life after choline-PET/CT directed salvage lymph node dissection and adjuvant radiotherapy in nodal recurrent prostate cancer.
Topics: Aged; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Humans; Lymph Node Excision; Lymphatic | 2014 |
Salvage lymph node dissection for prostate cancer nodal recurrence detected by 11C-choline positron emission tomography/computerized tomography.
Topics: Aged; Carbon Radioisotopes; Choline; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle | 2015 |
Comparison of [¹¹C]choline ([¹¹C]CHO) and S(+)-β-methyl-[¹¹C]choline ([¹¹C]SMC) as imaging probes for prostate cancer in a PC-3 prostate cancer xenograft model.
Topics: Animals; Carbon Radioisotopes; Cell Line, Tumor; Choline; Humans; Male; Mice, Nude; Molecular Probes | 2015 |
Impact of 11C-choline PET/CT on clinical decision making in recurrent prostate cancer: results from a retrospective two-centre trial.
Topics: Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Humans; Male; Middle Aged; Multimodal | 2014 |
11C-Choline PET/pathology image coregistration in primary localized prostate cancer.
Topics: Carbon Radioisotopes; Choline; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Predi | 2014 |
Temporal B0 field variation effects on MRSI of the human prostate at 7 T and feasibility of correction using an internal field probe.
Topics: Adenocarcinoma; Algorithms; Artifacts; Choline; Citrates; Feasibility Studies; Humans; Magnetic Reso | 2014 |
Clinical utility of (18)F-fluorocholine positron-emission tomography/computed tomography (PET/CT) in biochemical relapse of prostate cancer after radical treatment: results of a multicentre study.
Topics: Aged; Choline; Fluorine Radioisotopes; Humans; Male; Middle Aged; Positron-Emission Tomography; Pros | 2015 |
Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure?
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Brachytherapy; Carbon Radioisotopes; Choline; Humans; Lymph | 2017 |
Comparative effectiveness of [(18) F]-fluorocholine PET-CT and pelvic MRI with diffusion-weighted imaging for staging in patients with high-risk prostate cancer.
Topics: Aged; Choline; Fluorine Radioisotopes; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neopla | 2015 |
[18F]fluoromethylcholine as a chemotherapy response read-out in prostate cancer cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Choline; Docetaxel; Drug Screening Assays, Antitumor; Fluor | 2015 |
Role of 11C-choline positron emission tomography in prostate cancer recurrence--potential for delayed cure or just resetting the clock of the disease?
Topics: Carbon Radioisotopes; Choline; Humans; Lymph Node Excision; Male; Multimodal Imaging; Neoplasm Recur | 2015 |
Prostate cancer: Identifying sites of recurrence with choline-PET-CT imaging.
Topics: Carbon Radioisotopes; Choline; Humans; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Positro | 2015 |
(11)C-choline PET/CT and multiparametric MRI in patients with biochemical relapse of prostate cancer.
Topics: Adenocarcinoma; Bone Neoplasms; Carbon Radioisotopes; Choline; Combined Modality Therapy; Humans; Ly | 2015 |
Molecular imaging of prostate cancer: tapping into the opportunities.
Topics: Choline; Humans; Male; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; P | 2015 |
Gleason score at diagnosis predicts the rate of detection of 18F-choline PET/CT performed when biochemical evidence indicates recurrence of prostate cancer: experience with 1,000 patients.
Topics: Aged; Analysis of Variance; Biopsy; Choline; Humans; Male; Middle Aged; Multivariate Analysis; Neopl | 2015 |
Significant increase in detection of prostate cancer recurrence following radical prostatectomy with an early imaging acquisition protocol with ¹⁸F-fluorocholine positron emission tomography/computed tomography.
Topics: Aged; Choline; Early Detection of Cancer; Fluorine Radioisotopes; Follow-Up Studies; Humans; Male; M | 2015 |
Value of bimodal (18)F-choline-PET/MRI and trimodal (18)F-choline-PET/MRI/TRUS for the assessment of prostate cancer recurrence after radiation therapy and radical prostatectomy.
Topics: Aged; Aged, 80 and over; Choline; Diagnosis, Computer-Assisted; Fluorine Radioisotopes; Humans; Imag | 2015 |
The role of 18F-flourocholine PET/CT in biochemically relapsed prostate cancer: a case of osteolytic prostate metastasis.
Topics: Adenocarcinoma; Bone Neoplasms; Choline; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emi | 2015 |
Brain metastases in patient with prostate cancer found in 18F-choline PET/CT.
Topics: Aged; Brain Neoplasms; Choline; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Pros | 2015 |
Comparison between conventional imaging (abdominal-pelvic computed tomography and bone scan) and [(18)F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- tohigh-risk prostate cancer: A
Topics: Abdomen; Aged; Aged, 80 and over; Bone Neoplasms; Choline; Fluorine Radioisotopes; Humans; Lymph Nod | 2015 |
Final analysis of a prospective trial on functional imaging for nodal staging in patients with prostate cancer at high risk for lymph node involvement.
Topics: Aged; Biopsy; Carbon Radioisotopes; Choline; Diffusion Magnetic Resonance Imaging; Humans; Lymph Nod | 2015 |
Anthracosis mimicking mediastinal lymph node metastases with 18F-FCholine in high-risk prostate cancer.
Topics: Adenocarcinoma; Anthracosis; Choline; False Positive Reactions; Humans; Lymphatic Metastasis; Male; | 2015 |
Unusual lymph node metastases of prostate cancer detected by 18F-fluorocholine PET/CT.
Topics: Adenocarcinoma; Aged; Choline; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Positron-Emis | 2015 |
Incidental detection of colorectal cancer via 1(8)F-choline PET/CT in a patient with recurrent prostate cancer: usefulness of early images.
Topics: Aged; Carcinoma; Choline; Colorectal Neoplasms; Fluorine Radioisotopes; Humans; Incidental Findings; | 2015 |
Quantification of 18F-fluorocholine kinetics in patients with prostate cancer.
Topics: Aged; Calibration; Choline; Humans; Kinetics; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; | 2015 |
In reply to Zilli and Miralbell.
Topics: Choline; Fluorine Radioisotopes; Humans; Male; Neoplasm Recurrence, Local; Prostatic Neoplasms; Radi | 2015 |
High-dose salvage radiation therapy for prostate cancer after relapse: in regard to D'Angelillo et al.
Topics: Choline; Fluorine Radioisotopes; Humans; Male; Neoplasm Recurrence, Local; Prostatic Neoplasms; Radi | 2015 |
[¹¹C]Choline PET/CT predicts survival in hormone-naive prostate cancer patients with biochemical failure after radical prostatectomy.
Topics: Adenocarcinoma; Aged; Carbon Radioisotopes; Choline; Humans; Male; Middle Aged; Multimodal Imaging; | 2015 |
Use of 18F-choline positron emission tomography/CT in high-risk prostate cancer: a case of solitary adrenal metastasis.
Topics: Adenocarcinoma; Adrenal Gland Neoplasms; Adrenalectomy; Aged; Antineoplastic Agents, Hormonal; Bioma | 2015 |
Optimized protocol for (18)F-choline PET/CT in patients with biochemically relapsed prostate cancer: experiences on 250 consecutive cases.
Topics: Aged; Choline; Fluorine Radioisotopes; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emiss | 2015 |
[Biochemical recurrence after curative treatment for localized prostate cancer: Performance of choline PET/CT in the assessment of local recurrence].
Topics: Adenocarcinoma; Aged; Choline; Fluorine Radioisotopes; Humans; Male; Middle Aged; Multimodal Imaging | 2015 |
Usefulness of MRI-assisted metabolic volumetric parameters provided by simultaneous (18)F-fluorocholine PET/MRI for primary prostate cancer characterization.
Topics: Aged; Aged, 80 and over; Choline; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal | 2015 |
[11C-choline PET/CT in the diagnosis of prostate cancer -- Hungarian experience].
Topics: Aged; Carbon Radioisotopes; Choline; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Hungar | 2015 |
11C-choline PET/CT identifies osteoblastic and osteolytic lesions in patients with metastatic prostate cancer.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Choline; Humans; Male; Middle Aged; M | 2015 |
Asymptomatic metastasis to cricoid from prostate carcinoma: an incidental finding detected on 18F-choline PET/CT.
Topics: Choline; Humans; Incidental Findings; Laryngeal Neoplasms; Larynx; Male; Middle Aged; Multimodal Ima | 2015 |
(18)F-choline PET/CT for early detection of metastases in biochemical recurrence following radical prostatectomy.
Topics: Aged; Choline; Combined Modality Therapy; Diagnosis, Differential; Early Diagnosis; Fluorine Radiois | 2015 |
Volumetric modulated arc therapy planning for primary prostate cancer with selective intraprostatic boost determined by 18F-choline PET/CT.
Topics: Aged; Aged, 80 and over; Alpha Particles; Beta Particles; Choline; Feasibility Studies; Femur Head; | 2015 |
Comparison of [(11)C]choline Positron Emission Tomography With T2- and Diffusion-Weighted Magnetic Resonance Imaging for Delineating Malignant Intraprostatic Lesions.
Topics: Adult; Aged; Analysis of Variance; Carbon Radioisotopes; Choline; Diffusion Magnetic Resonance Imagi | 2015 |
Targeted salvage lymphadenectomy in patients treated with radical prostatectomy with biochemical recurrence: complete biochemical response without adjuvant therapy in patients with low volume lymph node recurrence over a long-term follow-up.
Topics: Aged; Biopsy, Needle; Choline; Cohort Studies; Follow-Up Studies; Humans; Immunohistochemistry; Lymp | 2015 |
PET/CT Dose Planning for Volumetric Modulated Arc Radiation Therapy (VMAT) -Comparison with Conventional Approach in Advanced Prostate Cancer Patients.
Topics: Aged; Aged, 80 and over; Choline; Fluorine Radioisotopes; Humans; Male; Middle Aged; Multimodal Imag | 2015 |
Incidental Detection of a Hodgkin Lymphoma on 18F-Choline PET/CT and Comparison With 18F-FDG in a Patient With Prostate Cancer.
Topics: Aged; Choline; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Incidental Findings; Male; Multimoda | 2015 |
Prostate-Specific Membrane Antigen PET/CT in Splenic Sarcoidosis.
Topics: Aged; Choline; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Magnetic Resonance Imag | 2015 |
Incidental Neurofibroma on 18F-Fluorocholine PET/MR.
Topics: Aged; Choline; Humans; Incidental Findings; Magnetic Resonance Imaging; Male; Neurofibroma; Positron | 2015 |
11C-Choline and 18F-FDG PET/CT in the Detection of Occult Prostate Cancer in the Context of a Paraneoplastic Syndrome.
Topics: Aged; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mal | 2015 |
Choline-positron emission tomography/CT in patients with relapsing prostate cancer: to be performed with therapeutic consequences only.
Topics: Choline; Humans; Male; Prostatic Neoplasms; Radiography; Radionuclide Imaging | 2015 |
Simplified Methods for Quantification of 18F-Fluoromethylcholine Uptake: Is SUVAUC,PP Actually an SUV?
Topics: Choline; Humans; Male; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals | 2015 |
18F-Fluciclovine PET/CT for the Detection of Prostate Cancer Relapse: A Comparison to 11C-Choline PET/CT.
Topics: Aged; Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutanes; Humans; Male; Middle Aged; Mult | 2015 |
Impact of 18F-Choline PET/CT in the Decision-Making Strategy of Treatment Volumes in Definitive Prostate Cancer Volumetric Modulated Radiation Therapy.
Topics: Aged; Choline; Clinical Decision-Making; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emi | 2015 |
Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy.
Topics: Aged; Aged, 80 and over; Antigens, Surface; Biopsy; Choline; False Positive Reactions; Gallium Radio | 2015 |
[Biochemical recurrence after curative treatment for localized prostate cancer: Performance of choline PET/CT in the assessment of local recurrence].
Topics: Choline; Fluorine Radioisotopes; Humans; Male; Positron-Emission Tomography; Prostatic Neoplasms; To | 2015 |
Prognostic value of metabolic parameters and clinical impact of ¹⁸F-fluorocholine PET/CT in biochemical recurrent prostate cancer.
Topics: Aged; Aged, 80 and over; Choline; Disease-Free Survival; Follow-Up Studies; Humans; Male; Middle Age | 2015 |
Significance of 18F-fluorocholine PET/CT positive pulmonary lesions in prostate cancer patients.
Topics: Aged; Choline; Comorbidity; Humans; Incidence; Incidental Findings; Lung Neoplasms; Male; Multimodal | 2015 |
18F-Choline PET/CT and Prostate MRI for Staging Patients With Biochemical Relapse After Irradiation for Prostate Cancer.
Topics: Aged; Case-Control Studies; Choline; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimod | 2015 |
Detection of local recurrence of prostate cancer after radical prostatectomy: Is there a role for early ¹⁸F-FCH PET/CT?
Topics: Aged; Choline; Humans; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomog | 2015 |
The nonspecific lymph node uptake of 18F-choline in patients with prostate cancer--a prospective observational study.
Topics: Aged; Aged, 80 and over; Biological Transport; Choline; Humans; Lymph Nodes; Male; Middle Aged; Pros | 2015 |
Index lesion characterization by (11)C-Choline PET/CT and Apparent Diffusion Coefficient parameters at 3 Tesla MRI in primary prostate carcinoma.
Topics: Aged; Biopsy; Carbon Radioisotopes; Carcinoma; Choline; Comparative Effectiveness Research; Diffusio | 2016 |
Radiation Treatment of Lymph Node Recurrence from Prostate Cancer: Is 11C-Choline PET/CT Predictive of Survival Outcomes?
Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Disease-Free Survival; Female; Humans; Image | 2015 |
Comparison of meta-analyses among elastosonography (ES) and positron emission tomography/computed tomography (PET/CT) imaging techniques in the application of prostate cancer diagnosis.
Topics: Choline; Elasticity Imaging Techniques; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomo | 2016 |
Contribution of Histopathologic Tissue Composition to Quantitative MR Spectroscopy and Diffusion-weighted Imaging of the Prostate.
Topics: Biomarkers, Tumor; Choline; Citric Acid; Creatine; Diffusion Magnetic Resonance Imaging; Humans; Ima | 2016 |
The ability of 18F-choline PET/CT to identify local recurrence of prostate cancer.
Topics: Aged; Aged, 80 and over; Choline; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence | 2015 |
Reply: Simplified Methods for Quantification of 18F-Fluoromethylcholine Uptake: Is SUVAUC,PP Actually an SUV?
Topics: Choline; Humans; Male; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals | 2015 |
Comparison of [(11)C]Choline ([(11)C]CHO) and [(18)F]Bombesin (BAY 86-4367) as Imaging Probes for Prostate Cancer in a PC-3 Prostate Cancer Xenograft Model.
Topics: Animals; Bombesin; Carbon Radioisotopes; Cell Line, Tumor; Choline; Fluorine Radioisotopes; Humans; | 2016 |
Prostate-specific antigen and radiolabelled choline PET/CT for the assessment of response to therapy: synergy or conflicting?
Topics: Biological Transport; Carbon Radioisotopes; Choline; Disease Progression; Humans; Male; Multimodal I | 2016 |
Pairwise comparison of 18F-FDG and 18F-FCH PET/CT in prostate cancer patients with rising PSA and known or suspected second malignancy.
Topics: Aged; Aged, 80 and over; Biological Transport; Choline; Fluorodeoxyglucose F18; Humans; Male; Neopla | 2016 |
Intensity-modulated salvage radiotherapy with simultaneous integrated boost for local recurrence of prostate carcinoma: a pilot study on the place of PET-choline for guiding target volume delineation.
Topics: Aged; Choline; Humans; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Pilot Projects; Positro | 2016 |
Choline-phospholipids inter-conversion is altered in elderly patients with prostate cancer.
Topics: Aged; Aged, 80 and over; Choline; Humans; Male; Phospholipids; Prostatic Neoplasms | 2016 |
PET/CT with (18)F-choline after radical prostatectomy in patients with PSA ≤2 ng/ml. Can PSA velocity and PSA doubling time help in patient selection?
Topics: Aged; Choline; Humans; Image Processing, Computer-Assisted; Kinetics; Male; Middle Aged; Patient Sel | 2016 |
[(18)F]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: preliminary results.
Topics: Aged; Choline; Contrast Media; Decision Making; Decision Support Techniques; Diffusion Magnetic Reso | 2016 |
18F-Choline PET/CT-Positive Lytic Bone Lesions in Prostate Cancer and Accidental Myeloma Detection.
Topics: Aged; Bone Neoplasms; Carcinoma; Choline; Humans; Incidental Findings; Male; Multiple Myeloma; Posit | 2016 |
PET/CT and MRI directed extended salvage radiotherapy in recurrent prostate cancer with lymph node metastases.
Topics: Aged; Choline; Cohort Studies; Contrast Media; Disease Progression; Follow-Up Studies; Humans; Lymph | 2016 |
Incidental Detection of Oxyphilic Papillary Thyroid Carcinoma by 18F-Fluorocholine PET/CT.
Topics: Aged; Biopsy, Fine-Needle; Carcinoma; Carcinoma, Neuroendocrine; Carcinoma, Papillary; Choline; Huma | 2016 |
Distribution of prostate nodes: a PET/CT-derived anatomic atlas of prostate cancer patients before and after surgical treatment.
Topics: Aged; Aged, 80 and over; Choline; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neop | 2016 |
68Ga-PSMA-PET/CT in Patients With Biochemical Prostate Cancer Recurrence and Negative 18F-Choline-PET/CT.
Topics: Aged; Aged, 80 and over; Antigens, Surface; Choline; Gallium Radioisotopes; Glutamate Carboxypeptida | 2016 |
Re: Incidental Detection of a Hodgkin Lymphoma on 18F-Choline PET/CT and Comparison With 18FDG PET/CT in a Patient With Prostate Cancer.
Topics: Choline; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Multimodal Imaging; Positron Emissio | 2016 |
Detection of recurrent prostate cancer lesions before salvage lymphadenectomy is more accurate with (68)Ga-PSMA-HBED-CC than with (18)F-Fluoroethylcholine PET/CT.
Topics: Aged; Choline; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Lymph Node Excision; Ma | 2016 |
Have we overcome choline PET/CT for early detection of prostate cancer recurrence?
Topics: Biomarkers, Tumor; Choline; Early Detection of Cancer; Edetic Acid; Evidence-Based Medicine; Gallium | 2016 |
[ROLE OF KINETIC PERFORMANCE OF PSA IN SELECTION OF THE PATIENTS FOR CONDUCTION OF 11C-CHOLINE PET/CT AIMED TO REVEAL LOCAL RECURRENCES OF PROSTATE CANCER].
Topics: Aged; Carbon Radioisotopes; Choline; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm | 2015 |
Brain 18F-choline PET/CT in primary diffuse leptomeningeal melanomatosis.
Topics: Adenocarcinoma; Choline; Humans; Male; Melanoma; Meningeal Carcinomatosis; Middle Aged; Neoplasms, M | 2016 |
Incidental Detection of a Hodgkin Lymphoma on 18F-Choline PET/CT and Comparison With 18FDG PET/CT in a Patient With Prostate Cancer: Reply.
Topics: Choline; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Multimodal Imaging; Positron Emissio | 2016 |
A pilot study of the utility of choline PET-CT in prostate cancer biochemical relapse following radical prostatectomy.
Topics: Choline; Humans; Longitudinal Studies; Male; Neoplasm Recurrence, Local; Pilot Projects; Positron Em | 2016 |
Toxicity and efficacy of salvage carbon 11-choline positron emission tomography/computed tomography-guided radiation therapy in patients with lymph node recurrence of prostate cancer.
Topics: Aged; Aged, 80 and over; Choline; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imagin | 2017 |
Can (68)GA-PSMA or radiolabeled choline PET/CT guide salvage lymph node dissection in recurrent prostate cancer?
Topics: Aged; Choline; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Isotope Labeling; Lymph | 2016 |
[Not Available].
Topics: Antigens, Surface; Choline; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Glutamate Carboxyp | 2015 |
Increased choline uptake in macrophages and prostate cancer cells does not allow for differentiation between benign and malignant prostate pathologies.
Topics: Biological Transport; Cell Line, Tumor; Choline; Diagnosis, Differential; Fluorodeoxyglucose F18; Hu | 2016 |
(11)C-Choline PET/CT for restaging prostate cancer. Results from 4,426 scans in a single-centre patient series.
Topics: Aged; Aged, 80 and over; Choline; Disease-Free Survival; Feasibility Studies; Humans; Italy; Lymphat | 2016 |
[PET/CT with 18F-Fluorocholine in Patients with Prostatic Cancer in Biochemical Recurrence].
Topics: Aged; Aged, 80 and over; Choline; Fluorine Radioisotopes; Humans; Male; Middle Aged; Neoplasm Recurr | 2016 |
No clinically relevant differences between positron emission tomography (PET) reconstructions based on low-dose or contrast-enhanced CT in combined integrated multiphase (18) F-Fluorethylcholine PET/CT for prostate cancer.
Topics: Aged; Choline; Contrast Media; Fluorine Radioisotopes; Humans; Image Processing, Computer-Assisted; | 2016 |
The effects of androgen deprivation therapy on the 18F-Chcoline uptake in prostate cancer patients undergoing neoadjuvant treatment.
Topics: Aged; Androgen Antagonists; Biological Transport; Choline; Humans; Male; Neoadjuvant Therapy; Neopla | 2019 |
Contemporary Mapping of Post-Prostatectomy Prostate Cancer Relapse with
Topics: Academic Medical Centers; Aged; Analysis of Variance; Biopsy, Needle; Carbon Radioisotopes; Choline; | 2017 |
Pituitary Non-Functioning Adenoma Disclosed at 18F-Choline PET/CT to Investigate a Prostate Cancer Relapse.
Topics: Adenoma; Choline; Humans; Incidental Findings; Male; Middle Aged; Pituitary Neoplasms; Positron Emis | 2016 |
Preclinical acute toxicity, biodistribution, pharmacokinetics, radiation dosimetry and microPET imaging studies of [(18)F]fluorocholine in mice.
Topics: Absorption, Radiation; Animals; Choline; Drug Evaluation, Preclinical; Humans; Male; Metabolic Clear | 2016 |
The aging effect on prostate metabolite concentrations measured by
Topics: Adult; Aged; Choline; Citrates; Creatinine; Decision Making; Humans; Magnetic Fields; Magnetic Reson | 2017 |
Quantification of metabolite concentrations in benign and malignant prostate tissues using 3D proton MR spectroscopic imaging.
Topics: Aged; Biomarkers, Tumor; Choline; Citric Acid; Humans; Imaging, Three-Dimensional; Male; Middle Aged | 2017 |
Comparison of
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choline; Edetic Acid; Gallium Isotopes; Gallium Radioisotop | 2017 |
[11C]Choline PET/CT in therapy response assessment of a neoadjuvant therapy in locally advanced and high risk prostate cancer before radical prostatectomy.
Topics: Aged; Antineoplastic Agents; Apoptosis; Biopsy; Carbon Isotopes; Choline; Humans; Lymph Nodes; Male; | 2016 |
Detection of a second malignancy in prostate cancer patients by using [(18)F]Choline PET/CT: a case series.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choline; Fluorodeoxyglucose F18; Humans; Kallikreins; Lung | 2016 |
Identification of Site-specific Recurrence Following Primary Radiation Therapy for Prostate Cancer Using C-11 Choline Positron Emission Tomography/Computed Tomography: A Nomogram for Predicting Extrapelvic Disease.
Topics: Aged; Carbon Radioisotopes; Choline; Humans; Logistic Models; Male; Middle Aged; Multivariate Analys | 2017 |
Breast Cancer Incidentally Detected by 18F-Choline PET/CT in a Patient With Recurrent Prostate Carcinoma.
Topics: Aged; Breast Neoplasms, Male; Carcinoma; Choline; Humans; Incidental Findings; Male; Positron Emissi | 2016 |
Topics: Aged; Choline; Humans; Image-Guided Biopsy; Magnetic Resonance Imaging, Interventional; Male; Middle | 2016 |
MR Spectroscopy in Prostate Cancer: New Algorithms to Optimize Metabolite Quantification.
Topics: Algorithms; Choline; Citric Acid; Creatine; Humans; Magnetic Resonance Spectroscopy; Male; Phantoms, | 2016 |
Choline Positron Emission Tomography/Computed Tomography for Selection of Patients for Salvage Strategies After Primary Local Treatment of Prostate Cancer and Rising Prostate-specific Antigen: Ready for Prime Time?
Topics: Carbon Radioisotopes; Choline; Humans; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Positro | 2017 |
Reply from Authors re: Alberto Bossi, Nicolas Mottet, Pierre Blanchard. Choline Positron Emission Tomography/Computed Tomography for Selection of Patients for Salvage Strategies After Primary Local Treatment of Prostate Cancer and Rising Prostate-specific
Topics: Carbon Radioisotopes; Choline; Humans; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Positro | 2017 |
How we read FCH-PET/CT for prostate cancer.
Topics: Aged; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; M | 2016 |
Evaluation of tumor recurrences after radical prostatectomy using 18F-Choline PET/CT and 3T multiparametric MRI without endorectal coil: a single center experience.
Topics: Aged; Choline; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Po | 2016 |
Salvage Lymph Node Dissection for Node-only Recurrence of Prostate Cancer: Ready for Prime Time?
Topics: Carbon Radioisotopes; Choline; Humans; Kallikreins; Lymph Node Excision; Lymph Nodes; Male; Neoplasm | 2017 |
Patterns of Recurrence After Postprostatectomy Fossa Radiation Therapy Identified by C-11 Choline Positron Emission Tomography/Computed Tomography.
Topics: Aged; Bone Neoplasms; Carbon Radioisotopes; Choline; Humans; Lymphatic Metastasis; Male; Middle Aged | 2017 |
Parathyroid Adenoma Mimicking a Malignant Lymph Node on 18F-Choline PET-CT.
Topics: Adenoma; Carcinoma; Choline; Diagnosis, Differential; Humans; Lymphatic Metastasis; Male; Middle Age | 2017 |
Long-term Results of a Comparative PET/CT and PET/MRI Study of 11C-Acetate and 18F-Fluorocholine for Restaging of Early Recurrent Prostate Cancer.
Topics: Acetates; Aged; Carbon; Choline; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal I | 2017 |
Prostate Cancer Imaging in the Era of Molecular Medicine.
Topics: Carbon Radioisotopes; Choline; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; N | 2017 |
Prostate biopsy guided by 18F-fluorocholine PET in men with persistently elevated PSA levels.
Topics: Aged; Biopsy, Needle; Choline; False Negative Reactions; Humans; Male; Middle Aged; Positron-Emissio | 2008 |
Effects of irradiation on the [Methyl-3H]choline uptake in the human prostate cancer cell lines LNCaP and PC3.
Topics: Cell Line, Tumor; Cell Survival; Choline; Dose-Response Relationship, Radiation; Humans; Male; Neopl | 2008 |
[Visualization of prostate cancer with 11C-choline positron emission tomography (PET): localization of primary and recurrent prostate cancer].
Topics: Aged; Carbon Radioisotopes; Choline; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron | 2008 |
[11C]Choline uptake with PET/CT for the initial diagnosis of prostate cancer: relation to PSA levels, tumour stage and anti-androgenic therapy.
Topics: Androgen Antagonists; Carbon Radioisotopes; Choline; Humans; Male; Neoplasm Staging; Positron-Emissi | 2008 |
Quantification of choline- and ethanolamine-containing metabolites in human prostate tissues using 1H HR-MAS total correlation spectroscopy.
Topics: Choline; Ethanolamine; Ethanolamines; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Ph | 2008 |
Two-dimensional spectroscopic imaging for pretreatment evaluation of prostate cancer: comparison with the step-section histology after radical prostatectomy.
Topics: Adult; Aged; Biopsy; Case-Control Studies; Choline; Citric Acid; Creatine; False Negative Reactions; | 2009 |
Two-dimensional MR spectroscopy of healthy and cancerous prostates in vivo.
Topics: Choline; Creatine; Epithelial Cells; Humans; Image Enhancement; Magnetic Resonance Spectroscopy; Mal | 2008 |
[(11)C]Choline positron emission tomography/computed tomography for staging and restaging of patients with advanced prostate cancer.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Choline; Humans; Male; Middle Aged; N | 2008 |
[11C]Choline PET/CT for targeted salvage lymph node dissection in patients with biochemical recurrence after primary curative therapy for prostate cancer. Preliminary results of a prospective study.
Topics: Aged; Biomarkers; Choline; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neo | 2008 |
C-11 choline PET/CT imaging for differentiating malignant from benign prostate lesions.
Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Diagnosis, Differential; Humans; Male; Middl | 2008 |
Simplified fast and high yielding automated synthesis of [18F]fluoroethylcholine for prostate cancer imaging.
Topics: Automation; Choline; Humans; Male; Molecular Structure; Prostatic Neoplasms; Radiochemistry; Time Fa | 2008 |
Prostate carcinoma: diffusion-weighted imaging as potential alternative to conventional MR and 11C-choline PET/CT for detection of bone metastases.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Choline; Diffusion Magnetic Resonance | 2008 |
Increased C-11 choline uptake in pagetic bone in a patient with coexisting skeletal metastases from prostate cancer.
Topics: Aged; Bone Neoplasms; Carbon Radioisotopes; Cell Proliferation; Choline; Diagnosis, Differential; Fe | 2008 |
Positron-emission tomography in imaging and staging prostate cancer.
Topics: Acetates; Aged; Biopsy; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Humans; Male; Neoplas | 2008 |
Regarding the focal treatment of prostate cancer: inference of the Gleason grade from magnetic resonance spectroscopic imaging.
Topics: Algorithms; Biopsy; Choline; Citric Acid; Creatine; Humans; Logistic Models; Magnetic Resonance Spec | 2009 |
High resolution magic angle spinning NMR spectroscopy for metabolic assessment of cancer presence and Gleason score in human prostate needle biopsies.
Topics: Biopsy, Needle; Choline; Creatinine; Humans; Magnetic Resonance Spectroscopy; Male; Prostatic Neopla | 2008 |
1H-MRSI of prostate cancer: the relationship between metabolite ratio and tumor proliferation.
Topics: Aged; Aged, 80 and over; Algorithms; Biomarkers, Tumor; Choline; Citric Acid; Creatine; Diagnosis, C | 2010 |
Reduced power magnetic resonance spectroscopic imaging of the prostate at 4.0 Tesla.
Topics: Adult; Biomarkers, Tumor; Choline; Citric Acid; Creatine; Electromagnetic Fields; Humans; Magnetic R | 2009 |
Three-phase 18F-fluorocholine PET/CT in the evaluation of prostate cancer recurrence.
Topics: Aged; Aged, 80 and over; Choline; Fluorine Radioisotopes; Humans; Male; Middle Aged; Neoplasm Recurr | 2009 |
[(11)C]choline PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy.
Topics: Aged; Choline; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; | 2009 |
Characterization of preclinical models of prostate cancer using PET-based molecular imaging.
Topics: Animals; Biological Transport; Carbon Radioisotopes; Cell Line, Tumor; Choline; Disease Models, Anim | 2009 |
Imaging of a paraganglioma on C-11 choline PET/CT.
Topics: Aged; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Humans; Incidental Findings; Male; Para | 2009 |
Characterization of choline uptake in prostate cancer cells following bicalutamide and docetaxel treatment.
Topics: Androgen Antagonists; Anilides; Antineoplastic Agents; Biological Transport; Cell Line, Tumor; Choli | 2009 |
Silibinin feeding alters the metabolic profile in TRAMP prostatic tumors: 1H-NMRS-based metabolomics study.
Topics: Adenocarcinoma; Animals; Biomarkers, Tumor; Choline; Citrates; Glucose; Inositol; Lipid Metabolism; | 2009 |
The role of PET/CT and current challenges in prostate cancer management.
Topics: Acetates; Bone Neoplasms; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Humans; Male; Posit | 2009 |
One-carbon metabolism and prostate cancer risk: prospective investigation of seven circulating B vitamins and metabolites.
Topics: Adult; Betaine; Case-Control Studies; Chi-Square Distribution; Choline; Cysteine; Humans; Male; Meth | 2009 |
Optimization of automated large-scale production of [(18)F]fluoroethylcholine for PET prostate cancer imaging.
Topics: Automation; Choline; Chromatography, High Pressure Liquid; Humans; Male; Positron-Emission Tomograph | 2009 |
Dual tracer 11C-choline and FDG-PET in the diagnosis of biochemical prostate cancer relapse after radical treatment.
Topics: Adult; Aged; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neopl | 2010 |
Influence of trigger PSA and PSA kinetics on 11C-Choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy.
Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Humans; Male; Metabolic Clearance Rate; Midd | 2009 |
Diffusion-weighted MR imaging: adjunct or alternative to T1-weighted MR imaging for prostate carcinoma bone metastases?
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Choline; Diffusion Magnetic Resonance | 2009 |
Dose-escalation using intensity-modulated radiotherapy for prostate cancer--evaluation of the dose distribution with and without 18F-choline PET-CT detected simultaneous integrated boost.
Topics: Aged; Choline; Fluorine Radioisotopes; Humans; Male; Middle Aged; Positron-Emission Tomography; Pros | 2009 |
Predictive factors of [(11)C]choline PET/CT in patients with biochemical failure after radical prostatectomy.
Topics: Aged; Aged, 80 and over; Choline; Humans; Italy; Male; Middle Aged; Positron-Emission Tomography; Pr | 2010 |
Peripheral zone prostate cancer. Pre-treatment evaluation with MR and 3D ¹H MR spectroscopic imaging: correlation with pathologic findings.
Topics: Aged; Biopsy; Choline; Creatine; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy | 2010 |
18F-fluorocholine PET-guided target volume delineation techniques for partial prostate re-irradiation in local recurrent prostate cancer.
Topics: Aged; Aged, 80 and over; Choline; Fluorine Radioisotopes; Humans; Male; Middle Aged; Neoplasm Recurr | 2009 |
Proton MRS detects metabolic changes in hormone sensitive and resistant human prostate cancer models CWR22 and CWR22r.
Topics: Androgens; Benzoquinones; Biomarkers, Tumor; Cell Line, Tumor; Choline; Humans; Lactams, Macrocyclic | 2009 |
Detection of local, regional, and distant recurrence in patients with psa relapse after external-beam radiotherapy using (11)C-choline positron emission tomography.
Topics: Aged; Carbon Radioisotopes; Choline; Follow-Up Studies; Humans; Male; Neoplasm Recurrence, Local; Po | 2010 |
Correlation of endorectal 2D JPRESS findings with pathological Gleason scores in prostate cancer patients.
Topics: Aged; Choline; Citric Acid; Creatine; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Pr | 2010 |
[Usefulness of PET scans in diagnosing recurrent prostate cancer. Prostate with PSA level < 5 ng/ml].
Topics: Adult; Aged; Choline; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; | 2009 |
MRI in the detection of prostate cancer: combined apparent diffusion coefficient, metabolite ratio, and vascular parameters.
Topics: Aged; Area Under Curve; Choline; Citric Acid; Contrast Media; Gadolinium DTPA; Humans; Image Interpr | 2009 |
[F(18)]-fluoroethylcholine combined in-line PET-CT scan for detection of lymph-node metastasis in high risk prostate cancer patients prior to radical prostatectomy: Preliminary results from a prospective histology-based study.
Topics: Choline; False Negative Reactions; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Positron | 2010 |
18F-choline PET/CT physiological distribution and pitfalls in image interpretation: experience in 80 patients with prostate cancer.
Topics: Aged; Aged, 80 and over; Brain; Choline; Humans; Image Interpretation, Computer-Assisted; Inflammati | 2010 |
Choline PET for monitoring early tumor response to photodynamic therapy.
Topics: Algorithms; Animals; Cell Line, Tumor; Cell Survival; Choline; Humans; Image Processing, Computer-As | 2010 |
Active inflammation in 18F-methylcholine PET/CT.
Topics: Aged; Choline; Humans; Inflammation; Male; Neoplasm Metastasis; Positron-Emission Tomography; Prosta | 2010 |
[18F]-fluorocholine positron-emission/computed tomography for lymph node staging of patients with prostate cancer: preliminary results of a prospective study.
Topics: Aged; Choline; Epidemiologic Methods; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; | 2010 |
Detection of synchronous primary breast and prostate cancer by F-18 fluorocholine PET/CT.
Topics: Aged; Breast Neoplasms; Choline; Humans; Male; Neoplasms, Multiple Primary; Positron-Emission Tomogr | 2010 |
Influence of trigger PSA and PSA kinetics on (11)C-choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy.
Topics: Carbon Radioisotopes; Choline; Humans; Kinetics; Male; Positron-Emission Tomography; Prostate-Specif | 2010 |
18F choline PET/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients.
Topics: Aged; Choline; Humans; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Stagi | 2010 |
Validation of automatic target volume definition as demonstrated for 11C-choline PET/CT of human prostate cancer using multi-modality fusion techniques.
Topics: Algorithms; Artificial Intelligence; Carbon Radioisotopes; Choline; Humans; Image Enhancement; Image | 2010 |
First results of [11C]choline PET/CT-guided secondary lymph node surgery in patients with PSA failure and single lymph node recurrence after radical retropubic prostatectomy.
Topics: Aged; Carbon Radioisotopes; Choline; Feasibility Studies; Germany; Humans; Lymph Node Excision; Lymp | 2010 |
PSA doubling time for prediction of [(11)C]choline PET/CT findings in prostate cancer patients with biochemical failure after radical prostatectomy.
Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Humans; Logistic Models; Male; Middle Aged; | 2010 |
3D MR-spectroscopic imaging assessment of metabolic activity in the prostate during the PSA "bounce" following 125iodine brachytherapy.
Topics: Brachytherapy; Choline; Citric Acid; Creatine; Humans; Iodine Radioisotopes; Magnetic Resonance Imag | 2011 |
Restricted water diffusibility as measured by diffusion-weighted MR imaging and choline uptake in (11)C-choline PET/CT are correlated in pelvic lymph nodes in patients with prostate cancer.
Topics: Aged; Carbon Radioisotopes; Choline; Diffusion Magnetic Resonance Imaging; Follow-Up Studies; Humans | 2011 |
[11C]Choline as pharmacodynamic marker for therapy response assessment in a prostate cancer xenograft model.
Topics: Animals; Biomarkers, Tumor; Carbon Radioisotopes; Cell Line, Tumor; Choline; Docetaxel; Humans; Male | 2010 |
Role of 11C-choline PET/CT in the restaging of prostate cancer patients showing a single lesion on bone scintigraphy.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Choline; Humans; Male; Middle Aged; N | 2010 |
The phosphoinositide 3-kinase inhibitor PI-103 downregulates choline kinase alpha leading to phosphocholine and total choline decrease detected by magnetic resonance spectroscopy.
Topics: Adenocarcinoma; Cell Line, Tumor; Choline; Choline Kinase; Down-Regulation; Furans; HCT116 Cells; Hu | 2010 |
Tumor volume and metabolism of prostate cancer determined by proton magnetic resonance spectroscopic imaging at 3T without endorectal coil reveal potential clinical implications in the context of radiation oncology.
Topics: Aged; Biomarkers, Tumor; Choline; Citric Acid; Creatine; Humans; Magnetic Resonance Spectroscopy; Ma | 2011 |
Metabolic signatures of malignant progression in prostate epithelial cells.
Topics: Amino Acids; Animals; Biomarkers, Tumor; Cell Line; Choline; Disease Progression; Epithelial Cells; | 2011 |
[11C]choline positron emission tomography/computerized tomography to restage prostate cancer cases with biochemical failure after radical prostatectomy and no disease evidence on conventional imaging.
Topics: Aged; Aged, 80 and over; Choline; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm St | 2010 |
Response assessment of hormonal therapy in prostate cancer by [11C] choline PET/CT.
Topics: Antineoplastic Agents, Hormonal; Carbon Radioisotopes; Choline; Humans; Male; Middle Aged; Positron- | 2010 |
Pilot comparison of F-fluorocholine and F-fluorodeoxyglucose PET/CT with conventional imaging in prostate cancer.
Topics: Aged; Choline; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Stagin | 2010 |
Is there a role for ¹¹C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml?
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Carbon Radioisotopes; Choline; Early Detection of Can | 2011 |
Detection of fully refocused polyamine spins in prostate cancer at 7 T.
Topics: Biomarkers, Tumor; Choline; Citric Acid; Creatine; Humans; Magnetic Resonance Spectroscopy; Male; Po | 2011 |
Intensity-modulated radiotherapy for prostate cancer implementing molecular imaging with 18F-choline PET-CT to define a simultaneous integrated boost.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Biopsy; Choline; Dose Fractionation, Radia | 2010 |
Quantitative (1) H MR spectroscopic imaging of the prostate gland using LCModel and a dedicated basis-set: correlation with histologic findings.
Topics: Adenocarcinoma; Choline; Citric Acid; Creatine; Humans; In Vitro Techniques; Magnetic Resonance Spec | 2011 |
Colchicine must be stopped before imaging with [18F]-methylcholine PET/CT.
Topics: Aged; Choline; Colchicine; Humans; Male; Neoplasm Staging; Positron-Emission Tomography; Prostatic N | 2010 |
The rising PET: the increasing use of choline PET/CT in prostate cancer.
Topics: Carbon Radioisotopes; Choline; Humans; Male; Positron-Emission Tomography; Prostatic Neoplasms; Tomo | 2011 |
[¹⁸F]-fluorocholine positron-emission/computed tomography for lymph node staging of patients with prostate cancer: preliminary results of a prospective study.
Topics: Choline; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Positron-Emission Tomography; Prostatic Ne | 2011 |
Re: 11Ccholine positron emission tomography/computerized tomography to restage prostate cancer cases with biochemical failure after radical prostatectomy and no disease evidence on conventional imaging. G. Giovacchini, M. Picchio, A. Briganti, C. Cozzarin
Topics: Choline; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; P | 2011 |
Human prostate cell lines from normal and tumourigenic epithelia differ in the pattern and control of choline lipid headgroups released into the medium on stimulation of protein kinase C.
Topics: Cell Line, Tumor; Choline; Culture Media; Epithelium; Gene Expression Regulation, Enzymologic; Gene | 2011 |
Robotic image-guided stereotactic radiotherapy, for isolated recurrent primary, lymph node or metastatic prostate cancer.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Carbon Radioisotopes; Choline; Disease-Free Survival; | 2012 |
Prospective evaluation of 11C-choline positron emission tomography/computed tomography and diffusion-weighted magnetic resonance imaging for the nodal staging of prostate cancer with a high risk of lymph node metastases.
Topics: Adenocarcinoma; Aged; Carbon Radioisotopes; Choline; Diffusion Magnetic Resonance Imaging; Humans; L | 2011 |
In vivo assessment of prostate cancer aggressiveness using magnetic resonance spectroscopic imaging at 3 T with an endorectal coil.
Topics: Adult; Aged; Biomarkers, Tumor; Biopsy; Choline; Citric Acid; Creatine; Equipment Design; Humans; Ma | 2011 |
Gastrin-releasing peptide receptor-based targeting using bombesin analogues is superior to metabolism-based targeting using choline for in vivo imaging of human prostate cancer xenografts.
Topics: Animals; Bombesin; Cell Line, Tumor; Cell Transformation, Neoplastic; Choline; Fluorine Radioisotope | 2011 |
Safety and feasibility of image-guided robotic radiosurgery for patients with limited bone metastases of prostate cancer.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choline; Feasibility Studies; Fluorine Radioisotopes; Follo | 2013 |
The sensitivity of [11C]choline PET/CT to localize prostate cancer depends on the tumor configuration.
Topics: Aged; Choline; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prostatic | 2011 |
¹⁸F-Fluorocholine integrated PET/MRI for the initial staging of prostate cancer.
Topics: Choline; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-E | 2011 |
Histopathological correlation of (11)C-choline PET scans for target volume definition in radical prostate radiotherapy.
Topics: Aged; Analysis of Variance; Choline; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Male | 2011 |
Early choline levels from 3-tesla MR spectroscopy after exclusive radiation therapy in patients with clinically localized prostate cancer are predictive of plasmatic levels of PSA at 1 year.
Topics: Aged; Androgen Antagonists; Body Water; Chemotherapy, Adjuvant; Choline; Citric Acid; Humans; Magnet | 2011 |
Influence of (11)C-choline PET/CT on the treatment planning for salvage radiation therapy in patients with biochemical recurrence of prostate cancer.
Topics: Aged; Carbon Radioisotopes; Choline; Humans; Logistic Models; Lymphatic Metastasis; Male; Middle Age | 2011 |
Androgen deprivation therapy influences the uptake of 11C-choline in patients with recurrent prostate cancer: the preliminary results of a sequential PET/CT study.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Androgens; Anilides; Biological Transport; Carbon Rad | 2011 |
Do androgens control the uptake of 18F-FDG, 11C-choline and 11C-acetate in human prostate cancer cell lines?
Topics: Acetates; Androgens; Biological Transport; Carbon Radioisotopes; Cell Line, Tumor; Choline; Fluorode | 2011 |
Fluorocholine (18F) and sodium fluoride (18F) PET/CT in the detection of prostate cancer: prospective comparison of diagnostic performance determined by masked reading.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choline; Fluorine Radioisotopes; Humans; Male; Middle Aged; | 2011 |
Role of ¹¹C-choline positron emission tomography/computed tomography in evaluating patients affected by prostate cancer with suspected relapse due to prostate-specific antigen elevation.
Topics: Aged; Choline; Contrast Media; Endpoint Determination; Humans; Male; Multimodal Imaging; Neoplasm Re | 2011 |
Correlation of phospholipid metabolites with prostate cancer pathologic grade, proliferative status and surgical stage - impact of tissue environment.
Topics: Aged; Cell Proliferation; Choline; Ethanolamine; Humans; Ki-67 Antigen; Male; Neoplasm Staging; Phos | 2011 |
Pelvic/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C]choline positron emission tomography/computed tomography.
Topics: Aged; Choline; Disease-Free Survival; Feasibility Studies; Humans; Italy; Kaplan-Meier Estimate; Lym | 2011 |
Assessment of PET tracer uptake in hormone-independent and hormone-dependent xenograft prostate cancer mouse models.
Topics: Animals; Carbon Radioisotopes; Cell Line, Tumor; Choline; Dideoxynucleosides; Fluorodeoxyglucose F18 | 2011 |
Salvage lymph node dissection in recurrent prostate cancer patients.
Topics: Choline; Humans; Lymph Node Excision; Lymph Nodes; Male; Multimodal Imaging; Positron-Emission Tomog | 2011 |
Do we have to withdraw antiandrogenic therapy in prostate cancer patients before PET/CT with [11C]choline?
Topics: Androgen Antagonists; Androgens; Choline; Humans; Male; Multimodal Imaging; Positron-Emission Tomogr | 2011 |
[11C]Choline PET/CT detection of bone metastases in patients with PSA progression after primary treatment for prostate cancer: comparison with bone scintigraphy.
Topics: Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Carbon Radioisotopes; Choline; Humans; Male | 2012 |
A phase and frequency alignment protocol for 1H MRSI data of the prostate.
Topics: Algorithms; Choline; Citric Acid; Computer Simulation; Creatine; Databases, Factual; Humans; Magneti | 2012 |
Choline phosphorylation and regulation of transcription of choline kinase α in hypoxia.
Topics: Base Sequence; Cell Hypoxia; Cell Line, Tumor; Choline; Choline Kinase; Down-Regulation; Electrophor | 2012 |
Use of [11C]choline PET-CT as a noninvasive method for detecting pelvic lymph node status from prostate cancer and relationship with choline kinase expression.
Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Choline Kinase; Humans; Immunohistochemistry | 2011 |
Mediastinal lymph node uptake in patients with prostate carcinoma on F18-choline PET/CT.
Topics: Aged; Choline; Fluorine Radioisotopes; Humans; Lymph Nodes; Male; Mediastinum; Middle Aged; Multimod | 2011 |
Feasibility of TCP-based dose painting by numbers applied to a prostate case with (18)F-choline PET imaging.
Topics: Algorithms; Artifacts; Choline; Feasibility Studies; Humans; Image Processing, Computer-Assisted; Ma | 2012 |
Relationship between PSA kinetics and [18F]fluorocholine PET/CT detection rates of recurrence in patients with prostate cancer after total prostatectomy.
Topics: Aged; Aged, 80 and over; Choline; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kinetics; Lymph | 2012 |
Nonlinear compartmental model of 18F-choline.
Topics: Choline; Humans; Kidney; Liver; Male; Metabolic Clearance Rate; Models, Biological; Nonlinear Dynami | 2012 |
Progression of prostate carcinogenesis and dietary methyl donors: temporal dependence.
Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Cell Transformation, Neoplastic; Choline; Dec | 2012 |
[11C]-choline PET/CT in imaging locally advanced prostate cancer.
Topics: Aged; Carbon Radioisotopes; Choline; Humans; Male; Multimodal Imaging; Neoplasm Recurrence, Local; P | 2011 |
Influence of PSA, PSA velocity and PSA doubling time on contrast-enhanced 18F-choline PET/CT detection rate in patients with rising PSA after radical prostatectomy.
Topics: Aged; Aged, 80 and over; Choline; Contrast Media; Humans; Kinetics; Male; Middle Aged; Multimodal Im | 2012 |
Evaluation of deuterated 18F- and 11C-labeled choline analogs for cancer detection by positron emission tomography.
Topics: Animals; Carbon Radioisotopes; Cell Line, Tumor; Choline; Deuterium; Disease Models, Animal; Fluorod | 2012 |
Effect of gold marker seeds on magnetic resonance spectroscopy of the prostate.
Topics: Biomarkers; Choline; Citrates; Creatine; Fiducial Markers; Gold; Humans; Magnetic Resonance Spectros | 2012 |
Choline PET/CT compared with bone scintigraphy in the detection of bone metastases in prostate cancer patients.
Topics: Bone and Bones; Bone Neoplasms; Choline; Humans; Male; Multimodal Imaging; Positron-Emission Tomogra | 2012 |
Is there an additional value of ¹¹C-choline PET-CT to T2-weighted MRI images in the localization of intraprostatic tumor nodules?
Topics: Aged; Biopsy; Carbon Radioisotopes; Choline; Humans; Magnetic Resonance Imaging; Male; Middle Aged; | 2012 |
Dose-escalation using intensity-modulated radiotherapy for prostate cancer - evaluation of quality of life with and without (18)F-choline PET-CT detected simultaneous integrated boost.
Topics: Aged; Aged, 80 and over; Choline; Dose-Response Relationship, Radiation; Fluorine Radioisotopes; Hum | 2012 |
[68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH.
Topics: Aged; Antigens, Surface; Choline; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Glutamate Ca | 2012 |
Compressive sensing could accelerate 1H MR metabolic imaging in the clinic.
Topics: Algorithms; Analysis of Variance; Aspartic Acid; Brain Neoplasms; Choline; Citric Acid; Creatine; Da | 2012 |
Measurement of circulating cell-free DNA in relation to 18F-fluorocholine PET/CT imaging in chemotherapy-treated advanced prostate cancer.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bioma | 2012 |
Prostate-specific antigen velocity versus prostate-specific antigen doubling time for prediction of 11C choline PET/CT in prostate cancer patients with biochemical failure after radical prostatectomy.
Topics: Carbon Radioisotopes; Choline; Hormones; Humans; Kinetics; Logistic Models; Male; Multimodal Imaging | 2012 |
Unusual F-18 choline uptake in penile metastasis from prostate cancer.
Topics: Biological Transport; Choline; Fluorine Radioisotopes; Humans; Male; Middle Aged; Multimodal Imaging | 2012 |
[11C]choline PET for the intraprostatic tumor characterization and localization in recurrent prostate cancer after EBRT.
Topics: Aged; Carbon Radioisotopes; Choline; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; | 2012 |
Clinical impact of 18F-choline PET/CT in patients with recurrent prostate cancer.
Topics: Adult; Aged; Choline; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; P | 2012 |
Value of PET/CT and MR lymphography in treatment of prostate cancer patients with lymph node metastases.
Topics: Aged; Carbon Radioisotopes; Choline; Contrast Media; Dextrans; Humans; Lymph Nodes; Lymphatic Metast | 2012 |
Introducing parametric fusion PET/MRI of primary prostate cancer.
Topics: Carbon Radioisotopes; Choline; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imagi | 2012 |
Locally advanced prostate cancer: three-dimensional magnetic resonance spectroscopy to monitor prostate response to therapy.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Choline; Combined Moda | 2012 |
Targeting free prostate-specific antigen for in vivo imaging of prostate cancer using a monoclonal antibody specific for unique epitopes accessible on free prostate-specific antigen alone.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Autoradiography; Choline; Feasibility Studies; Fluo | 2012 |
Combined 18F-fluorocholine and 18F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer.
Topics: Aged; Bone Neoplasms; Choline; Fluorides; Fluorine Radioisotopes; Humans; Lymphatic Metastasis; Male | 2012 |
Changes in gene transcription underlying the aberrant citrate and choline metabolism in human prostate cancer samples.
Topics: Aconitate Hydratase; ATP Citrate (pro-S)-Lyase; Choline; Choline Kinase; Citric Acid; Gene Expressio | 2012 |
[18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
Topics: Aged; Bone Neoplasms; Choline; Fluorine Radioisotopes; Humans; Lymph Node Excision; Lymph Nodes; Lym | 2012 |
A compartmental model for biokinetics and dosimetry of 18F-choline in prostate cancer patients.
Topics: Aged; Choline; Fluorine Radioisotopes; Humans; Kinetics; Male; Middle Aged; Models, Biological; Pros | 2012 |
Incidental finding of parathyroid adenoma with 11C-choline PET/CT.
Topics: Adenoma; Aged; Carbon Radioisotopes; Choline; Humans; Incidental Findings; Male; Multimodal Imaging; | 2012 |
Role of 11C-choline PET/CT in the re-staging of prostate cancer patients with biochemical relapse and negative results at bone scintigraphy.
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Bone and Bones; Carbon Radioisotopes; Choline; Humans; M | 2012 |
Intensity modulated radiation therapy dose painting for localized prostate cancer using ¹¹C-choline positron emission tomography scans.
Topics: Aged; Carbon Radioisotopes; Choline; Feasibility Studies; Humans; Male; Middle Aged; Models, Biologi | 2012 |
Benign fibrous dysplasia on [(11)C]choline PET: a potential mimicker of disease in patients with biochemical recurrence of prostate cancer.
Topics: Aged; Carbon Radioisotopes; Choline; Diagnosis, Differential; Fibrous Dysplasia of Bone; Humans; Mal | 2012 |
Diagnosis of penile metastases of prostatic origin with 11C-Choline PET/CT.
Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Carbon Radioisotopes; Choline; Combined Modality Th | 2012 |
[18F]choline positron emission tomography in prostate cancer patients with biochemical recurrence after radical prostatectomy: influence of antiandrogen therapy - a preliminary study.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Choline; Fluorine Radioisotopes; Follow-Up Studies; H | 2012 |
Impact of total PSA, PSA doubling time and PSA velocity on detection rates of 11C-Choline positron emission tomography in recurrent prostate cancer.
Topics: Aged; Biomarkers, Tumor; Carbon Radioisotopes; Choline; Disease Progression; Humans; Kallikreins; Ma | 2013 |
[Metabolic and osteogenic pattern of prostate cancer bone metastases].
Topics: Aged; Bone Neoplasms; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Humans; Male; Multimoda | 2013 |
Target volume definition in high-risk prostate cancer patients using sentinel node SPECT/CT and 18 F-choline PET/CT.
Topics: Aged; Choline; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lym | 2012 |
A case of multimodality multiparametric 11C-choline PET/MR for biopsy targeting in prior biopsy-negative primary prostate cancer.
Topics: Aged; Biopsy; Carbon Radioisotopes; Choline; Humans; Magnetic Resonance Imaging; Male; Positron-Emis | 2012 |
18F-Fluoroethylcholine PET/CT identifies lymph node metastasis in patients with prostate-specific antigen failure after radical prostatectomy but underestimates its extent.
Topics: Aged; Choline; Disease Progression; Humans; Kallikreins; Lymph Node Excision; Lymph Nodes; Lymphatic | 2013 |
Choline intake and risk of lethal prostate cancer: incidence and survival.
Topics: Adult; Aged; Betaine; Choline; Cohort Studies; Diet; Disease Progression; Follow-Up Studies; Health | 2012 |
The promise of choline-PET/CT in the detection of recurrent prostate cancer: what are the limits of our investigation?
Topics: Choline; Humans; Kallikreins; Lymph Nodes; Male; Multimodal Imaging; Positron-Emission Tomography; P | 2013 |
PET/CT and choline: diagnosis and staging.
Topics: Choline; Humans; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prostatic | 2012 |
Restaging prostate cancer patients with biochemical failure with PET/CT and radiolabeled choline.
Topics: Choline; Humans; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prostate- | 2012 |
PET/CT in prostate cancer: non-choline radiopharmaceuticals.
Topics: Choline; Humans; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prostatic | 2012 |
[11C]Choline-PET/CT for outcome prediction of salvage radiotherapy of local relapsing prostate carcinoma.
Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Humans; Male; Middle Aged; Multimodal Imagin | 2012 |
Correlation of [11C]choline PET-CT with time to treatment and disease-specific survival in men with recurrent prostate cancer after radical prostatectomy.
Topics: Aged; Carbon Radioisotopes; Choline; Disease-Free Survival; Humans; Male; Prostate-Specific Antigen; | 2012 |
In-vivo metabolic characterization of healthy prostate and orthotopic prostate cancer in rats using proton magnetic resonance spectroscopy at 4.7 T.
Topics: Animals; Cell Line, Tumor; Choline; Creatine; Humans; Inositol; Magnetic Resonance Imaging; Magnetic | 2013 |
Dual-phase PET-CT to differentiate [18F]Fluoromethylcholine uptake in reactive and malignant lymph nodes in patients with prostate cancer.
Topics: Aged; Aged, 80 and over; Choline; Humans; Lymph Nodes; Male; Middle Aged; Multimodal Imaging; Positr | 2012 |
Operational characteristics of (11)c-choline positron emission tomography/computerized tomography for prostate cancer with biochemical recurrence after initial treatment.
Topics: Adult; Aged; Carbon Radioisotopes; Choline; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm | 2013 |
(11)C-Choline PET/CT in patients with hormone-resistant prostate cancer showing biochemical relapse after radical prostatectomy.
Topics: Aged; Aged, 80 and over; Biopsy; Carbon Isotopes; Choline; Hormones; Humans; Image Processing, Compu | 2013 |
[11C]choline positron emission tomography/computerized tomography for early detection of prostate cancer recurrence in patients with low increasing prostate specific antigen.
Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Early Detection of Cancer; Humans; Male; Mid | 2013 |
[Pitfalls with 18F-choline PET/CT in patients with prostate cancer].
Topics: Choline; False Positive Reactions; Fluorine Radioisotopes; Humans; Male; Multimodal Imaging; Positro | 2013 |
Predictive factors of [18F]-Choline PET/CT in 170 patients with increasing PSA after primary radical treatment.
Topics: Aged; Carcinoma; Choline; Cohort Studies; Fluorine Radioisotopes; Humans; Male; Middle Aged; Multimo | 2013 |
FDA approves 11C-choline for PET in prostate cancer.
Topics: Carbon Radioisotopes; Choline; Diagnostic Test Approval; Humans; Male; Positron-Emission Tomography; | 2012 |
Role of 18F-choline PET/CT in biochemically relapsed prostate cancer after radical prostatectomy: correlation with trigger PSA, PSA velocity, PSA doubling time, and metastatic distribution.
Topics: Aged; Aged, 80 and over; Choline; Humans; Male; Middle Aged; Multimodal Imaging; Multivariate Analys | 2013 |
Spatially matched in vivo and ex vivo MR metabolic profiles of prostate cancer -- investigation of a correlation with Gleason score.
Topics: Aged; Aged, 80 and over; Choline; Citric Acid; Creatine; Humans; Magnetic Resonance Spectroscopy; Ma | 2013 |
Bone metastases from prostate cancer: 18F-fluoride PET/CT in a patient with discordant bone scintigraphy and 11C-choline PET/CT.
Topics: Bone Neoplasms; Carbon Radioisotopes; Choline; Fluorides; Fluorine Radioisotopes; Humans; Male; Mult | 2013 |
18F-fluorocholine uptake in a case of adrenal incidentaloma: possible diagnostic pitfall or potential tool for adrenocortical tumors characterization?
Topics: Adrenal Gland Neoplasms; Aged; Biological Transport; Choline; False Positive Reactions; Humans; Imag | 2013 |
Effect of erythropoietin on bone marrow uptake of 18F-fluorocholine in prostate cancer: comparison with 18F-fluoride uptake.
Topics: Aged; Biological Transport; Bone Marrow; Choline; Erythropoietin; Fluorides; Fluorine Radioisotopes; | 2013 |
Tumour volume delineation in prostate cancer assessed by [11C]choline PET/CT: validation with surgical specimens.
Topics: Algorithms; Carbon Radioisotopes; Carcinoma; Choline; Humans; Image Processing, Computer-Assisted; M | 2013 |
[[¹¹C]choline as a pharmacodynamic marker for docetaxel therapy. Response assessment in a LNCaP prostate cancer xenograft mouse model].
Topics: Animals; Antineoplastic Agents; Carbon Radioisotopes; Cell Line, Tumor; Choline; Docetaxel; Male; Mi | 2013 |
2D JPRESS of human prostates using an endorectal receiver coil.
Topics: Adult; Biomarkers, Tumor; Choline; Citric Acid; Creatine; Humans; Magnetic Resonance Spectroscopy; M | 2002 |
Visualization of prostate cancer with 11C-choline positron emission tomography.
Topics: Aged; Carbon Radioisotopes; Choline; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; | 2002 |
Positive [11C]choline and negative [18F]FDG with positron emission tomography in recurrence of prostate cancer.
Topics: Adenocarcinoma; Aged; Bone Neoplasms; Choline; False Negative Reactions; Fluorodeoxyglucose F18; Hum | 2002 |
Proton two-dimensional chemical shift imaging for evaluation of prostate cancer: external surface coil vs. endorectal surface coil.
Topics: Adult; Aged; Choline; Citric Acid; Creatine; Humans; Magnetic Resonance Imaging; Magnetic Resonance | 2002 |
[The (11C) acetate positron emission tomography in prostatic carcinoma. New prospects in metabolic imaging].
Topics: Acetates; Adenocarcinoma; Amino Acids; Biopsy; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18 | 2002 |
Intraindividual comparison of [11C]acetate and [11C]choline PET for detection of metastases of prostate cancer.
Topics: Acetates; Aged; Aged, 80 and over; Biological Transport; Biopsy; Carbon Radioisotopes; Choline; Huma | 2003 |
Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET.
Topics: Adenocarcinoma; Aged; Carbon Radioisotopes; Choline; Humans; Image Processing, Computer-Assisted; Ly | 2003 |
Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography.
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; H | 2003 |
Pathologic characterization of human prostate tissue with proton MR spectroscopy.
Topics: Adenocarcinoma; Biomarkers, Tumor; Choline; Citrates; Creatinine; Diagnosis, Differential; Humans; L | 2003 |
Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging--initial results.
Topics: Choline; Citric Acid; Creatine; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; | 2003 |
Proton magnetic resonance spectroscopy with a body coil in the diagnosis of carcinoma prostate.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Choline; Citric Acid; Creatine; Diagnosis, Differential; | 2004 |
Metabolic response of the CWR22 prostate tumor xenograft after 20 Gy of radiation studied by 1H spectroscopic imaging.
Topics: Animals; Choline; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Mice; N | 2003 |
Dynamic magnetic resonance tomography and proton magnetic resonance spectroscopy of prostate cancers in rats treated by radiotherapy.
Topics: Animals; Antigens, CD34; Choline; Creatine; Disease Models, Animal; Immunohistochemistry; Magnetic R | 2004 |
Is 11C-choline the most appropriate tracer for prostate cancer? Against.
Topics: Carbon Radioisotopes; Choline; Clinical Trials as Topic; Evidence-Based Medicine; Humans; Male; Posi | 2004 |
Is 11C-choline the most appropriate tracer for prostate cancer? For.
Topics: Carbon Radioisotopes; Choline; Clinical Trials as Topic; Evidence-Based Medicine; Humans; Male; Posi | 2004 |
Highly efficient automated synthesis of [(11)C]choline for multi dose utilization.
Topics: Automation; Carbon Isotopes; Choline; Humans; Indicators and Reagents; Isotope Labeling; Male; Prost | 2004 |
[11C]Choline as a PET biomarker for assessment of prostate cancer tumor models.
Topics: Animals; Carbon Radioisotopes; Choline; Disease Models, Animal; Humans; Male; Mice; Positron-Emissio | 2004 |
Synthesis and preclinical evaluation of the choline transport tracer deshydroxy-[18F]fluorocholine ([18F]dOC).
Topics: Animals; Biological Transport; Biomarkers, Tumor; Cell Line, Tumor; Choline; Dose-Response Relations | 2004 |
Prostate cancer localization with 18fluorine fluorocholine positron emission tomography.
Topics: Aged; Aged, 80 and over; Choline; Fluorine Radioisotopes; Humans; Male; Middle Aged; Neoplasm Stagin | 2005 |
Prostate cancer localization with 18fluorine fluorocholine positron emission tomography.
Topics: Aged; Aged, 80 and over; Choline; Fluorine Radioisotopes; Humans; Male; Middle Aged; Neoplasm Stagin | 2005 |
Prostate cancer localization with 18fluorine fluorocholine positron emission tomography.
Topics: Aged; Aged, 80 and over; Choline; Fluorine Radioisotopes; Humans; Male; Middle Aged; Neoplasm Stagin | 2005 |
Prostate cancer localization with 18fluorine fluorocholine positron emission tomography.
Topics: Aged; Aged, 80 and over; Choline; Fluorine Radioisotopes; Humans; Male; Middle Aged; Neoplasm Stagin | 2005 |
11C-choline positron emission tomography in prostate cancer: primary staging and recurrent site staging.
Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Drug Combinations; Feasibility Studies; Huma | 2005 |
In vivo prostate magnetic resonance spectroscopic imaging using two-dimensional J-resolved PRESS at 3 T.
Topics: Choline; Citrates; Creatine; Humans; Magnetic Resonance Spectroscopy; Male; Phantoms, Imaging; Prost | 2005 |
Sequence design for magnetic resonance spectroscopic imaging of prostate cancer at 3 T.
Topics: Choline; Citrates; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Phantoms, Imaging; Pr | 2005 |
Optimal timing for in vivo 1H-MR spectroscopic imaging of the human prostate at 3T.
Topics: Choline; Citric Acid; Computer Simulation; Humans; Magnetic Resonance Spectroscopy; Male; Phantoms, | 2005 |
Prostate cancer: a comparative study of 11C-choline PET and MR imaging combined with proton MR spectroscopy.
Topics: Aged; Biopsy; Carbon Radioisotopes; Choline; Citrates; Creatine; Humans; Magnetic Resonance Spectros | 2005 |
Detection and localization of prostate cancer: correlation of (11)C-choline PET/CT with histopathologic step-section analysis.
Topics: Aged; Choline; Female; Humans; Image Enhancement; Male; Middle Aged; Neoplasm Staging; Positron-Emis | 2005 |
Magnetic resonance spectroscopy in patients with locally confined prostate cancer: association of prostatic citrate and metabolic atrophy with time on hormone deprivation therapy, PSA level, and biopsy Gleason score.
Topics: Aged; Angiogenesis Inhibitors; Atrophy; Biomarkers, Tumor; Biopsy; Choline; Citric Acid; Cross-Secti | 2007 |
Distant metastasis of prostate cancer: early detection of recurrent tumor with dual-phase carbon-11 choline positron emission tomography/computed tomography in two cases.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Hormonal; Carbon Radioisotopes; Choline; Early Diagnosi | 2006 |
[18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients.
Topics: Aged; Aged, 80 and over; Cell Differentiation; Cell Proliferation; Choline; Humans; Male; Middle Age | 2006 |
11C-choline positron emission tomography/computerized tomography for tumor localization of primary prostate cancer in comparison with 12-core biopsy.
Topics: Aged; Biopsy, Needle; Carbon Radioisotopes; Choline; Humans; Male; Middle Aged; Positron-Emission To | 2006 |
High-resolution 3D MR spectroscopic imaging of the prostate at 3 T with the MLEV-PRESS sequence.
Topics: Aged; Algorithms; Choline; Citrates; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dim | 2006 |
Value of 11C-choline PET and PET/CT in patients with suspected prostate cancer.
Topics: Aged; Aged, 80 and over; Algorithms; Carbon Radioisotopes; Choline; Humans; Image Enhancement; Image | 2007 |
18F-choline PET/CT for initial staging of advanced prostate cancer.
Topics: Aged; Bone Neoplasms; Choline; Humans; Male; Neoplasm Staging; Positron-Emission Tomography; Prostat | 2006 |
Effect of hypoxia on the uptake of [methyl-3H]choline, [1-14C] acetate and [18F]FDG in cultured prostate cancer cells.
Topics: Acetates; Adenosine Triphosphate; Carbon Radioisotopes; Cell Count; Cell Hypoxia; Cell Line, Tumor; | 2006 |
High-grade prostatic intraepithelial neoplasia in patients with prostate cancer: MR and MR spectroscopic imaging features--initial experience.
Topics: Aged; Cell Nucleus; Cell Nucleus Size; Choline; Citric Acid; Cohort Studies; Creatine; Humans; Image | 2007 |
3D-segmentation of the 18F-choline PET signal for target volume definition in radiation therapy of the prostate.
Topics: Choline; Humans; Imaging, Three-Dimensional; Male; Positron-Emission Tomography; Prostate; Prostatic | 2007 |
11C-choline positron-emission tomography/computed tomography and transrectal ultrasonography for staging localized prostate cancer.
Topics: Aged; Carbon Radioisotopes; Choline; Humans; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Stag | 2007 |
Detection and management of isolated lymph node recurrence in patients with PSA relapse.
Topics: Choline; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Prosta | 2007 |
Editorial comment on: Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy.
Topics: Aged; Choline; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurr | 2007 |
Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy.
Topics: Aged; Choline; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurr | 2007 |
Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy.
Topics: Aged; Choline; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurr | 2007 |
Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy.
Topics: Aged; Choline; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurr | 2007 |
Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy.
Topics: Aged; Choline; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurr | 2007 |
18F-choline and/or 11C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (<1 ng/mL) after radical prostatectomy.
Topics: Acetates; Aged; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Human | 2007 |
[18F]fluorocholine PET/CT in the assessment of bone metastases in prostate cancer.
Topics: Bone Neoplasms; Choline; Hormones; Humans; Male; Neoplasm Metastasis; Positron-Emission Tomography; | 2007 |
Prostate and lymph node proton magnetic resonance (MR) spectroscopic imaging with external array coils at 3 T to detect recurrent prostate cancer after radiation therapy.
Topics: Adenocarcinoma; Aged; Choline; Humans; Image Processing, Computer-Assisted; Lymph Node Excision; Lym | 2007 |
[Pro and contra: 11C choline PET in diagnosis of prostate cancer].
Topics: Carbon Radioisotopes; Choline; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imagi | 2007 |
The impact of urinary excretion of (18)F-labeled choline analogs.
Topics: Carboxylic Acids; Choline; Cyclobutanes; Fluorine Radioisotopes; Humans; Male; Positron-Emission Tom | 2007 |
11C/ 18F-choline PET or 11C/18F-acetate PET in prostate cancer: may a choice be recommended?
Topics: Acetates; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Humans; Image Enhancement; Male; Po | 2007 |
Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT.
Topics: Adult; Aged; Biopsy; Carbon Radioisotopes; Choline; Humans; Image Processing, Computer-Assisted; Ima | 2007 |
[Comparison of the accuracy of manual and automatic evaluation of MR spectra in prostate carcinoma].
Topics: Choline; Citrates; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic | 2007 |
Evaluation of [11C]-choline positron-emission/computed tomography in patients with increasing prostate-specific antigen levels after primary treatment for prostate cancer.
Topics: Aged; Choline; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm St | 2007 |
Evaluation of [11C]-choline positron-emission/computed tomography in patients with increasing prostate-specific antigen levels after primary treatment for prostate cancer.
Topics: Aged; Choline; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm St | 2007 |
Evaluation of [11C]-choline positron-emission/computed tomography in patients with increasing prostate-specific antigen levels after primary treatment for prostate cancer.
Topics: Aged; Choline; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm St | 2007 |
Evaluation of [11C]-choline positron-emission/computed tomography in patients with increasing prostate-specific antigen levels after primary treatment for prostate cancer.
Topics: Aged; Choline; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm St | 2007 |
[11C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy.
Topics: Adenocarcinoma; Aged; Biopsy; Carbon Radioisotopes; Choline; Follow-Up Studies; Humans; Male; Middle | 2008 |
The detection rate of [11C]choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Carbon Radioisotopes; Choline; Humans; Male; Middle A | 2008 |
Could choline PET play a role in malignancies other than prostate cancer?
Topics: Carbon Radioisotopes; Choline; Humans; Male; Neoplasms; Positron-Emission Tomography; Prostatic Neop | 2008 |
Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer.
Topics: Aged; Choline; Fluorine Radioisotopes; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emissio | 2008 |
Hypoxia regulates choline kinase expression through hypoxia-inducible factor-1 alpha signaling in a human prostate cancer model.
Topics: Animals; Cell Hypoxia; Choline; Choline Kinase; Chromatin Immunoprecipitation; Gene Expression Regul | 2008 |
The value of 18F-choline PET/CT in patients with elevated PSA-level and negative prostate needle biopsy for localisation of prostate cancer.
Topics: Aged; Biopsy, Needle; Choline; False Negative Reactions; Humans; Male; Middle Aged; Positron-Emissio | 2008 |
[(11)C]choline uptake with PET/CT for the initial diagnosis of prostate cancer: relation to PSA levels, tumour stage and anti-androgenic therapy.
Topics: Aged; Androgen Antagonists; Antineoplastic Agents; Carbon Radioisotopes; Choline; Humans; Male; Midd | 2008 |
Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer.
Topics: Analysis of Variance; Carbon Radioisotopes; Choline; Humans; Length of Stay; Lymph Node Excision; Ly | 2008 |
Role of whole-body 18F-choline PET/CT in disease detection in patients with biochemical relapse after radical treatment for prostate cancer.
Topics: Aged; Biopsy; Choline; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pos | 2008 |
Editorial comment on: 11C-choline-positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms.
Topics: Carbon Radioisotopes; Choline; Humans; Lymphatic Metastasis; Male; Neoplasm Staging; Nomograms; Posi | 2008 |
11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms.
Topics: Aged; Carbon Radioisotopes; Choline; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Stagi | 2008 |
Metabolic profiling of transgenic adenocarcinoma of mouse prostate (TRAMP) tissue by 1H-NMR analysis: evidence for unusual phospholipid metabolism.
Topics: Adenocarcinoma; Animals; Biomarkers, Tumor; Choline; Choline Kinase; Disease Models, Animal; Gene Ex | 2008 |
Combined morphological, [1H]-MR spectroscopic and contrast-enhanced imaging of human prostate cancer with a 3-Tesla scanner: preliminary experience.
Topics: Aged; Choline; Citric Acid; Contrast Media; Creatine; Gadolinium; Humans; Image Processing, Computer | 2008 |
A clinical assay for prostatic acid phosphatase using choline phosphate as a substrate: comparison with thymolphthalein phosphate.
Topics: Acid Phosphatase; Choline; Clinical Enzyme Tests; Colorimetry; Humans; Male; Phenolphthaleins; Phosp | 1981 |
Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution.
Topics: Adenocarcinoma; Adult; Aged; Choline; Citrates; Citric Acid; Creatine; Diagnosis, Differential; Huma | 1996 |
Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging.
Topics: Aged; Choline; Citrates; Citric Acid; Creatine; Cryosurgery; Humans; Magnetic Resonance Imaging; Mag | 1996 |
PET imaging of prostate cancer using carbon-11-choline.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Huma | 1998 |
PET imaging of prostate cancer using carbon-11-choline.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Huma | 1998 |
PET imaging of prostate cancer using carbon-11-choline.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Huma | 1998 |
PET imaging of prostate cancer using carbon-11-choline.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Huma | 1998 |
In vivo differential diagnosis of prostate cancer and benign prostatic hyperplasia: localized proton magnetic resonance spectroscopy using external-body surface coil.
Topics: Adult; Aged; Aged, 80 and over; Choline; Citrates; Diagnosis, Differential; Humans; Magnetic Resonan | 1998 |
In vivo proton magnetic resonance spectroscopy of diseased prostate: spectroscopic features of malignant versus benign pathology.
Topics: Aged; Aged, 80 and over; Choline; Citric Acid; Creatine; Diagnosis, Differential; Humans; Inositol; | 1999 |
[Spectroscopic imaging (1H-2D-CSI) of the prostate: sequence optimization and correlation with histopathological results].
Topics: Aged; Choline; Citrates; Creatine; Diagnosis, Differential; Humans; Magnetic Resonance Spectroscopy; | 2000 |
Experience with carbon-11 choline positron emission tomography in prostate carcinoma.
Topics: Aged; Carbon Radioisotopes; Choline; Humans; Lymphatic Metastasis; Male; Middle Aged; Prostatic Neop | 2000 |
Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer.
Topics: Aged; Aged, 80 and over; Animals; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; I | 2001 |
Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells.
Topics: Androgens; Cell Line; Cell Transformation, Neoplastic; Choline; Epithelial Cells; Humans; Male; Neop | 2001 |
Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers.
Topics: Adult; Aged; Animals; Brain Neoplasms; Breast Neoplasms; Choline; Female; Fluorine Radioisotopes; Hu | 2001 |
Development of (18)F-fluoroethylcholine for cancer imaging with PET: synthesis, biochemistry, and prostate cancer imaging.
Topics: Adenosine Triphosphate; Alcohol Oxidoreductases; Animals; Carbon Radioisotopes; Carcinoma, Ehrlich T | 2002 |
PET for prostate cancer imaging: still a quandary or the ultimate solution?
Topics: Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Humans; Male; Prostatic Neoplasms; Radiopharm | 2002 |
Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer.
Topics: Animals; Choline; Fluorine Compounds; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; | 2002 |